PNP 2015-029 

April 27,2015 

U. S. Nuclear Regulatory Commission 

ATTN: Document Control Desk 

Washington, DC 20555-0001 

Entergy Nuclear Operations, Inc. 

Palisades Nuclear Plant 

27780 Blue Star Memorial Highway 

Covert, MI 49043 

Tel 269 7642000 

Jeffery A. Hardy 

Regulatory Assurance Manager 

10 CFR 50.36a 

Subject: 2014 Annual Radioactive Effluent Release and Waste Disposal Report 

Palisades Nuclear Plant 

Docket 50-255 

License No. DPR-20 

Dear Sir or Madam: 

Big Rock Point 

Dockets 50-155 and 72-043 

License No. DPR-6 

Attached are the Entergy Nuclear Operations, Inc. 2014 Annual Radioactive Effluent 

Release and Waste Disposal Reports for Palisades Nuclear Plant (PNP) and Big Rock 

Point (BRP) Independent Spent Fuel Storage Installation (ISFSI). These reports are 

submitted in accordance with 10 CFR 50.36a(a)(2). 

Attachment 1 contains the report for PNP. Attachment 2 contains the report for the 

BRP ISFSI. 

These reports provide a summary of the quantities of radioactive liquid and gaseous 

effluent releases and solid radioactive waste processed during the period of 

January 1, 2014, through December 31 , 2014. 
PNP 2015-029 

Document Control Desk 

Page 2 

This letter contains no new commitments and no revision to existing commitments. 

Sincerely, 

JAH/bed 

Attachment 1: Palisades Nuclear Plant 2014 Radioactive Effluent Release Report 

Attachment 2: Big Rock Point Independent Spent Fuel Storage Installation 2014 

Radioactive Effluent Release Report 

CC Administrator, Region III, USNRC 

Project Manager, Palisades, USNRC (w/o Attachments) 

Resident Inspector, Palisades, USNRC (w/o Attachmens) 

NRC NMSS Project Manager, USNRC (w/o Attachments) 

American Nuclear Insurers (ANI) 
Attachment 1 

Palisades Nuclear Plant 2014 Radioactive Effluent Release Report 

2014 Plant Operating History 

Palisades Nuclear Plant (PNP) entered the reporting period online on January 1 , 2014, 

at nominal full power (NFP). PNP commenced a controlled shutdown on January 19, 

2014, for refueling outage 1 R23. The unit attained criticality on March 15, 2014, and 

returned to NFP on March 18, 2014. PNP performed a planned shutdown on June 20, 

2014, to address P-50C Primary Coolant Pump mechanical seal leakage. The unit 

attained criticality on June 26, 2014, and returned to NFP on June 30, 2014. PNP was 

on line for the remainder of 2014. The unit generated 5,830,363 MWHrs of net 

electrical energy during 2014. 

A. Gaseous Effluents 

Tables 1 A, "Gaseous Effluents - Summation of All Discharges," 1 B, "Gaseous 

Effluents - Ground-Level Release - Batch Mode," and 1 C, "Gaseous Effluents -

Ground-Level Release - Continuous Mode," list and summarize gaseous effluents 

released during this reporting period. 

B. Liquid Effluents 

Tables 2A, "Liquid Effluents - Summation of All Discharges," 2B, "Liquid Effluents -

Batch Mode," and 2C, "Liquid Effluents - Continuous Mode," list and summarize 

liquid effluents released during this reporting period. 

C. Solid Waste Storage and Shipments 

Table 3, "Low-Level Waste for Waste Classification A, Band C, summarizes solid 

radioactive waste shipped for processing or burial in 2014 for the following waste 

streams: resins, filters and evaporator bottoms, dry active waste, irradiated 

components and other waste. 

D. Dose Assessments 

Tables 4, "Dose Assessments, 10 CFR Part 50, Appendix 1," and 5, "EPA 

40 CFR Part 190, Individual in the Unrestricted Area," lists annual dose to the 

members of the public. 

Page 1 of 8 
E. Supplemental Information 

1. Regulatory Limits 

a. Noble Gases 

The air dose in unrestricted areas due to noble gas released in 

gaseous effluents shall be limited to the following: 

• During the calendar quarter, to :s; 5 mrad for gamma radiation 

and :5 10 mrad for beta radiation. 

• During the calendar year, to :s; 10 mrad gamma radiation and 

:s; 20 mrad for beta radiation. 

b. lodines - Particulates 

The dose to a member of the public from radioiodines, radioactive 

material in particulate form with half-lives greater than eight days, 

and radionuclides other than noble gas, e.g., tritium, in gaseous 

effluents released to unrestricted areas shall be limited to the 

following: 

• During any calendar quarter, to :s; 7.5 mrem to any organ 

• During any calendar year, to :s; 15 mrem to any organ 

c. Liquid Effluents 

The dose or dose commitment to an individual from radioactive 

material in liquid effluents released to unrestricted areas shall be 

limited to the following: 

• During any calendar quarter to :s; 1.5 mrem to the total body and 

:s; 5 mrem to any organ. 

• During any calendar quarter to :s; 3 mrem to the total body and :s; 

10 mrem to any organ. 

d. Total Dose 

The dose or dose commitment to a real individual from all uranium 

fuel cycle sources is limited to :s; 25 mrem to the total body or any 

organ (except the thyroid, which is limited to :5 75 mrem) over a 

period of 12 consecutive months. 

Page 2 of 8 
2. Maximum Permissible Concentrations (Effluent Concentration Limits) 

a. Gaseous Effluents 

The dose rate due to radioactive material released in gaseous 

effluents from the site shall be limited to the following: 

• For noble gases: s 500 mrem/yr to the total body and S 3000 

mrem/yr to the skin. 

• For all radioiodines and for all radioactive materials in 

particulate form with half-lives greater than eight days and for 

radionuclides other than noble gases: s 1500 mrem/yr to any 

organ. 

The above limits are provided to ensure that radioactive material 

discharged in gaseous effluents will not result in the exposure of an 

individual in an unrestricted area to annual average concentrations 

exceeding the limits of 10 CFR 20, Appendix B, Table 2, Column 1. 

b. Liquid Effluents 

The concentration of radioactive material released at any time from the 

site to unrestricted areas shall be limited to the concentrations 

specified in 10 CFR 20, Appendix B, Table 2, Column 2, for 

radionuclides other than dissolved or entrained noble gases. For 

dissolved or entrained noble gases, the concentration shall be limited 

to 2E-4 jJCilml total activity. 

3. Average Energy 

The average energy ( E) of the radionuclide mixture in releases of fission and 

activation gases as defined in Regulatory Guide 1.21, Appendix B, Section 

A.3 is not applicable because the limits used for gaseous releases are based 

on calculated dose to members of the public. 

4. Measurements and Approximations of Total Radioactivity 

Palisades upgraded to a 8192 channel analyzer from a 4096 channel 

analyzer in the second quarter of 2014. 

a. Fission and activation gases are sampled and then analyzed on a 

8192 channel analyzer with a high purity germanium (HpGe) 

detector. 

b. lodines are sampled and then analyzed on a 8192 channel 

analyzer with a HpGe detector. 

Page 3 of 8 
c. Particulates are sampled and then analyzed on a 8192 channel 

analyzer with a HpGe detector. 

d. Liquid effluents are sampled and then analyzed on a 8192 channel 

analyzer with a HpGe detector. Tritium analysis is performed using 

liquid scintillation. Fe-55, Ni-63, Sr-89, and Sr-90 analyses are 

performed by an offsite vendor. 

5. Batch Releases - 2014 

For PNP, these totals are not directly proportional to actual release volumes 

due to PNP having two sets of tanks with different volumes in both the 

gaseous and liquid release systems that are utilized for batch releases. The 

number of batches performed in this section will fluctuate from year to year 

due to the utilization of the smaller and larger tanks in different frequencies. 

This information is better quantified in the tables contained later in this 

report. Reporting average stream flow during periods of release of effluent 

into a flowing stream is not required as PNP's releases are made into Lake 

Michigan, and not a flowing stream of water. 

a. Liquid 

Number of batch releases for each quarter: 5 in the 18t quarter 

6 in the 2nd quarter 

2 in the 3rd quarter 

1 in the 4th quarter 

Total time period for batch releases: 15222 minutes 

Maximum time period for a batch release: 2409 minutes 

Average time period for a batch release: 1087.2 minutes 

Minimum time period for a batch release: 170 minutes 

b. Gaseous 

Number of batch releases for each quarter: 11 in the 18t quarter 

11 in the 2nd quarter 

1 in the 3rd quarter 

1 in the 4th quarter 

Page 4 of 8 
Total time period for batch releases: 7637 minutes 

Maximum time period for a batch release: 2317 minutes 

Average time period for a batch release: 318 minutes 

Minimum time period for a batch release: 62 minutes 

6. Abnormal Discharges 

a. Liquid 

Number of releases for each quarter 

1 st Quarter 2nd Quarter 3rd Quarter 4th Quarter 

o 0 0 0 

Total activity released in Curies (Ci) 

1 st Quarter 2nd Quarter 3rd Quarter 4th Quarter 

o 0 0 0 

b. Gaseous 

Number of releases for each quarter 

1 st Quarter 2nd Quarter 3rd Quarter 4th Quarter 

o 0 0 0 

Total activity released in Curies (Ci) 

1 st Quarter 2nd Quarter 3rd Quarter 4th Quarter 

o 0 0 0 

7. Non-Routine Planned Discharges 

None. 

8. Radioactive Waste Treatment System Changes 

None. 

9. Annual Land Use Census Changes 

The garden critical receptor is unchanged and remains located in the SSE 

sector at .69 miles. The residence critical receptor has changed and is now 

located in the SSW sector at 0.49 miles. The goats are now located in the 

NE sector at 2.45 miles and are fed stored feed. Beef cattle remain located 

in the SE sector at 4.27 miles. There are no dairy cows located within five 

miles of the plant. 

Page 5 of 8 
10. Effluent Monitoring System Inoperability 

Three effluent monitors were out of service for greater than 30 days during 

the reporting period. 

RIA-0631, condenser off-gas monitor, was declared inoperable on 

November 5,2013, due to failing to respond to a source check during 

performance of MR-14, Process Monitor Function Checks - Monthly. 

Compensatory sampling was initiated per the ODCM. Troubleshooting 

remained in progress entering 2014. Compensatory actions were performed 

until the monitor was returned to service on March 6, 2015. 

RIA-5211, turbine building sump effluent monitor was out of service for two 

separate periods of greater than 30 days. The monitor was initially declared 

non-functional on February 7, 2014, after displaying a false high reading. 

Compensatory sampling was initiated in accordance with the ODCM until the 

monitor was declared functional on March 19, 2014. RIA-5211 was then 

removed from service on March 23, 2014, due to the return of false high 

readings. Compensatory daily sampling was performed until the monitor was 

returned to service on June 6, 2014. 

RIA-1113, waste gas discharge monitor, was declared inoperable on 

March 26, 2014, due to failing to meet acceptance criteria during a source 

check following calibration. Compensatory sampling was initiated per the 

ODCM, and continued until RIA-1113 was returned to service on 

October 14, 2014. The extended delay was caused by a parts issue. 

11. Offsite Dose Calculation Manual (ODCM) Changes 

The Offsite Dose Calculation Manual and Offsite Dose Calculation Manual 

Appendix A were revised in 2014 to update 1 O-year X/Q data. The General 

Manager Plant Operations approval is documented on the procedure cover 

page. The description and evaluation of the changes are documented on 

the Offsite Dose Calculation Manual Change Reviews and are supplied with 

the copies of the revisions. These revisions did not reduce the accuracy or 

reliability of dose calculations or setpoint determinations. Enclosure 1 

contains a copy of the ODCM revision with changes indicated by marginal 

markings. 

12. Process Control Program Changes 

None. 

13. Errata/Corrections to Previous Reports 

None. 

Page 6 of 8 
14. Other 

Groundwater Monitoring 

PNP has 21 ground water monitoring wells (MW) strategically placed within 

the owner controlled area to allow for detection of radioactive contamination 

of ground water due to leaks or spills from plant systems, four of which were 

installed in December, 2014, for monitoring starting in 2015. PNP added 18 

temporary wells (TW) in 2009 to determine the potential source of tritium in 

groundwater in the vicinity of MW-3. Tanks T-90, primary makeup tank, 

T-91, utility water storage tank, and associated underground piping between 

these tanks and the auxiliary building addition are in this area. TW-15 is 

most indicative of a historic leak that continues to be monitored and 

addressed through piping repairs. 

Tritium levels in TW-15 trended downward until October, 2014, when tritium 

peaked at 101,000 pCi/L due to washout from rising groundwater levels. No 

indications were present of any new underground piping leaks in 2014. 

Monitoring of the groundwater tritium plume continues to assess repair 

effectiveness and follow the site hydrology data. Well locations are depicted 

in Figure 1. 

Depth to Local Water Table - The depth is approximately eight to nine feet. 

Classification of Subsurface Aquifers - Not used for drinking water. 

Expected MovemenUMobility of Groundwater Plume - Westerly direction 

down-gradient toward Lake Michigan at approximately two feet per day. 

Land Use Characteristics - PNP site property, water not used for drinking or 

irrigation. 

NRC Notification, Date and contact Organization - The NRC was notified on 

December 10,2007, by PNP. 

Page 7 of 8 
Carbon-14 

In 2010, PNP and other facilities participated in an EPRI task force to build a 

model to accurately estimate gaseous C-14 releases, given some key sitespecific plant parameters (mass of the primary coolant, average thermal 

neutron cross section, rated MW, etc). This work was completed in 

November 2010. The estimates for C-14 were constructed using the 

aforementioned EPRI methodology contained with EPRI 1021106, 

Estimation of Carbon-14 in Nuclear Power Plant Gaseous Effluents. Using 

the C-14 curie estimates, the annual dose to man was derived from 

guidance contained within Regulatory Guide 1.109. Because the dose 

contribution of C-14 from liquid radioactive waste is much less than that 

contributed by gaseous radioactive waste, evaluation of C-14 in liquid 

radioactive waste is not required. 

Annual C-14 release PNP and subsequent doses for 2014: 

Total Gaseous C-14 Released Curies = 

Gaseous C-14 as C02 Curies = 

Effective Child TB Dose, C-14 mrem = 

Effective Child Bone Dose, C-14 mrem = 

7.11 

2.13 

0.052 

0.26 

The quarterly curies released are provided in Table 1 B. Airborne doses due 

to C-14 are grouped under the category of Particulate, Iodine, and Tritium 

which are contained in Table A-4. 

Meteorological Data 

Meteorological Data recovery was at 97.05%. The two most frequently 

occurring directions for the year at the 10 meter level were SSE and SE, 

accounting for over 21 % of all observations. At 60 meters, the two 

predominant directions were Sand SW, accounting for over 17% of all 

observations. The highest average speeds were associated with ESE winds 

at 10 meters and W winds at 60 meters. The mean speed for all directions at 

10 meters was 3.17 mls (7.09 mph), and at 60 meters was 6.03 mls (13.49 

mph). When compared to last year, the 10 meter average is 0.09 mls (0.20 

mph) lower while the 60 meter average is 0.02 mls (0.04mph) lower. Data 

from this report and the annual meteorological data (Hourly Average Data or 

Joint Frequency Distribution) will be maintained on site in a file that shall be 

provided to the NRC upon request. 

Page 8 of 8 
FIGURE 1 

GROUNDWATER MONITORING WELL LOCATIONS 

figum4.t 

Page 1 of 1 
Summation of 

All Releases Units 

Fission and 

Activation 

Gases Ci 

Average 

Release Rate 

% of Limit 

1-131 

Average 

Release Rate 

0/0 of Limit 

Particulates 

Average 

Release Rate 

0/0 of Limit 

Tritium 

Average 

Release Rate 

0/0 of Limit 

Gross Alpha 

Average 

Release Rate 

0/0 of Limit % 

ATTACHMENT 1 

Palisades - Table 1A 

2014 Gaseous Effluents - Sum of All Releases 

Quarter 1 Quarter 2 Quarter 3 Quarter 4 

6.2BE+OO 1.S1 E+OO S.B7E-01 1.46E+OO 

7.B7E-01 1.91 E-01 7.20E-02 1.7SE-01 

B.99E-03 7.2BE-04 9.73E-04 1.71 E-03 

1.24E-04 3.26E-OS 4.76E-OS 3.36E-OS 

1.S9E-OS 4.1SE-06 S.99E-06 4.22E-06 

1.B2E-07 4.73E-OB 6.B3E-OB 4.B1 E-OB 

7.79E-06 7.30E-06 2.34E-07 1.03E-02 

1.00E-06 B.4SE-07 2.34E-OB 1.S4E-07 

2.2BE-07 7.90E-07 S.34E-09 7.02E-07 

4.3SE+OO 3.0BE+OO 1.SSE+OO 1.9BE+OO 

S.60E-01 3.91 E-01 1.9SE-01 2.49E-01 

1.2BE-03 B.92E-04 4.44E-04 S.6BE-04 

NO NO NO 

.7BE+OO 1.7BE+OO 1.7BE+OO 1.7BE+OO 

2.29E-01 2.26E-01 2.24E-01 2.24E-01 

1.74E-06 1.72E-06 1.70E-06 1.70E-06 

Page 1 of 1 

Uncertainty Total (%) 

9.B4E+OO B.7B 

3.12E-01 

3.07E-03 

2.3BE-04 

7.S4E-06 

B.S9E-OB 

1.03E-02 

3.2BE-04 

4.31 E-07 

1.10E+01 

3.47E-01 

7.92E-04 

9.66E-07 

7.12E+OO 

2.26E-01 

1.72E-06 
ATTACHMENT 1 

Palisades - Table 1 B 

2014 Gaseous Effluents - Ground Level Release, Continuous Mode 

Fission and Activation Units 

Gases 

Ar-41 Ci 

Kr-85 Ci 

Kr-85m Ci 

Kr-87 Ci 

Kr-88 Ci 

Xe-131m Ci 

Xe-133 Ci 

Xe-133m Ci 

Xe-135 Ci 

Xe-135m Ci 

Xe-138 Ci 

Total Ci 

lodines/Halogens Units 

1-131 Ci 

1-132 Ci 

1-133 Ci 

1-134 Ci 

1-135 Ci 

Total Ci 

Particulates Units 

Co-58 Ci 

Co-6O Ci 

Na-24 Ci 

Cr-51 Ci 

Mn-56 Ci 

Y-88 Ci 

Sr-92 Ci 

Cs-138 Ci 

Nb-95 Ci 

Zr-95 Ci 

Mn-54 Ci 

Ag-110m Ci 

Total Ci 

I Tritium I Ci 

I Gross Alpha I Ci 

I C-14 I Ci 

NO = Measurements performed but no activity detected. 

NA = Analysis not required & not performed 

Quarter 1 Quarter 2 

3.59E-02 NO 

NO NO 

NO NO 

NO NO 

NO NO 

1.74E-03 5.75E-03 

8.46E-01 9.92E-01 

NO 6.99E-03 

7.61 E-03 1.66E-02 

NO NO 

NO NO 

8.91 E-01 1.02E+OO 

Quarter 1 Quarter 2 

1.52E-08 1.52E-06 

NO 8.28E-07 

2.88E-06 1.49E-06 

NO NO 

NO NO 

2.90E-06 3.84E-06 

Quarter 1 Quarter 2 

NO 4.90E-06 

8.71E-11 1.10E-06 

NO NO 

NO NO 

NO NO 

NO NO 

NO NO 

NO NO 

NO 6.41 E-07 

NO 3.87E-07 

NO 8.27E-08 

NO 2.71 E-07 

8.71 E-11 7.38E-06 

I 3.12E-02 I 4.97E-01 I 

I 4.83E-07 I NO 

I NA NA 

Page 1 of 1 

Quarter 3 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

O.OOE+OO 

Quarter 3 

NO 

NO 

NO 

NO 

NO 

O.OOE+OO 

Quarter 3 

1.86E-07 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

NO 

4.79E-08 

NO 

NO 

2.34E-07 

NO 

NO 

NA' 

Quarter 4 

NO 

NO 

NO 

NO 

NO 

NO 

1.57E-04 

NO 

NO 

NO 

NO 

1.57E-04 

Quarter 4 

NO 

NO 

NO 

NO 

NO 

O.OOE+OO 

Quarter 4 

NO 

1.22E-06 

NO 

NO 

NO 

9.34E-03 

NO 

9.80E-04 

NO 

NO 

NO 

NO 

1.03E-02 

NO 

NO 

NA 
ATTACHMENT 1 

Palisades - Table 1 C 

2014 Gaseous Effluents - Ground Level Release, Continuous Mode 

Fission and Activation Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 

Gases 

Ar-41 Ci 1.96E+OO 9.39E-02 1.98E-01 1.33E-01 

Kr-85 Ci NO NO NO NO 

Kr-85m Ci 8.87E-03 1.02E-04 2.44E-03 4.18E-02 

Kr-87 Ci 6.33E-02 2.43E-02 2.98E-02 1.07E-01 

Kr-88 Ci 4.59E-01 1.95E-02 2.09E-02 9.28E-02 

Xe-131m Ci NO NO NO NO 

Xe-133 Ci 6.91 E-02 4.71 E-02 1.12E-02 1.36E-01 

Xe-133m Ci NO NO NO NO 

Xe-135 Ci 2.06E+OO 1.32E-01 1.46E-01 3.90E-01 

Xe-135m Ci 3.46E-01 9.19E-03 1.94E-03 6.91 E-03 

Xe-137 Ci 1.67E-01 NO 1.43E-02 6.86E-02 

Xe-138 Ci 2.63E-01 1.58E-01 1.62E-01 4.85E-01 

Total Ci 5.39E+OO 4.84E-01 5.87E-01 1.46E+OO 

lodines/Halogens Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 

1-131 Ci 1.24E-04 3.11 E-05 4.76E-05 3.36E-05 

1-132 Ci 1.13E-03 1.51 E-05 NO NO 

1-133 Ci 1.02E-04 4.85E-05 8.68E-05 1.00E-04 

1-134 Ci NO NO NO NO 

1-135 Ci NO NO NO NO 

Total Ci 1.36E-03 9.48E-05 1.34E-04 1.34E-04 

Particulates Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 

Co-58 Ci 7.79E-06 NO NO NO 

Co-60 Ci NO NO NO NO 

Mn-54 Ci NO NO NO NO 

Cr-51 Ci NO NO NO NO 

Co-57 Ci NO NO NO NO 

Nb-95 Ci NO NO NO NO 

Zr-95 Ci NO NO NO NO 

Ag-110m Ci NO NO NO NO 

Sn-113 Ci NO NO NO NO 

Sb-125 Ci NO NO NO NO 

Cs-137 Ci NO NO NO NO 

Ce-144 Ci NO NO NO NO 

Total Ci 7.79E-06 O.OOE+OO O.OOE+OO O.OOE+OO 

I Tritium I Ci 4.32E+OO I 2.58E+OO I 1.55E+OO I 1.98E+OO I 

I Gross Alpha I Ci 4.83E-071 O.OOE+OO I O.OOE+OO I O.OOE+OO I 

I C-14 I Ci 1.78E+OO I 1.78E+OO I 1.78E+OO I 1.78E+OO I 

NO = Measurements performed but no activity detected. 

Page 1 of 1 
ATTACHMENT 1 

Palisades - Table 2A 

2014 Liquid Effluents - Sum of All Releases 

Summation of All Uncertainty Liquid Releases Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 Total 

Fission and 

Activation Products 

(excluding tritium, 

gases, and gross 

al Ci 1.02E-02 B.9BE-03 1.59E-03 1.4BE-04 2.09E-02 6.54 

Average 

Concentration Cilml 5.B5E-10 2.42E-10 3.97E-11 3.BOE-12 1.57E-10 

0/0 of Limit 4.91 E-03 4.0BE-03 7.01 E-04 9.25E-05 2.01 E-03 

Tritium 7.B9E+01 3.79E+01 9.64E+01 2.73E+01 2.40E+02 

Average 

Concentration Cilml 4.52E-06 1.02E-06 2.40E-06 7.02E-07 1.BOE-06 

0/0 of Limit 0/0 4.52E-01 1.02E-01 2.40E-01 7.02E-02 1.BOE-01 

Dissolved and 

Entrained Gases Ci B.66E-05 O.OOE+OO O.OOE+OO O.OOE+OO B.66E-05 

Average 

Concentration 4.96E-12 O.OOE+OO O.OOE+OO O.OOE+OO 6.49E-13 

% Of Limit 2.4BE-06 O.OOE+OO O.OOE+OO O.OOE+OO 3.24E-07 

0.00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 

Volume of Primary 

System Liquid 

Effluent (Before 

Dilution Liters B.06E+05 7.21 E+05 3.B3E+05 1.45E+05 2.05E+06 

Dilution Water Used 

for Above Liters 1.74E+10 3.71 E+1 0 4.01 E+10 3.BBE+10 1.33E+11 

Volume of 

Secondary or 

Balance-of-Plant 

Liquid Effluent (e.g., 

low-activity or 

unprocessed) 

Before Dilution Liters 5.94E+09 B.23E+09 1.02E+10 B.01E+09 3.24E+10 

Average Stream 

Flow m3/s 2.24E+00 4.71E+00 5.05E+00 4.BBE+00 4.22E+00 

Dilution flow rate (gal/qtr) = # of Dilution pumps running x days running/qtr x 40,000 gpm/pump x min/day 

Page 1 of 1 
Fission and Activation 

Products 

Cr-51 

Mn-54 

Fe-55 

Fe-59 

Co-57 

Co-58 

Co-60 

Sr-89 

Sr-90 

Nb-95 

Ag-110m 

Sn-113 

Sb-124 

Sb-125 

1-131 

1-133 

1-135 

Cs-134 

Cs-137 

Ni-63 

Zn-65 

Zr-95 

La-140 

Totals 

Dissolved and 

Entrained Gases 

Kr-85 

Kr-85m 

Kr-88 

Xe-131m 

Xe-133 

Xe-133m 

Xe-135 

Xe-135m 

Totals 

I Tritium 

I Gross Alpha 

ND = None Detected 

ATTACHMENT 1 

Palisades - Table 2B 

2014 liquid Effluents - Batch Mode 

Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 

Ci ND ND ND ND 

Ci ND ND 3.78E-05 ND 

Ci 1.33E-04 ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci 6.60E-03 4.23E-03 7.44E-04 3.74E-05 

Ci 1.20E-03 1.05E-03 5.13E-04 9.40E-05 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci 1.38E-04 2.10E-04 ND ND 

Ci 5.60E-04 1.02E-03 2.72E-04 1.62E-05 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci 4.20E-04 9.21 E-04 ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND 7.36E-04 2.64E-05 ND 

Ci 1.14E-03 8.14E-04 ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci 1.02E-02 8.98E-03 1.59E-03 1.48E-04 

Units Quarter 1 Quarter 2 Quarter 3 Quarter 4 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci 8.66E-05 ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

Ci ND ND ND ND 

8.66E-05 O.OOE+OO O.OOE+OO O.OOE+OO 

Ci 7.89E+01 3.79E+01 9.64E+01 2.46E+01 

ND ND ND ND 

Page 1 of 1 
Fission and Activation 

Products 

Cr-51 

Mn-54 

Fe-55 

Fe-59 

Co-57 

Co-58 

Co-60 

Sr-89 

Sr-90 

Nb-95 

Ag-110m 

Sn-113 

Sb-124 

Sb-125 

1-131 

1-133 

1-135 

Cs-134 

Cs-137 

Ni-63 

Zn-65 

Zr-95 

La-140 

Totals 

Dissolved and 

Entrained Gases 

Kr-85 

Kr-85m 

Kr-88 

Xe-131m 

Xe-133 

Xe-133m 

Xe-135 

Xe-135m 

Totals 

I Tritium 

I Gross Alpha 

N D = None Detected 

ATTACHMENT 1 

Palisades - Table 2C 

2014 liquid Effluents - Continuous Mode 

Units Quarter 1 Quarter 2 Quarter 3 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci O.OOE+OO O.OOE+OO O.OOE+OO 

Units Quarter 1 Quarter 2 Quarter 3 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

Ci ND ND ND 

O.OOE+OO O.OOE+OO O.OOE+OO 

I Ci ND 2.16E-02 3.02E-02 

I Ci ND ND ND 

Page 1 of 1 

Quarter 4 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

O.OOE+OO 

Quarter 4 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

ND 

O.OOE+OO 

2.67E+OO 

ND 
ATTACHMENT 1 

Palisades - Table 3 

2014 Low-Level Waste 

1. Solid waste shipped offsite for burial or disposal (not irradiated 

fuel) 

1. Type of waste Unit Estimated amount 

a. Spent resin, filters, m;j 1.38E+01 

evaporator bottoms, etc. Curies 3.01E+00 

b. Dry compressible waste, m;j 3.27E+02 

contaminated equipment, etc. Curies 5.41 E+OO 

c. Irradiated components, m;j O.OOE+OO 

control rods, etc. Curies O.OOE+OO 

d. Other (describe) m;j 2.34E+01 

DAW / Metal Waste / Oil Curies 1.22E-02 

2. Estimate of Major Nuclide composition (by type of waste), list 

nuclides as needed 

a. Fe-55 5.50/0 Ag-110m 5.1%) 

Co-58 11 % Sb-125 3.6% 

Co-60 30% Cs-137 2.8%) 

Ni-63 390/0 

b. Cr-51 130/0 Ni-63 60/0 

Fe-55 4% Zr-95 5% 

Co-58 39% Nb-95 8% 

Co-60 13.50/0 Ag-110m 4% 

c. 

d. C-14 2% Co-60 17% 

Cr-51 7% Ni-63 80/0 

Mn-54 1 % Zr-95 50/0 

Fe-55 12% Nb-95 8% 

Co-58 28% Ag-110m 5% 

Page 1 of 2 

Est Total 

Error, % 

25 

25 

0 

25 

Cs-137 10/0 

Cm-243 1 % 
3. Solid waste disposition 

N umber of shipments 

1 

20 

1 

ATTACHMENT 1 

Palisades - Table 3 

2014 Low-Level Waste 

Mode of transportation 

Truck 

Destination 

Kingston, Tn 

Truck Oakridge, Tn 

Truck Erwin, Tn 

Irradiated fuel shipments (disposition) 

Number of shipments 

o 

Mode of transportation 

N/A 

Page 2 of 2 

Destination 

N/A 
ATTACHMENT 1 

Palisades - Table 4 

2014 Dose Assessments, 10 CFR Part 50, Appendix I 

Quarter 1 Quarter 2 Quarter 3 Quarter 4 Yearly 

Liquid Effluent Dose Limit, Total 1.5 mrem 1.5 mrem 1.5 mrem 1.5 mrem 3 mrem 

Body 

Total Body Dose 1.37E-03 1.31 E-03 2.99E-04 5.47E-05 3.03E-03 

0/0 Of Limit 0.09%) 0.090/0 0.02% 0.00% 0.10% 

Liquid Effluent Dose Limit, Any 5 mrem 5 mrem 5 mrem 5 mrem 10 mrem 

Organ 

Organ Dose 2.65E-03 2.33E-03 2.97E-04 5.58E-05 5.33E-03 

% of Limit 0.05% 0.05%) 0.010/0 0.00% 0.050/0 

Gaseous Effluent Dose Limit, 5 mrad 5 mrad 5 mrad 5 mrad 10 mrad 

Gamma Air 

Gamma Air Dose 2.49E-03 2.50E-04 3.04E-04 6.41 E-04 3.69E-03 

0/0 of Limit 0.05% 0.01 % 0.01 0/0 0.01 % 0.04% 

Gaseous Effluent Dose Limit, 10 mrad 10 mrad 10 mrad 10 mrad 20 mrad 

Beta Air 

Beta Air Dose 1.33E-03 1.99E-04 1.72E-04 4.52E-04 2.15E-03 

0/0 of Limit 0.013% 0.0020/0 0.002% 0.005% 0.011 % 

Gaseous Effluent Dose Limit, Any 7.5 mrem 7.5 mrem 7.5 mrem 7.5 mrem 15 mrem 

Organ (Iodine, Tritium, 

Particulates with >8 day half-life) 

Gaseous Effluent Organ Dose 1.18E-02 3.83E-03 3.69E-03 2.22E-02 4.16E-02 

(Iodine, Tritium, Particulates with 

>8-Day half-life) 

% of Limit 0.16% 0.050/0 0.05% 0.300/0 0.28% 

Palisades - Table 5 

2014 EPA 40 CFR Part 190, Individual in the Unrestricted Area 

Whole Body Thyroid Any Other Organ 

Dose Limit 25 mrem 75 mrem 25 mrem 

Dose 1.51 E-01 2.01 E-02 5.33E-03 

0/0 of Limit 0.61% 0.03% 0.02% 

Page 1 of 1 
ENCLOSURE 1 

PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL, REVISION 26 

OFFSITE DOSE CALCULATION MANUAL APPENDIX A, REVISION 18 

144 Pages Follow 
ENCLOSURE 1 

PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL, REVISION 26 

OFFSITE DOSE CALCULATION MANUAL APPENDIX A, REVISION 18 

78 Pages Follow 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

ODCM 

Revision 26 

Issued Date 7/30/14 

TITLE: OFFSITE DOSE CALCULATION MANUAL 

I Process Applicability Exclusion D 

AKGennrich 1 7/30/14 

Procedure Sponsor Date 

MESoja 1 6/22/14 

Technical Reviewer Date 

CLJones 1 7/29/14 

User Reviewer Date 

ALWiliiams 1 7/29/14 

General Manager Plant Operations Date 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

Table of Contents 

I. GASEOUS EFFLUENTS ............................................................................................... 1 

A. ALARMITRIP SETPOINT METHOD .............................................................. 1 

1. Allowable Concentration ................................... 2 

2. Monitor Response ............................................. 3 

B. DOSE RATE CALCULATION ........................................................................ 4 

C. GASEOUS RADWASTE TREATMENT SYSTEM OPERATION ................. 19 

1. System Description ......................................... 19 

2. Determination of Satisfactory Operation ....... 19 

D. RELEASE RATE FOR OFFSITE EC ........................................................... 20 

E. PARTICULATE AND IODINE SAMPLING .................................................. 20 

F. NOBLE GAS SAMPLING ............................................................................ 21 

G. TRITIUM SAMPLING ................................................................................... 21 

H. FIGURE - GASEOUS EFFLUENTS FLOW PATHS ................................... 22 

II. LIQUID EFFLUENTS ................................................................................................... 23 

A. CONCENTRATION ...................................................................................... 23 

1. Requirements ................................................... 23 

2. Prerelease Analysis ......................................... 23 

3. Effluent Concentration (EC) - Sum of the 

Ratios ................................................................ 24 

B. INSTRUMENT SETPOINTS ......................................................................... 25 

1. Setpoint Determination ................................... 25 

2. Composite Samplers ....................................... 25 

3. Post-Release Analysis .................................... 26 

C. DOSE ........................................................................................................... 26 

1. RETS Requirement .......................................... 26 

2. Release Analysis ............................................. 26 

D. OPERABILITY OF LIQUID RADWASTE EQUIPMENT .............................. 30 

E. RELEASE RATE FOR OFFSITE EC (50 MREMNR) .................................. 30 

F. FIGURES ..................................................................................................... 31 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

Table of Contents 

III. URANIUM FUEL CYCLE DOSE .................................................................................. 33 

A. SPECiFiCATION .......................................................................................... 33 

B. ASSUMPTIONS ........................................................................................... 33 

C. DOSE CALCULATION ................................................................................ 34 

IV. SOURCE REFERENCE DOCUMENTS ....................................................................... 34 

Attachment 1, 

Attachment 2, 

Attachment 3, 

Attachment 4, 

Attachment 5, 

Attachment 6, 

Attachment 7, 

Attachment 8, 

Attach ment 9, 

"Palisades Gaseous And Liquid Source Terms, CurieslYear" 

"Basic RadionuC/ide Data" 

"Dose Factors for Submersion in Noble Gases" 

"Stable Element Transfer Data" 

"Inhalation Dose Commitment Factors" 

"External Dose Factors for Standing on Contaminated Ground (DFGi) 

(mrem/hr per pCilm2)" 

"Bioaccumulation Factors (jJCilgm per jJCilml)" 

"Ingestion Dose Commitment Factors" 

"Palisades 1 0 Year X/Q - D/Q Data" 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

I. GASEOUS EFFLUENTS 

A. ALARM/TRIP SETPOINT METHOD 

Appendix A, Section I/I.B.1 requires that the dose rate due to radioactive materials 

released in gaseous effluents from the site to areas at and beyond the SITE 

BOUNDARY shall be limited to the following: 

For noble gases: Less than or equal to 500 mrems/yr to the total body and 

less than or equal to 3000 mrems/yr to the skin, and 

For iodine-131, for iodine-133, for tritium, and for all radionuclides in 

particulate form with half lives greater than 8 days: Less than or equal to 

1500 mrems/yr to any organ. 

Appendix A, Section /I I.A.1 requires gaseous effluent monitors to have alarm/trip 

setpoints to ensure that offsite concentrations, when averaged over 1 hour, will not 

be greater than Appendix A, Section I/I.B.1. This section of the aDeM describes the 

methodology that will be used to determine these setpoints. 

The methodology for determining alarm/trip setpoints is divided into two major parts. 

The first consists of calculating an allowable concentration for the nuclide mixture to 

be released. The second consists of determining monitor response to this mixture in 

order to establish the physical settings on the monitors. 

1 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

1. Allowable Concentration 

NOTE: If a batch release is made while a continuous release or another batch release is 

in progress, the sum of all values of Rk must be less than 10.0. 

The total EC-fraction (Rk) for each release point will be calculated by the 

relationship defined by Note 4 of Appendix B, 10 CFR 20: 

(1.1 ) 

where: 

Cj = Actual or measured concentration, at ambient temperature and 

pressure of nuclide i (/-lCilcc) 

ECj = The EC of nuclide i from 10 CFR 20, Appendix B, Table 2 

R(k) = The total EC-fraction for release point k 

X/Q = Most conservative sector site boundary dispersion (sec/m3) 

(listed in site procedure CH 6.41, "Land Use Census") 

F = Release flow rate (83,000 cfm = 39.2 m3

/sec) for stack monitor 

considerations; variable for other monitors 

2 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

2. Monitor Response 

Normal radioactivity releases consist mainly of well-decayed fission gases. 

Therefore, monitor response calibrations are performed to fission gas typical 

of normal releases (mainly Xe-133). Response of monitors used to define 

fission product release rates under accident conditions may vary from that of 

Xe-133, however. Monitor response for the two categories of monitor is 

determined as follows: 

a. Normal Release (aged fission gasses) 

Total gas concentration (IlCilcc) at the monitor is calculated. The 

detector response to isotopic activities (cpmIIlCilcc) is applied to 

determine cpm expected. The setting for monitor alarms is established 

at some factor (b) greater than 1 but less than 1 IRk (Equation 1.1) 

times the measured concentration (c): 

s=bxc 

b. Accident Releases 

Monitors are preset to alarm at or before precalculated offsite dose 

rates would be achieved under hypothetical accident conditions. 

(1.2) 

These setpoints are established in accordance with Emergency Plan 

requirements for defining Emergency Action Levels and associated 

actions. Emergency Implementing Procedures contain 

monitor-specific curves or calibration constants for conversion between 

cpm and IlCilcc (or Rlhr and IlCilcc), depending on monitor type, for 

fission product mixtures as a function of mixture decay time. 

When these monitors are utilized for other than accident conditions, 

either an appropriately decayed "accident" conversion curve may be 

used, or a decayed fission gas calibration factor may be applied. In 

these cases, setpoints are established as in 1.A above. 

Setpoints of accident monitors (if set to monitor normal releases) are 

reset to the accident alarm settings at the end of normal release. 

Setpoints of other release monitors are maintained at the level used at 

the latest release (well below the level which would allow 10 times EC 

to be'exceeded at the site boundary), or are reset to approximately 

three times background in order to detect leakage or inadvertent 

releases of low level gases. 

3 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

B. DOSE RATE CALCULATION 

1. Dose rates are calculated for (1) noble gases and (2) iodines and particulates. 

Dose rates as defined in this section are based on 10 CFR 50 Appendix I 

limits of mrem per quarter and millirem per year. All dose pathways of major 

importance in the Palisades environs are considered. NRCDose is the 

Effluent Dose Calculation software that supports LADTAP, GASPAR, and 

XOQDOQ which perform the actual dose calculations using the equations 

supplied here. 

a. Equations and assumptions for calculating doses from noble gases are 

as follows: 

1) Assumptions 

a) Doses to be calculated are the maximum offsite point in 

air, total body and skin. 

b) Exposure pathway is submersion within a cloud of noble 

gases. 

c) Noble gas radionuclide mix is based on the historically 

observed source term given in Attachment 2, plus 

additional nuclides. 

d) Basic radionuclide data are given in Attachment 2. 

e) All releases are treated as ground-level. 

f) Meteorological data expressed as joint-frequency 

distribution of wind speed, wind direction, and 

atmospheric stability for the period resulting in X/Q's and 

D/Q's shown in site procedure CH 6.41, "Land Use 

Census." 

g) Raw meteorological data consists of wind speed and 

direction measurements at 10m and temperature 

measurements at 10m and 60m. 

h) Dose is to be evaluated at the offsite exposure points 

where maximum concentrations are expected to exist 

(overland sector site boundaries), and nearest residents. 

4 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

i) Potential maximum population (resident) exposure points 

are identified in site procedure CH 6.41, "Land Use 

Census." 

j) A semi-infinite cloud model is used. 

k) Radioactive decay is considered for the plume. 

I) Building wake effects on effluent dispersion are 

considered. 

m) A sector-average dispersion equation is used. 

n) The wind speed classes that are used are as follows: 

Wind Speed 

Class Number 

1 

2 

3 

4 

5 

6 

7 

Range (m/s) 

0.0-0.4 

0.4-1.5 

1.5-3.0 

3.0-5.0 

5.0-7.5 

7.5-10.0 

> 10.0 

Midpoint (m/s) 

0.2 

0.95 

2.25 

4.0 

6.25 

8.75 

0) The stability classes that will be used are the standard A 

through G classifications. The stability classes 1-7 will 

correspond to A=1, B=2, ... , G=7. 

p) Terrain effects are not considered. 

5 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

2) Equations 

To calculate the dose for anyone of the exposure points, the 

following equations are used. 

For determining the air concentration of any radionuclide: 

9 7 

Xi = L L (2 )1/2 Qi P [exp- (Ai ~J] j = 1 k = 1 rc L::k U j (2rc xln) Uj 

(1.3) 

where: 

= 

= 

Oi = 

P = 

~zk = 

Uj = 

x = 

n = 

Ai = 

2nx/n = 

Air concentration of radionuclide i, f.lCilm3. 

Joint relative frequency of occurrence of winds in 

wind speed class j, stability class k, blowing 

toward this exposure point, expressed as a 

fraction. 

Average release rate of radionuclide i, f.lCils. 

Fraction of radionuclide remaining in plume. 

Vertical dispersion coefficient for stability 

class k (m). 

Midpoint value of wind speed class interval j, m/s. 

Downwind distance, m. 

Number of sectors, 16. 

Radioactive decay coefficient of radionuclide i, S-1. 

Sector width at point of interest, m. 

6 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

For determining the total body dose rate: 

where: 

OTB 

Xi 

OFBi 

= 

= 

= 

(1.4) 

Total body dose rate, mrem/y. 

Air concentration of radionuclide I, /-lCilm3

. 

Total body dose factor due to gamma radiation, 

mrem/y per /-lCilm3 (Attachment 3). 

For determining the skin dose rate: 

where: 

Os = 

Xi = 

OFSi = 

1.11 = 

(1.5) 

Skin dose rate, mrem/y. 

Air concentration of radionuclide i, /-lCilm3 

Skin dose factor due to beta radiation, mrem/y per 

/-lCilm3 (Attachment 3). 

The average ratio of tissue to air energy 

absorption coefficients, mrem/mrad. 

Gamma-to-air dose factor for 

radionuclide i, mrad/y per /-lCilm3 (Attachment 3). 

For determining dose rate to a point in air: 

(1.6) 

where: 

= Air dose rate, mrad/yr. 

Air dose factor for beta radiation (Attachment 3). 

7 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

b. Equations and assumptions for calculating doses from radioiodines 

and particulates are as follows: 

1) Assumptions 

a) Dose is to be calculated for the critical organ, thyroid, and 

the critical age groups (adult, teen, child, infant), infant 

(milk) and child (green, leafy vegetables). 

b) Exposure pathways from iodines and particulates are 

milk ingestion, ground contamination, green leafy 

vegetables from home gardens, and inhalation. 

c) The radioiodine and particulate mix is based on the 

historically observed source term given in Attachment 2. 

d) Basic radionuclide data are given in Attachment 3. 

e) All releases are treated as ground-level. 

f) Mean annual average X/Q's are given in site procedure 

CH 6.41, "Land Use Census." 

g) Raw meteorological data for ground-level releases 

consist of wind speed and direction measurements at 

1 Om and temperature measurements at 1 Om and 60m. 

h) Dose is to be evaluated at the potential offsite exposure 

points where maximum doses to man are expected to 

exist. 

i) Real cow, goat and garden locations are considered. 

j) Potential maximum exposure points (site procedure 

CH 6.41, "Land Use Census") considered are the nearest 

cow, goat, and home garden locations in each sector. 

k) Terrain effects and open terrain recirculation factors are 

not considered. 

I) Building wake effects on effluent dispersion are 

considered. 

8 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

m) Plume depletion and radioactive decay are considered 

for air-concentration calculations. 

n) Radioactive decay is considered for 

ground-concentration calculations. 

0) Deposition is calculated based on the curves given in 

Figure 1.2. 

p) Milk cows and goats obtain 100% of their food from 

pasture grass May through October of each year. Use 

default values of 0.58 for cows and 0.67 for goats for 

fraction of year on pasture. 

2) Equations 

To calculate the dose for anyone of the potential 

maximum-exposure points, the following equations in 

Section 1.2.2 are used. 

a) Inhalation 

Equation for calculating air concentration, Xj is the same 

as in the Noble Gas Section (Equation 1.3). 

For determining the organ dose rate: 

where: 

OJ = 

Xj = 

DFh = 

BR = 

9 

(1.7) 

Organ dose rate due to inhalation, mrem/y. 

Air concentration of radionuclide i, /-lCi/m3

. 

Inhalation dose factor, mrem/pCi 

(Attachment 5). 

Breathing rate 1400 m3/y infant; 

3700 m3

/y child; or 8000 m3/y teen and 

adult. 

pCiI/-lCi conversion factor. 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

b) Ground Contamination 

For determining the ground concentration of any nuclide; 

where: 

k = 

DR = 

x = 

n = 

2nx/n = 

= 

= 

3.15x107 = 

10 

Ground concentration of radionuclide i, 

/-lCi/m2. 

Stability class. 

Joint relative frequency of occurrence of 

winds in stability class k blowing toward this 

exposure point, expressed as a fraction. 

Average release rate of radionuclide i, 

/-lCi/s. 

Relative deposition rate, m-1 (Fig 1.2). 

Downwind distance, m. 

Number of sectors, 16. 

Sector width at point of interest, m. 

Radioactive decay coefficient of 

radionuclide i, y-1. 

Time for buildup of radionuclides on the 

ground, 15 y. 

sly conversion factor. 
-

a: 

w 

tW 

:I 

a: 

w 

~ 

w 

le( 

a: 

Z 

0 

t= 

en 

~ w 

0 

w 

> j: 

e( 

....I 

W 

a: 

10-4 ~ 

10-5 

,0-6 

,0-7 

0.1 

" ...... ..... "'l1lI 

" 

PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

Figure 1.2 

"-. 

'Ira... '"'-'-

'-,~ 

~~ iii: 

""""IIIiO: 

""'" ~ 

" "'II, .... r\. 

,~ 1~O 

Corrected 

January 1971 

! 

I 

: 

! 

Ii! 1 I 

I 

i! 

II ! 

I i I 

I 

i 

! 

1 

1 

I 

"-

'" I ,~ I 

~ I 

'" .~ 

I 

I I I 

II ! 

! I 

i 

, 

I 

IIIII I 

, 

II 'I i 

100.0 200.0 

PLUME TRAVEL DISTANCE (KILOMETERS) 

Figure 7. Rllative Deposition for Ground Level RaiuMS (All Atmospheric 

Stability Classes) 

11 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

For determining the total body or organ dose rate from 

ground contamination: 

where: 

= 

= 

8,760 = 

1x106 = 

0.7 = 

Dose rate due to ground contamination, 

mrem/y. 

Ground concentration of radionuclide i, 

JlCilm2. 

(1.9) 

Dose factor for standing on contaminated 

ground, mrem/h per pCi/m2 (Attachment 6). 

Occupation time, h/y. 

pCilJlCi conversion factor. 

Shielding factor accounting for a distance of 

1.0 meter above ordinary ground, 

dimensionless. 

c) Milk and Vegetation Ingestion 

For determining the concentration of any nuclide (except 

C-14 and H-3) in and on vegetation: 

7 

-3600 " fk DR (r[l-eXP(-AEite)] Biv[l-eXp(-A/b)]J~[ ( )]] CVi -, L. + U exp - Aih 

(2IT xln) Yv AEi P Ai k = 1 

(1.10) 

where: 

CVj = 

k = 

fk = 

12 

Concentration of radionuclide i in and on 

vegetation, JlCi/kg. 

Stability class. 

Frequency of this stability class and wind 

direction combination, expressed as a 

fraction. 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

Oi = Average release rate of radionuclide i, 

/-lei/so 

DR = Relative deposition rate, m-1 (Figure 1.2). 

x = Downwind distance, m. 

n = Number of sectors, 16. 

2nx/n = Sector width at point of interest, m. 

r = Fraction of deposited activity retained on 

vegetation (1.0 for iodines, 0.2 for 

particulates ). 

AEi = Effective removal rate constant, 

AEi = Ai + Aw, where Ai is the radioactive 

decay coefficient, h-1

, and Aw is a measure 

of physical loss by weathering 

(Aw = 0.0021 h-). 

te = Period over which deposition occurs, 720 h. 

Yv = Agricultural yield, 0.7 kg/m2

. 

Biv = Transfer factor from soil to vegetation of 

radionuclide i (Attachment 4). 

Ai = Radioactive decay coefficient of 

radionuclide i, h-1

. 

tb = Time for buildup of radionuclides on the 

ground, 1.31 x1 05 h (15Y). 

P = Effective surface density of soil, 240 kg/m2

. 

3,600 = s/h conversion factor. 

th = Holdup time between harvest and 

consumption of food (2,160 hours for stored 

food). 

13 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

For determining the concentration of C-14 in vegetation: 

CV14 = 1 x 1 03 X14 (0.11 I 0.16) (1.11) 

where: 

CV14 = 

X14 = 

0.11 = 

0.16 = 

1 x1 03 = 

Concentration of C-14 in vegetation, JlCilkg. 

Air concentration of C-14, JlCilm3

. 

Fraction of total Plant mass that is natural 

carbon. 

Concentration of natural carbon in the 

atmosphere, g/m3

. 

g/kg conversion factor. 

For determining the concentration of H-3 in vegetation: 

CVT = 1 x 103 XT (0.75)(0.5 IH) ( 1.12) 

where: 

CVT = 

XT = 

0.75 = 

0.5 = 

H = 

14 

Concentration of H-3 in vegetation, JlCi/m3

. 

Air concentration of H-3, JlCilm3

. 

Fraction of total Plant mass that is water. 

Ratio of tritium concentration in Plant water 

to tritium concentration in atmospheric 

water. 

Absolute humidity of the atmosphere, g/m3

. 

g/kg conversion factor. 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

For determining the concentration of any nuclide in cow's 

or goat's milk: 

where: 

CMj = 

CVj = 

FMj = 

Qf = 

= 

= 

15 

(1.13) 

Concentration of radionuclide i (including 

C-14 and H-3) in milk, ~Ci/I. 

Concentration of radionuclide i in and on 

vegetation, ~Cilkg. 

Transfer factor from feed to milk for 

radionuclide i, d/I (Attachment 4). 

Amount of feed consumed by the milk 

animal per day, kg/d (cow, 50 kg/d or 

goat 6 kg/d). 

Radioactive decay coefficient of 

radionuclide i, d-1

. 

Transport time of activity from feed to milk 

to receptor, 2 days. 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

For determining the organ dose rate from ingestion of 

green leafy vegetables and milk: 

where: 

0 = 

CMj = 

DFj = 

UM = 

(1.14) 

Organ dose rate due to ingestion, mrem/y. 

Concentration of radionuclide i in 

vegetables or milk, JlCilkg (or liters). 

Ingestion dose factor, mrem/pCi 

(Attachment 8). 

Ingestion rate for milk, 330 lIy; for 

vegetables 26 kg/yr (child), no ingestion by 

infant. 

pCilJlCi conversion factor. 

d) Meat Ingestion (BeeD 

To calculate the concentration of a nuclide in animal 

flesh: 

where: 

Cfj = 

16 

( 1.15) 

Concentration of nuclide i in the animal 

flesh, pCilkg. 

Fraction of animal's daily intake which 

appears in each kg of flesh, days/kg 

(Attachment 4). 

Concentration of radionuclide i in the 

animal's feed (Equation 1.10). 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

= 

= 

Amount of feed consumed by the cow per 

day, 50 kg/d. 

Average time from slaughter to 

consumption, 20 days. 

To determine the organ dose from ingestion of beef: 

where: 

= 

= 

Ingestion dose factor for age group, 

mrem/pCi (Attachment 8) for nuclide i. 

Ingestion rate of meat for age group, 

kg/y (child-41, teen-65, adult-11 0). 

( 1.16) 

e) Organ Dose Rates 

For determining the total body and organ dose rate from 

iodines and particulates: 

(1.17) 

where: 

0 = Total organ dose rate, mrem/y. 

0 1 = Dose rate due to inhalation, mrem/y. 

DG = Dose rate due to ground contamination, 

mrem/y. 

OM = Dose rate due to milk ingestion, mrem/y. 

Dv = Dose rate due to vegetable ingestion, 

mrem/y. 

OF = Dose rate due to beef ingestion, mrem/y. 

17 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

3) The maximum organ dose rate, maximum total body dose rate, 

and maximum skin dose rate calculated in the previous section 

(Sec I.B) are used to calculate design basis quantities as 

described in Section I.B.1.3. 

c. Land Use Census 

Appendix A, Sections J.3.b and J.3.c describe the requirements for an 

annual land use census. Changes will be effective on January 1 of the 

year following the year of the survey. 

d. Gaseous Releases From the Steam Generator Blowdown Vent and 

Atmosphere Release Valves 

Releases from the steam generator blowdown vent and atmospheric 

relief valves are difficult to quantify as there are no sampling 

capabilities on these steam release systems. However, neither system 

is a normal release path. The steam generator blowdown vent is 

normally routed to the main condenser and recirculated. Radioactive 

releases will be calculated by analyzing steam generator blowdown 

liquid and assuming that 100 percent of Noble Gases, 10 percent of 

the lodines and 1 percent of the Particulates will be released to the 

environment in the steam phase. Volumes will be released to the 

environment in the steam phase. Volumes will be calculated using 

water balances or alternate means as available. 

18 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

C. GASEOUS RADWASTE TREATMENT SYSTEM OPERATION 

The gaseous radwaste treatment system (GRTS) described below shall be 

maintained and operated to keep releases ALARA. 

1. System Description 

A flow diagram for the GRTS is given in Figure 1-1. The system consists of 

three waste-gas compressor packages, six gas decay tanks, and the 

associated piping, valves, and instrumentation. Gaseous wastes are received 

from the following: degassing of the reactor coolant and purging of the 

volume control tank prior to a cold shutdown and displacing of cover gases 

caused by liquid accumulation in the tanks connected to the vent header. 

Design of the system precludes hydrogen explosion by means of ignition 

source elimination (diaphragm valves, low flow diaphragm compressors and 

system electrical grounding), and minimization of leakage outside the system. 

Explosive mixtures of hydrogen and oxygen have been demonstrated 

compatible with the system by operational experience. 

2. Determination of Satisfactory Operation 

Doses will be calculated for batch and continuous releases as described in 

Section LB. These calculations will be used to ensure that the GRTS is 

operating as designed. Because the Plant was designed to collect and hold 

for decay a vast majority of the high level gases generated within the primary 

system, and because the operating history of the Plant has demonstrated the 

system's consistent performance well below Appendix I limits, no additional 

operability requirements are specified. 

19 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

D. RELEASE RATE FOR OFFSITE EC 

10 CFR 20.1302 requires radioactive effluent releases to unrestricted areas be in 

concentrations less than the limits specified in Appendix B, Table 2 when averaged 

over a period not to exceed one year. (Note: there are no unrestricted areas 

anywhere within the site boundary as defined by Figure 1-1.) Concentrations at this 

level if inhaled or ingested continuously for one year will result in a dose of 50 mrem 

whole body except for submersion dose isotopes (gaseous tritium and noble gasses) 

which will results in a dose of 100 mrem whole body. 10 CFR 50.36a requires that 

the release of radioactive materials be kept as low as reasonably achievable. 

However, the section further states that the licensee is permitted the flexibility of 

operation, to assure a dependable source of power even under unusual operating 

conditions, to release quantities of material higher than a small percentage of 

10 CFR 20.1302 limits but still within those limits. Appendix I to 10 CFR 50 provides 

the numerical guidelines on limiting conditions for operations to meet the as low as 

reasonably achievable requirement. 

The GASPAR code has been run to determine the dose due to external radiation 

and inhalation. The source term used is listed in Attachment 2. The meteorology 

data is given in site procedure CH 6.41, "Land Use Census." Dose using annual 

average meteorology, to the most limiting organ of the person assume to be residing 

at the site boundary with highest X/Q, is 2.15E-02 mrem (for one year). The release 

rate which would result in a dose rate equivalent to 50 mrem/year (using the more 

conservative total body limit) is the curies/year given in Attachment 2 multiplied by 

50/2. 15E-02 or 0.11 Ci/sec. 

E. PARTICULATE AND IODINE SAMPLING 

Particulate and iodine samples are obtained from the continuous sample stream 

pulled from the Plant stack. Samples typically are obtained to represent an 

integrated release from a gas batch (waste gas decay tank or Containment purge, 

for example), or a series of samples are obtained to follow the course of a release. 

In any event, sample intervals are weekly, at a minimum. 

Because HEPA filters are present between most source inputs to the stack and the 

sample point, releases of particulates normally are significantly less than pre-release 

calculations indicate. This provides for conservatism in establishing setpoints and in 

estimation of pre-release dose calculations. However, for the sake of maintaining 

accurate release totals, monitor results (for gases) and sample results 

(for particulates and iodines) utilized rather than the pre-release estimates, for 

cumulative records. 

20 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

Gamma analytical results for particulate and halogen filters are combined for 

determination of total activity of particulates and halogens released. Sampling and 

analysis will be performed per Appendix A, Table B-1 requirements. 

F. NOBLE GAS SAMPLING 

Noble gases will be sampled from Waste Gas Decay Tanks prior to release and the 

Containment prior to purging. Analysis of these samples will be used for 

accountability of noble gases. Off gas will be sampled at least weekly and used to 

calculate monthly noble gas releases. Non-routine releases will be quantified from 

the stack noble gas monitor (RE 2326) which has a LLD of 1 E-06 JlCilcc. Sampling 

and analysis will be performed per Appendix A, Table B-1 requirements. 

G. TRITIUM SAMPLING 

Tritium has a low dose consequence to the public because of low energy decay. 

The major contributors to tritium effluents are evaporation from the fuel pool and 

reactor cavity (when flooded). Because of the low dose impact, gaseous tritium 

sampling will not be required. Tritium effluents will be estimated using conservative 

evaporation rate calculations from the fuel pool and reactor cavity. 

21 
N 

N 

T-a . 

lOWuva 

1 

I 

I _J 

Mn13 e e Omt •• '-M Il_r__ mAllf GaeERATOIII GAS _ COlLECTION· n ...- I 

SUFPl V --...IJI'LI 

HEPAlCMAltCOAl 

(REFUflltfG' 

RES1U· 

STACK 

fG8'A 

.tln 

_.'tV 

eM .D.I7I1 MID Inllll11' SIUfPl V MID 0. Of r.-\) 

F lCM IS NOT T£"""'" no 

PALISADES EFFLUENT FLOW PATHS 

GASEOUS 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

II. LIQUID EFFLUENTS 

A. CONCENTRATION 

1. Requirements 

Appendix A, Section III.G requires that the concentration of radioactive 

material released at any time from the site to unrestricted areas shall be 

limited to ten times the Effluent Concentration (EC) specified in 10 CFR 20, 

Appendix B, Table 2, Column 2 for nuclides other than dissolved or entrained 

noble gases. For dissolved or entrained noble gases, the concentration shall 

be limited to 2E-04 IlCilml total activity. To ensure compliance, the following 

approach will be used for each release. 

2. Prerelease Analysis 

Most tanks will be recirculated through two volume changes prior to sampling 

for release to the environment to ensure that a representative sample is 

obtained. The appropriate recirculation time for those tanks too large to 

provide two volume changes will be the time that the suspended particulate 

concentration reaches steady state. Either a one-time test, or prior sampling 

data, may be used to determine appropriate recirculation time. 

Prior to release, a grab sample will be analyzed for each release, and the 

concentration of each radionuclide determined. 

C = 

where: 

C = 

= 

Total concentration in the liquid effluent at the release 

point, IlCi/ml. 

Concentration of a single radionuclide i, IlCUml. 

23 

(2.1 ) 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

3. Effluent Concentration (EC) - Sum of the Ratios 

The EC-Fraction (Rj) for each release point will be calculated by the 

relationship defined by Note 4 of Appendix B, 10 CFR 20: 

Rj 

where: 

Cj 

ECj 

Rj 

= 

= 

= 

Effluent concentration of radionuclide i, JiCi/ml. 

The EC of radionuclide i, 10 CFR 20, Appendix B, Table 2, 

Column 2 - JiCilml. 

The Total EC-Fraction for the release point. 

(2.2) 

The sum of the ratios at the discharge to the lake must be :::; 10 due to the 

releases from any or all concurrent releases. The following relationship will 

assure this criterion is met: 

f 1 (R 1 -1) + f 2 (R2 -1) + f 3 (R3 -1) :s; F (2.3) 

where: 

= 

= 

F = 

The effluent flow rate (gallons/minute) for the respective 

releases, determined by Plant personnel. 

The Total EC-Fractions for the respective releases as 

determined by Equation 2.2. 

Minimum required dilution flow rate. Normally, a 

conservatively high dilution flow rate is used, that is, flow 

rate used = (bj)(F) where bj is a conservative factor 

greater than 1.0. 

24 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

B. INSTRUMENT SETPOINTS 

1. Setpoint Determination 

Appendix A, Section III.F requires alarm setpoints for each liquid effluent 

monitor will be established using Plant instructions to ensure the 

requirements of Appendix A, Section III.G are not exceeded. Concentration, 

flow rate, dilution, principal gamma emitter, geometry, and detector efficiency 

are combined to give an equivalent setpoint in counts per minute (cpm). The 

identification number for each liquid effluent radiation detector is contained in 

Figure 2-2. 

The respective alarm/trip setpoints at each release point will be set such that 

the sum of the ratios at each point, as calculated by Equation 2.2, will not be 

exceeded. The value of R is directly related to the total concentration 

calculated by Equation 2.1. An increase in the concentration would indicate 

an increase in the value of R. A large increase would cause the limits 

specified in Section 2.1.1 to be exceeded. The minimum alarm/trip setpoint 

value is equal to the release concentration, but for ease of operation it may be 

desired that the setpoint (S) be set above the effluent concentration (C) by the 

same factor (b) utilized in setting dilution flow. That is: 

S = bxC (2.4) 

Liquid effluent flow paths and release points are indicated in Figure 2.1. 

2. Composite Samplers 

Effluent pathways, Turbine Sump and Service Water, are equipped with 

continuous compositors to meet the requirements of Appendix A, Table 0-1. 

These compositors are adjustable and normally set in a time mode and 

collect three to six samples hourly, 24 hours a day with a total collection of 

approximately one gallon per day. A representative sample is collected daily 

from the compositor and saved for the weekly, monthly, and quarterly 

analysis requirements of Appendix A, Table 0-1. In the event that a 

compositor is not operational, effluent releases via this pathway may continue 

provided that grab samples are collected and analyzed for gross beta or 

gamma radioactivity at least once per 24 hours per Appendix A, Table C-1, 

Action 3. 

25 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

3. Post-Release Analysis 

c. DOSE 

A post-release analysis will be done using actual release data to ensure that 

the limits specified in Section 1 were not exceeded. 

A composite list on concentrations (Ci), by isotope, will be used with the 

actual liquid radwaste (f) and dilution (F) flow rates (or volumes) during the 

release. The data will be substituted into Equation 2.3 to demonstrate 

compliance with the limits in Section 1. This data and setpoints will be 

recorded in auditable records by Plant personnel. 

1. RETS Requirement 

Appendix A, Section III.H.1 requires that the quantity of radionuclides 

released by limited such that the dose or dose commitment to an individual 

from radioactive materials in liquid effluents release to unrestricted areas from 

the reactor (see Figure 2-1) will not exceed: 

a. During any calendar quarter, 1.5 mrem to the total body and 5 mrem to 

any organ, and 

b. During any calendar year, 3 mrem to the total body and 10 mrem to 

any organ. 

To ensure compliance, quantities of activity of each radionuclide released will 

be summed for each release and accumulated for each quarter as follows in 

Section 2. 

2. Release Analysis 

Dose calculations shall be performed for each batch release, and weekly for 

continuous releases unless documentation exists to demonstrate an activity 

below which dose limits of Section II.C.1 will not be exceeded. 

a. Water Ingestion 

The dose to an individual from ingestion of radioactivity from any 

source as described by the following equation: 

Dj I (DCF)jj x Ii 

i = I 

26 

(2.5) 
(DCF)ij 

PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

where: 

= Dose for the /h organ from radionuclides releases, mrem. 

= The organ of interest. 

= Ingestion dose commitment factor for the jth organ from 

the ith radionuclide mrem/pCi, see Attachment 8. 

= Activity ingested of the ith radionuclide, pCi. 

Ii is described by: 

. = (Aj)(V)(36S) (1E06) 

I, (1000)(d) (2.6) 

where: 

365 = 

v = 

d = 

1000 = 

1E06 = 

Days per year. 

Annual activity released of ith radionuclide, /-lCi. 

Average rate of water consumption (2000 mild - adult, 

1400 mild - teen and child, 900 mild - infant, ICRP 23, P 

358). 

Dilution water flow for year, ml. 

Dispersion factor from discharge to nearest drinking 

water supply. 

Conversion /-lCi to pCi. 

The dose equation then becomes: 

i 

- (3.6SEOS)(V) "" (DCF) Dj- L... jjxAjmrem 

d . 1 1= 

(2.7) 

27 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

b. Fish Ingestion 

The dose to an individual from the consumption of fish is described by 

Equation 2.10. In this case, the activity ingested of the ith radionuclide 

(Ii) is described by: 

- AiBjF(1E09) - C' 

h- 15d -p I 

where: 

= 

= 

Annual released of ith radionuclide, /-lCi. 

Fish concentration factor of ith radionuclide 

(see Attachment 7). 

I-lCilgm 

JlCilml 

(2.8) 

F = Amount of fish eaten per year (21 kg adult, 16 kg teen, 

6.9 kg child, none infant). 

15 = Dispersion factor from discharge to fish exposure point. 

d = Dilution water flow for year, ml. 

1E09 = Conversion of /-lCi, gm, and Kg to pCi. 

Substitution of Equation 2.8 into Equation 2.5 gives: 

i 

(6.7E07)F Dj= d I AiXBjXDCFimrem 

i=1 

28 

(2.9) 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

c. Annual Analysis 

A complete analysis utilizing the NRC computer code LADTAP with the 

total source release will be done annually in conjunction with the 

annual environmental report. This analysis will provide estimates of 

dose to the total body and various organs in addition to the dose 

limiting organs considered in the method of Section 2. The following 

approach is utilized on LADTAP. The dose to the /h organ from m 

radionuclides, OJ, is described by: 

m 

OJ= I Oijmrem 

i = 1 

m 

= I (OCF)ij x Ij mrem 

i=1 

where: 

(2.10) 

(2.11 ) 

= Dose to the jth organ from the ith radionuclide, mrem. 

= 

(DCFh = 

= 

The organ of interest (bone, GI tract, thyroid, liver, 

kidney, lung, or total body). 

Adult ingestion dose commitment factor for the /h organ 

from the ith radionuclide, mrem/pCi (see Attachment 8). 

Activity ingested of the ith radionuclide, J..lCi. 

h for water ingestion is described by: 

and for fish ingestion Ii is described by: 

1- AiBiFr CI· 

i- v d I-i 

29 

(2.12) 

(2.13) 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

where: 

Ai = 

V = 

r = 

v = 

d = 

Bi = 

F = 

Activity release of /h radionuclide during the year, /-lCi. 

Average rate of water consumption (2000 mild). 

Number of days during the year (365 d). 

Dispersion factor from point of discharge to point of 

exposure. 

Dilution water volume (ml). 

Fish concentration factor of the ith radionuclide, 

JlCilgm 

Attachment 7, JlCilml 

Amount of fish eaten per day (57.5 gm/d). 

D. OPERABILITY OF LIQUID RADWASTE EQUIPMENT 

The Palisades liquid radwaste system is designed to reduce the radioactive 

materials in liquid wastes prior to their discharge (through deep bed filtration and ion 

exchange) so that radioactivity in liquid effluent releases to unrestricted areas (see 

Figure 2-1) will not exceed the limits of Appendix A, III.H.1. 

E. RELEASE RATE FOR OFFSITE EC (50 MREMIYR) 

10 CFR 20.1302 requires radioactive effluent releases to unrestricted areas be less 

than the limits specified in Appendix B, Table 2 when averaged over a period not to 

exceed one year. Concentrations at this Effluent Concentration (EC) level, if 

ingested for one year, will result in a dose of 50 millirem to the total body. In 

addition, 10 CFR 50.36a requires that the release of radioactive materials be kept as 

low as is reasonably achievable. Appendix I to 10 CFR 50 provides the numerical 

guidelines on limiting conditions for operations to meet the as low as is reasonably 

achievable requirement. 

The LADT AP code has been run to determine the dose due to drinking water at 

Plant discharge concentration (1,000 x nearest drinking water intake concentration). 

The nominal average source term used is given in Attachment 2. Dose to the most 

limiting organ of the person hypothetically drinking this water is 3.88E-03 mrem. 

This is only 0.13%) of the more conservative 50 mrem/yr total body value. 

30 
j 

\ 

\ 

\ 

\ 

\ 

\ 

\ 

\ 

I 

"l 

<J 

- I 

I 

/ 

I 

/ 

/ 

/ 

/ 

,,\ NNW I N NNE I 

" W \ / / ,,\ / ,/ 

WNW.... \. . '. N' / ,/ 

....... 

...... 

_ ,. 

"- Y I' i ,// 

'''"__ ' ./. ;' GASEOUS II A--/ \1' STACK EfFLUENTS 

OU'O O,sdH . <! • ," 7., .,,, 

SURF ACE rl ARGE I >! ;, .. /' - - - !)86L .1..... - l' ",.:' i I· -, . - ,. / ;. -" i' "';'; ......;. •. 

[

SW .f" .' . / I \ \ . - :. 

.// .1' \...... 1 ..... • 

/' l / / \ '- - ./ I . , .... 

l 

I I' I \ "E Sf 

...- ./ / I / \ \ ..... 

I.J.J / / / I \ \ \ "- ....... 

4:- / / SSW \ i ' 

V I. I I". \ "- f. I \ \ ' 

• I \ \ " 

/ 

./ 

/' 

L 

.6 

8 

./ 

./ 

/' 

./ 

--

./ 

./ 

6 

14 

/' 

,/ 

--

611 

/.

'I I \ \ " " 

/; I \ \ " A \ \ \ ........ ! 

\ \ 

\ A 19\ 

\ 

lJNRESTRICTEO AAEA 

SI fF BOUNOAHV 

18. 

./ 

./ 

,/ 

" " 

/' 

.. 

--------, 

if 

I 

"-1 

:;) 1 

./ 

I": 715 MflfHS 

SITE ENVIRONMENT 

TLD STATIONS 

PALISADES NUCLEAR PLANT 

SITE 80UNDAR Y 

FIGURE 2 - I 

C") 
PALISADES RADWASTE EFFLUENTS - lIOUID 

CI.FAN 

W/\SH: 

SYSllM 

RrA/En 

ASTE 

ANKS(7j 

MIseI' L I ANEOUS WASTf SYSTEM 

IOlfll Y WASTf} 

UNDRY 

SHM 

FILHRrn 

WASH 

TANK 

UTILITY 

WATFR 

STORAGE 

TANI< 

T·91 

PRIMARY 

SYSTEM 

STORAGE 

TANK 

190 

STEAMGEN 

RE oeJJ 

"'&"...1---4'"--. 

LAKE 

;! 

SERVICE WATER LAKE INLET Xl. 

C\I 

M 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

III. URANIUM FUEL CYCLE DOSE 

A. SPECIFICATION 

In accordance with Appendix A, Section 111.1.1, if either liquid or gaseous quarterly 

releases exceed the quantity which would cause offsite doses more than twice the 

limit of Appendix A, Sections III.C.1, 111.0.1, or III.H.1, then the cumulative dose 

contributions from combined release plus direct radiation sources (from the reactor 

unit and radwaste storage tanks) shall be calculated. The dose is to be determined 

for the member of the public protected to be the most highly exposed to these 

combined sources. 

B. ASSUMPTIONS 

1. The full time resident determined to be maximally exposed individual 

(excluding infant) is assumed also to be a fisherman. This individual is 

assumed to drink water and ingest local fish at the rates specified in 

Sections II.C.2.1 and II.C.2.2. 

2. Amount of shore line fishing (at accessible shoreline adjacent to site security 

fence) is conservatively assumed as 48 hours per quarter (average of 

approximately 112 hour per day each day of the quarter) for the second and 

third quarters of the year, 36 hours for the fourth quarter and 16 hours for the 

first quarter. 

33 
PALISADES NUCLEAR PLANT 

OFFSITE DOSE CALCULATION MANUAL 

Revision 26 

C. DOSE CALCULATION 

Maximum doses to the total body and internal organs of an individual shall be 

determined by use of LADT AP and GASPAR computer codes, and doses to like 

organs and total body summed. Added to this sum will be a mean dose rate, 

calculated or measured for the shoreline due to Plant present curing the quarter in 

question, times the assumed fishing time. 

0 40 = (2.15) 

where: 

0 40 = 40 CFR 190 dose (mrem). 

DG = Limiting dose to an individual from gaseous source term (mrem). 

DL = Limiting dose to an individual from liquid source term (mrem). 

RT = Mean dose rate calculated to be applicable to Lake Michigan shoreline 

adjacent to Plant site (mrem/hr). 

T = Assumed shoreline fishing time for the quarter in questions (hours). 

IV. SOURCE REFERENCE DOCUMENTS 

1. Regulatory Guide 1.21, Measuring, Evaluating, and Reporting Radioactivity in 

Solid Wastes and Releases of Radioacitve Materials in Liquid and Gaseous 

Effluents from Light-Water-Cooled Nuclear Power Plants, R1. 

2. Regulatory Guide 1.109, Calculation of Annual Doses to Man from Routine 

Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 

CFR Part 50, Appendix I, R1. 

3. NUREG-1301, affsite Dose Calculation Manual Guidance: Standard Radiological 

Effluent Controls for Pressurized Water Reactors, April 91. 

4. NUREG-0472, Standard Radiological Effluent Technical Specifications for 

Pressurized Water Reactors, R3. 

5. NUREG/CR-4013, LADTAP " - Technical Reference and User Guide, April 86. 

6. NUREG/CR-4653, GASPAR" - Technical Reference and User Guide, March 87. 

7. CH 6.61, Revising the aDCM and aDCM Appendix A. 

34 
Proc No ODeM 

Attachment 1 

Revision 26 

Page 1 of 1 

PALISADES GASEOUS AND LIQUID SOURCE TERMS. CURIESNEAR (1) 

Nuclide 

H-3 

Kr-85 

Kr-85m 

Kr-87 

Kr-88 

Ar-41 

Xe-131 m 

Xe-133 

Xe-133m 

Xe-135 

Xe-135m 

1-131 

1-132 

1-133 

1-134 

1-135 

Na-24 

Cr-51 

Mn-54 

Co-57 

Co-58 

Fe-59 

Co-60 

Se-75 

Nb-95 

Zr-95 

Mo-99 

Ru-103 

Sb-127 

Cs-134 

Cs-136 

Cs-137 

8a-140 

La-140 

Unidentified beta 

Gaseous(2) 

5.5 

4.1 

0.12 

8.4E-02 

2.1 E-01 

3.1 E-02 

2.2 

1493 

0.43 

1.11 

0.3 

0.025 

2.91 E-03 

6.5E-03 

4.8E-04 

1.84E-02 

1.5E-06 

2.5E-04 

4.1E-04 

2.1 E-06 

8.6E-04 

6.6E-06 

1.1 E-03 

3.7E-06 

2.4E-05 

4.7E-06 

1.5E-07 

0.3E-07 

NA 

4.5E-05 

NA 

2.6E-04 

2.8E-07 

7.5E-07 

3.9E-04 

Liquid(2) 

159 

NA 

NA 

NA 

NA 

NA 

NA 

NA 

NA 

NA 

NA 

3.21 E-03 

NA 

4.7E-05 

NA 

NA 

NA 

3.9E-03 

7.8E-03 

3.2E-05 

2.9E-02 

4.1 E-04 

1.24E-02 

NA 

4.53E-04 

1.79E-04 

NA 

0.1 E-05 

3.5E-05 

0.7 

1.8E-06 

1.36E-02 

NA 

1.1 E-04 

3.3E-03 

(1) Data derived from taking the effluents released during July-December 1978 through 

January-June 1982 and dividing by 4. 

(2) Nuclide values listed as NA have not been observed at detectable levels in these waste 

streams. 
Proc No aDeM 

Attachment 2 

Revision 26 

Page 1 of2 

BASIC RADIONUCLIDE DATA 

NUCLIDE HALF-LIFE LAMBDA BETA1 GAMMA1 

~ 1.1L§} (MEV/DIS) (MEV/DIS) 

1 Tritium 4.49E 03 1.79E-09 S.68E-03 0.0 

2 C-14 2.09E 06 3.84E-12 4.9SE-02 0.0 

3 N-13 6.94E-03 1.16E-03 4.91 E-01 1.02E 00 

4 0-19 3.36E-04 2.39E-02 1.02E 00 1.0SE 00 

S F-18 7.62E-02 1.0SE-04 2.S0E-01 1.02E 00 

6 NA-24 6.33E-01 1.27E-OS S.SSE-01 4.12E 00 

7 P-32 1.43E 01 S.61 E-07 6.9SE-01 0.0 

8 AR-41 7.63E-02 1.0SE-04 4.64E-01 1.28E 00 

9 CR-S1 2.78E 01 2.89E-07 3.86E-03 3.28E-02 

10 MN-S4 3.03E 02 2.6SE-08 3.80E-03 8.36E-01 

11 MN-S6 1.07E-01 7.S0E-OS 8.29E-01 1.69E 00 

12 FE-S9 4.S0E 01 1.78E-07 1.18E-01 1.19E 00 

13 CO-S8 7.13E 01 1.12E-07 3.41 E-02 9.78E-01 

14 CO-60 1.92E 03 4.18E-09 9.68E-02 2.S0E 00 

1S ZN-69m S.7SE-01 1.39E-OS 2.21E-02 4.16E-01 

16 ZN-69 3.96E-02 2.03E-04 3.19E-01 0.0 

17 BR-84 2.21 E-02 3.63E-04 1.28E 00 1.77E 00 

18 BR-8S 2.08E-03 3.86E-03 1.04E 00 6.60E-02 

19 KR-8Sm 1.83E-01 4.38E-OS 2.S3E-01 1.S9E-01 

20 KR-8S 3.93E 03 2.04E-09 2.S1 E-01 2.21 E-03 

21 KR-87 S.28E-02 1.S2E-04 1.32E 00 7.93E-01 

22 KR-88 1.17E-01 6.86E-OS 3.61 E-01 1.96E 00 

23 KR-89 2.21 E-03 3.63E-03 1.36E 00 1.83E 00 

24 RB-88 1.24E-02 6.47E-04 2.06E 00 6.26E-01 

2S RB-89 1.07E-02 7.S0E-04 1.01 E 00 2.0SE-00 

26 SR-89 S.20E 01 1.S4E-07 S.83E-01 8.4SE-OS 

27 SR-90 1.03E 04 7.79E-10 1.96E-01 0.0 

28 SR-91 4.03E-01 1.99E-OS 6.S0E-01 6.9SE-01 

29 SR-92 1.13E-01 7.10E-OS 1.9SE-01 1.34E 00 

30 SR-93 S.S6E-03 1.44E-03 9.20E-01 2.24E 00 

31 Y-90 2.67E 00 3.00E-06 9.36E-01 0.0 

32 Y-91m 3.47E-02 2.31 E-04 2.73E-02 S.30E-01 

33 Y-91 S.88E 01 1.36E-07 6.06E-01 3.61 E-03 

34 Y-92 1.47E-01 S.46E-OS 1.44E 00 2.S0E-01 

3S Y-93 4.29E-01 1.87E-OS 1.17E 00 8.94E-02 

36 ZR-9S 6.S0E 01 1.23E-07 1.16E-01 7.3SE-01 

37 NB-9Sm 3.7SE 00 2.14E-06 1.81 E-01 6.06E-02 

38 NB-9S 3.S0E 01 2.29E-07 4.44E-02 7.64E-01 

39 MO-99 2.79E 00 2.87E-06 3.96E-01 1.S0E-01 

40 TC-99m 2.S0E-01 3.21 E-OS 1.S6E-02 1.26E-01 
41 

42 

43 

44 

45 

46 

47 

48 

49 

50 

51 

52 

53 

54 

55 

56 

57 

58 

59 

60 

61 

62 

63 

64 

65 

66 

67 

68 

Proc No aDeM 

Attachment 2 

Revision 26 

Page 2 of 2 

BASIC RADIONUCLIDE DATA 

NUCLIDE HALF-LIFE LAMBDA BETA1 GAMMA1 

~ (1/s) (MEV/DIS) (MEV/DIS) 

TC-99 7.74E 07 1.04E-13 8.46E-02 0.0 

TC-104 1.25E-02 6.42E-04 1.60E 00 1 .95E 00 

RU-106 3.67E 02 2.19E-08 1.01 E-02 0.0 

TE-132 3.24E 00 2.48E-06 1.00E-01 2.33E-01 

1-129 6.21 E 09 1.29E-15 5.43E-02 2.46E-02 

1-131 8.05E 00 9.96E-07 1.94E-01 3.81 E-01 

1-132 9.58E-02 8.37E-05 4.89E-01 2.24E 00 

1-133 8.75E-01 9.17E-06 4.08E-01 6.02E-01 

1-134 3.61 E-02 2.22E-04 6.16E-01 2.59E 00 

1-135 2.79E-01 2.87E-05 3.68E-01 1.55E 00 

XE-131m 1.18E01 6.80E-07 1.43E-01 2.01 E-02 

XE-133m 2.26E 00 3.55E-06 1.90E-01 4.15E-02 

XE-133 5.27E 00 1.52E-06 1.35E-01 4.60E-02 

XE-135m 1.08E-02 7.43E-04 9.58E-02 4.32E-01 

XE-135 3.83E-01 2.09E-05 3.17E-01 2.47E-01 

XE-137 2.71 E 03 2.96E-03 1.77E 00 1.88E-01 

XE-138 9.84E-03 8.15E-04 6.65E-01 1.10E 00 

CS-134 7A8E 02 1.07E-08 1.63E-01 1.55E 00 

CS-135 1.10E09 7.29E-15 5.63E-02 0.0 

CS-136 1.30E 01 6.17E-07 1.37E-01 2.15E 00 

CS-137 1.10E 04 7.29E-10 1.71E-01 5.97E-01 

CS-138 2.24E-02 3.58E-04 1.20E 00 2.30E 00 

BA-139 5.76E-02 1.39E-04 8.96E-01 3.53E-02 

BA-140 1.28E 01 6.27E-07 3.15E-01 1.71E-01 

LA-140 1.68E 00 4.77E-06 5.33E-01 2.31 E 00 

CE-144 2.84E 02 2.82E-08 9.13E-02 1.93E-02 

PR-143 1.36E 01 5.90E-07 3.14E-01 0.0 

PR-144 1.20E-02 6.68E-04 1.21EOO 3.18E 00 

Average energy per disintegration values were obtained from ICRP Publication No 38, 

Radionuclide Transformations: Energy and Intensity of Emissions 1983 and 

NUREG/CR-1413 (ORNLINUREG-70), a Radionuclide Decay Data Base - Index and 

Summary Table, DC Kocher, May 1980. 
Proc No aDeM 

Attachment 3 

Revision 26 

Page 1 of 1 

DOSE FACTORS FOR SUBMERSION IN NOBLE GASES* 

Gamma body Gamma air Beta skin Beta air 

dose1 dose2 dose1 dose2 

Kr-85m 1.17E3 1.23E3 1.46E3 1.97E3 

Kr-85 1.61 E1 1.72E1 1.34E3 1.95E3 

Kr-87 5.92E3 6.17E3 9.73E3 1.03E4 

Kr-88 1.47E4 1.52E4 2.37E3 2.93E3 

Kr-89 1.66E4 1.73E4 1.01 E4 1.06E4 

Xe-131m 9.15E1 1.56E2 4.76E2 1.11 E3 

Xe-133m 2.51 E2 3.27E2 9.94E2 1.48E3 

Xe-133 2.94E2 3.53E2 3.06E2 1.05E3 

Xe-135m 3.12E3 3.36E3 7.11 E2 7.39E3 

Xe-135 1.81 E3 1.92E3 1.86E3 2.46E3 

Xe-137 1.42E3 1.51 E3 1.22E4 1.27E4 

Xe-138 8.83E3 9.21 E3 4.13E3 4.75E3 

Ar-41 8.84E3 9.30E3 2.69E3 3.28E3 

1. mrem/y per IlCi/m3 

2. mrad/y per IlCilm3 

*Oose factors for exposure to a semi-infinite cloud of noble gases. Values were obtained from 

USNRC Regulatory Guide 1.109, Revision 1 (October 1977). 
ELEMENT 

H 

C 

Na 

P 

Cr 

Mn 

Fe 

Co 

Ni 

Cu 

Zn 

Rb 

Sr 

Y 

Zr 

Nb 

Mo 

Te 

Ru 

Rh 

Ag 

Te 

I 

Cs 

Ba 

La 

Ce 

Pr 

Nd 

W 

Np 

STABLE ELEMENT TRANSFER DATA 

Fm - MILK (COW) Fm - MILK (GOAT) Ff - MEAT 

(DAYS/L) (DAYS/L) (DAYS/KG) 

1.0E-02 1.7E-01 1.2E-02 

1.2E-02 1.0E-01 3.1 E-02 

4.0E-02 4.0E-02 3.0E-02 

2.5E-02 2.5E-01 4.6E-02 

2.2E-03 2.2E-03 2.4E-03 

2.5E-04 2.5E-04 8.0E-04 

1.2E-03 1.3E-04 4.0E-02 

1.0E-03 1.0E-03 1.3E-02 

6.7E-03 6.7E-03 5.3E-02 

1.4E-02 1.3E-02 8.0E-03 

3.9E-02 3.9E-02 3.0E-02 

3.0E-02 3.0E-02 3.1 E-02 

8.0E-04 1.4E-02 6.0E-04 

1.0E-05 1.0E-05 4.6E-03 

5.0E-06 5.0E-06 3.4E-02 

2.5E-03 2.5E-03 2.8E-01 

7.5E-03 7.5E-03 8.0E-03 

2.5E-02 2.5E-02 4.0E-01 

1.0E-06 1.0E-06 4.0E-01 

1.0E-02 1.0E-02 1.5E-03 

5.0E-02 5.0E-02 1.7E-02 

1.0E-03 1.0E-03 7.7E-02 

6.0E-03 6.0E-02 2.9E-03 

1.2E-02 3.0E-01 4.0E-03 

4.0E-04 4.0E-04 3.2E-03 

5.0E-06 5.0E-06 2.0E-04 

1.0E-04 1.0E-04 1.2E-03 

5.0E-06 5.0E-06 4.7E-03 

5.0E-06 5.0E-06 3.3E-03 

5.0E-04 5.0E-04 1.3E-03 

5.0E-06 5.0E-06 2.0E-04 

Proc No aDeM 

Attachment 4 

Revision 26 

Page 1 of 1 

Biv 

(VEG/SOIL) 

4.8E-OO 

5.5E-OO 

5.2E-02 

1.1 E-OO 

2.5E-04 

2.9E-02 

6.6E-04 

9.4E-03 

1.9E-02 

1.2E-01 

4.0E-01 

1.3E-01 

1.7E-02 

2.6E-03 

1.7E-04 

9.4E-03 

1.2E-01 

2.5E-01 

5.0E-02 

1.3E+01 

1.5E-01 

1.3E-OO 

2.0E-02 

1.0E-02 

5.0E-03 

2.5E-03 

2.5E-03 

2.5E-03 

2.4E-03 

1.8E-02 

2.5E-03 
INHALATION DOSE COMMITMENT FACTORS 

Proc No aDeM 

Attachment 5 

Revision 26 

Page 1 of 16 

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRSTYR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3* O. 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 

BE10 9.49E-04 1.25E-04 2.65E-05 O. O. 1.49E-03 1.73E-05 

C14 1.B9E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 

N13 4.39E-OB 4.39E-OB 4.39E-OB 4.39E-OB 4.39E-OB 4.39E-OB 4.39E-OB 

F1B 3.92E-06 O. 3.33E-07 O. O. O. 6.10E-07 

NA22 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05 7.37E-05 

NA24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 

P32 1.45E-03 B.03E-05 5.53E-05 O. O. O. 1.15E-05 

AR39 O. O. O. O. O. 1.00E-OB O. 

AR41 O. O. O. O. O. 3.14E-OB O. 

CA41 7.4BE-05 O. B.16E-06. O. O. 6.94E-02 2.96E-07 

SC46 3.75E-04 5.41 E-04 1.69E-04 O. 3.56E-04 O. 2.19E-05 

CR51 O. O. 6.39E-OB 4.11 E-OB 9.45E-09 9.17E-06 2.55E-07 

MN54 O. 1.B1 E-05 3.56E-06 O. 3.56E-06 7.14E-04 5.04E-06 

MN56 O. 1.10E-09 1.5BE-10 O. 7.B6E-10 B.95E-06 5.12E-05 

FE55 1.41 E-05 B.39E-06 2.3BE-06 O. O. 6.21 E-05 7.B2E-07 

FE59 9.69E-06 1.6BE-05 6.77E-06 O. O. 7.25E-04 1.77E-05 

C057 O. 4.65E-07 4.5BE-07 O. O. 2.71 E-04 3.47E-06 

C05B O. B.71 E-07 1.30E-06 O. O. 5.55E-04 7.95E-06 

C060 O. 5.73E-06 B.41 E-06 O. O. 3.22E-03 2.2BE-05 

NI59 1.B1 E-05 5.44E-06 3.10E-06 O. O. 5.4BE-05 6.34E-07 

NI63 2.42E-04 1.46E-05 B.29E-06 O. O. 1.49E-04 1.73E-06 

NI65 1.71 E-09 2.03E-10 B.79E-11 O. O. 5.BOE-06 3.5BE-05 

CU64 O. 1.34E-09 5.53E-10 O. 2.B4E-09 6.64E-06 1.07E-05 

ZN65 1.3BE-05 4.47E-05 2.22E-05 O. 2.32E-05 4.62E-04 3.67E-05 

ZN69M B.9BE-09 1.B4E-OB 1.67E-09 O. 7.45E-09 1.91 E-05 2.92E-05 

ZN69 3.B5E-11 6.91 E-11 5.13E-12 O. 2.B7E-11 1.05E-06 9.44E-06 

SE79 O. 2.25E-06 4.20E-07 O. 2.47E-06 2.99E-04 3.46E-06 

BRB2 O. O. 9.49E-06 O. O. O. O. 

BRB3 O. O. 2.72E-07 O. O. O. O. 

BRB4 O. O. 2.B6E-07 O. O. O. O. 

BRB5 O. O. 1.46E-OB O. O. O. O. 

KRB3M O. O. O. O. O. 2.50E-09 O. 

KRB5M O. O. O. O. O. 1.31 E-OB O. 

KRB5 O. O. O. O. O. 1.16E-OB O. 

KRB7 O. O. O. O. O. 6.59E-OB O. 

KRBB O. O. O. O. O. 1.3BE-07 O. 

KRB9 O. O. O. O. O. B.67E-OB O. 

RBB6 O. 1.36E-04 6.30E-05 O. O. O. 2.17E-06 

RBB7 O. 7.11 E-05 2.64E-05 O. O. O. 2.99E-07 

RBBB O. 3.9BE-07 2.05E-07 O. O. O. 2.42E-07 

RBB9 O. 2.29E-07 1.47E-07 O. O. O. 4.B7E-OB 

SRB9 2.B4E-04 O. B.15E-06 O. O. 1.45E-03 4.57E-05 

SR90 2.92E-02 O. 1.B5E-03 O. O. B.03E-03 9.36E-05 

SR91 6.B3E-OB O. 2.47E-09 O. O. 3.76E-05 5.24E-05 

SR92 7.50E-09 O. 2.79E-10 O. O. 1.70E-05 1.00E-04 

*Includes a 50% increase to account for percutaneous transpiration. 
INHALATION DOSE COMMITMENT FACTORS 

Proc No aDeM 

Attachment 5 

Revision 26 

Page 2 of 16 

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 2.3SE-06 O. 6.30E-OB O. O. 1.92E-04 7.43E-OS 

Y91M 2.91E-10 O. 9.90E-12 O. o. 1.99E-06 1.6BE-06 

Y91 4.20E-04 o. 1.12E-OS o. o. 1.7SE-03 S.02E-OS 

Y92 1.17E-OB O. 3.29E-10 O. O. 1.7SE-OS 9.04E-OS 

Y93 1.07E-07 o. 2.91 E-09 O. o. S.46E-OS 1.19E-04 

ZR93 2.24E-04 9.S1 E-OS 6.1BE-OS o. 3.19E-04 1.37E-03 1.4BE-OS 

ZR9S B.24E-OS 1.99E-OS 1.4SE-OS O. 2.22E-OS 1.2SE-03 1.SSE-OS 

ZR97 1.07E-07 1.B3E-OB B.36E-09 o. 1.BSE-OB 7.BBE-OS 1.00E-04 

N893M 1.3BE-04 3.S9E-OS 1.1SE-OS o. 3.6BE-OS 2.09E-04 2.47E-06 

N89S 1.12E-OS 4.S9E-06 2.70E-06 o. 3.37E-06 3.42E-04 9.0SE-06 

N897 2.44E-10 S.21 E-11 1.BBE-11 O. 4.07E-11 2.37E-06 1.92E-OS 

M093 o. 6.46E-06 2.22E-07 o. 1.S4E-06 3.40E-04 3.76E-06 

M099 o. 1.1BE-07 2.31 E-OB O. 1.B9E-07 9.63E-OS 3.4BE-OS 

TC99M 9.9BE-13 2.06E-12 2.66E-11 O. 2.22E-11 S.79E-07 1.4SE-06 

TC99 2.09E-07 2.6BE-07 B.BSE-OB O. 2.49E-06 6.77E-04 7.B2E-06 

TC101 4.6SE-14 S.BBE-14 S.BOE-13 O. 6.99E-13 4.17E-07 6.03E-07 

RU103 1.44E-06 O. 4.BSE-07 O. 3.03E-06 3.94E-04 1.1SE-OS 

RU10S B.74E-10 O. 2.93E-10 O. 6.42E-10 1.12E-OS 3.46E-OS 

RU106 6.20E-OS O. 7.77E-06 o. 7.61 E-OS B.26E-03 1.17E-04 

RH10S B.26E-09 S.41 E-09 3.63E-09 o. 1.S0E-OB 2.OBE-OS 1.37E-OS 

PD107 o. 4.92E-07 4.11 E-OB O. 2.7SE-06 6.34E-OS 7.33E-07 

PD109 O. 3.92E-09 1.0SE-09 O. 1.2BE-OB 1.6BE-OS 2.BSE-OS 

AG110M 7.13E-06 S.16E-06 3.S7E-06 O. 7.BOE-06 2.62E-03 2.36E-OS 

AG111 3.7SE-07 1.4SE-07 7.7SE-OB O. 3.0SE-07 2.06E-04 3.02E-OS 

CD113M O. 6.67E-04 2.64E-OS O. S.BOE-04 1.40E-03 1.6SE-OS 

CD11SM O. 1.73E-04 6.19E-06 o. 9.41 E-OS 1.47E-03 S.02E-OS 

SN123 2.09E-04 4.21E-06 7.2BE-06 4.27E-06 o. 2.22E-03 4.0BE-OS 

SN12S 1.01 E-OS 2.S1 E-07 6.00E-07 2.47E-07 O. 6.43E-04 7.26E-OS 

SN126 B.30E-04 1.44E-OS 3.S2E-OS 3.B4E-06 O. 4.93E-03 1.6SE-OS 

S8124 2.71 E-OS 3.97E-07 B.S6E-06 7.1BE-OB O. 1.B9E-03 4.22E-OS 

S812S 3.69E-OS 3.41 E-07 7.7BE-06 4.4SE-OB O. 1.17E-03 1.0SE-OS 

S8126 3.0BE-06 6.01 E-OB 1.11 E-06 2.3SE-OB O. 6.BBE-04 S.33E-OS 

S8127 2.B2E-07 S.04E-09 B.76E-OB 3.60E-09 O. 1.S4E-04 3.7BE-OS 

TE12SM 3.40E-06 1.42E-06 4.70E-07 1.16E-06 O. 3.19E-04 9.22E-06 

TE127M 1.19E-OS 4.93E-06 1.4BE-06 3.4BE-06 2.6BE-OS 9.37E-04 1.9SE-OS 

TE127 1.S9E-09 6.B1 E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-OS 

TE129M 1.01 E-OS 4.3SE-06 1.S9E-06 3.91 E-06 2.27E-OS 1.20E-03 4.93E-OS 

TE129 S.63E-11 2.4BE-11 1.34E-11 4.B2E-11 1.2SE-10 2.14E-06 1.BBE-OS 

TE131M 7.62E-OB 3.93E-OB 2.S9E-OB 6.3BE-OB 1.B9E-07 1.42E-04 B.S1 E-OS 

TE131 1.24E-11 S.B7E-12 3.S7E-12 1.13E-11 2.BSE-11 1.47E-06 S.B7E-06 

TE132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.1SE-OS 

TE133M 6.13E-11 3.S9E-11 2.74E-11 S.S2E-11 1.72E-10 3.92E-06 1.S9E-OS 

TE134 3.1BE-11 2.04E-11 1.6BE-11 2.91 E-11 9.S9E-11 2.93E-06 2.S3E-06 

1129 2.16E-OS 1.S9E-OS 1.16E-OS 1.04E-02 1.BBE-OS o. 2.12E-07 

1130 4.S4E-06 9.91 E-06 3.9BE-06 1.14E-03 1.09E-OS o. 1.42E-06 

1131 2.71 E-OS '3.17E-OS 1.40E-OS 1.06E-02 3.70E-OS O. 7.S6E-07 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 3 of 16 

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 1.21 E-06 2.S3E-06 8.99E-07 1.21 E-04 2.82E-06 o. 1.36E-06 

1133 9.46E-06 1.37E-OS 4.00E-06 2.S4E-03 1.60E-OS O. 1.S4E-06 

1134 6.S8E-07 1.34E-06 4.7SE-07 3.18E-OS 1.49E-06 o. 9.21 E-07 

113S 2.76E-06 S.43E-06 1.98E-06 4.97E-04 6.0SE-06 o. 1.31 E-06 

XE131M o. O. o. o. O. 6.77E-09 o. 

XE133M o. O. o. o. o. 8.89E-09 o. 

XE133 o. o. o. o. o. 7.41 E-09 o. 

XE13SM o. o. o. o. O. 8.0SE-09 o. 

XE13S o. O. o. O. o. 1.80E-08 o. 

XE137 o. o. o. o. o. 8.30E-08 o. 

XE138 o. o. o. o. o. 9.78E-08 o. 

CS134M 1.32E-07 2.10E-07 1.11 E-07 o. 8.S0E-08 2.00E-08 1.16E-07 

CS134 2.83E-04 S.02E-04 S.32E-OS o. 1.36E-04 S.69E-OS 9.S3E-07 

CS13S 1.00E-04 8.66E-OS 4.73E-06 o. 2.S8E-OS 1.01 E-OS 2.18E-07 

CS136 3.4SE-05 9.61 E-OS 3.78E-05 O. 4.03E-05 8.40E-06 1.02E-06 

CS137 3.92E-04 4.37E-04 3.25E-05 o. 1.23E-04 5.09E-05 9.53E-07 

CS138 3.61 E-07 5.S8E-07 2.84E-07 o. 2.93E-07 4.67E-08 6.26E-07 

CS139 2.32E-07 3.03E-07 1.22E-07 O. 1.65E-07 2.53E-08 1.33E-08 

BA139 1.06E-09 7.03E-13 3.07E-11 o. 4.23E-13 4.2SE-06 3.64E-05 

BA140 4.00E-05 4.00E-08 2.07E-06 O. 9.59E-09 1.14E-03 2.74E-05 

BA141 1.12E-10 7.70E-14 3.S5E-12 o. 4.64E-14 2.12E-06 3.39E-06 

BA142 2.84E-11 2.36E-14 1.40E-12 o. 1.36E-14 1.11 E-06 4.95E-07 

LA140 3.61 E-07 1.43E-07 3.68E-08 O. o. 1.20E-04 6.06E-05 

LA141 4.85E-09 1.40E-09 2.4SE-10 O. O. 1.22E-05 5.96E-05 

LA142 7.36E-10 2.69E-10 6.46E-11 o. o. 5.87E-06 4.25E-05 

CE141 1.98E-05 1.19E-05 1.42E-06 o. 3.75E-06 3.69E-04 1.54E-05 

CE143 2.09E-07 1.38E-07 1.58E-08 o. 4.03E-08 8.30E-05 3.55E-05 

CE144 2.28E-03 8.6SE-04 1.26E-04 O. 3.84E-04 7.03E-03 1.06E-04 

PR143 1.00E-05 3.74E-06 4.99E-07 o. 1.41 E-06 3.09E-04 2.66E-05 

PR144 3.42E-11 1.32E-11 1.72E-12 O. 4.80E-12 1.1SE-06 3.06E-06 

ND147 5.67E-06 5.81 E-06 3.S7E-07 o. 2.25E-06 2.30E-04 2.23E-05 

PM147 3.91 E-04 3.07E-OS 1.56E-05 O. 4.93E-05 4.55E-04 5.75E-06 

PM148M 5.00E-05 1.24E-OS 9.94E-06 O. 1.45E-05 1.22E-03 3.37E-05 

PM148 3.34E-06 4.82E-07 2.44E-07 O. 5.76E-07 3.20E-04 6.04E-05 

PM149 3.10E-07 4.08E-08 1.78E-08 o. 4.96E-08 6.S0E-05 3.01 E-05 

PM1S1 7.52E-08 1.10E-08 5.55E-09 o. 1.30E-08 3.2SE-05 2.58E-05 

SM151 3.38E-04 6.45E-OS 1.63E-05 o. 5.24E-05 2.98E-04 3.46E-06 

SM153 1.S3E-07 1.18E-07 9.06E-09 o. 2.47E-08 3.70E-OS 1.93E-05 

EU152 7.83E-04 1.77E-04 1.72E-04 O. 5.94E-04 1.48E-03 9.88E-06 

EU154 2.96E-03 3.46E-04 2.45E-04 o. 1.14E-03 3.0SE-03 2.84E-05 

EU15S 5.97E-04 5.72E-OS 3.46E-05 o. 1.58E-04 5.20E-04 5.19E-05 

EU156 1.56E-05 9.S9E-06 1.54E-06 o. 4.48E-06 6.12E-04 4.14E-05 

TB160 1.12E-04 O. 1.40E-05 o. 3.20E-OS 1.11 E-03 2.14E-05 

H0166M 1.45E-03 3.07E-04 2.51 E-04 o. 4.22E-04 2.05E-03 1.65E-05 

W181 4.86E-08 1.46E-08 1.67E-09 o. o. 1.33E-05 2.63E-07 

W185 1.S7E-06 4.83E-07 5.58E-08 O. o. 4.48E-04 1.12E-05 

W187 9.26E-09 6.44E-09 2.23E-09 O. o. 2.83E-05 2.54E-05 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 4 of 16 

INFANT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 B.62E-02 2.02E-02 3.43E-03 O. 6.BSE-02 1.76E-01 3.79E-OS 

BI210 O. 1.33E-OS 1.1BE-06 O. 1.03E-04 9.96E-03 3.27E-OS 

P0210 2.9BE-03 S.63E-03 7.12E-04 O. 1.30E-02 2.40E-01 4.36E-OS 

RN222 O. O. o. o. O. 9.BBE-06 O. 

RA223 1.S6E-03 2.26E-06 3.12E-04 O. 4.16E-OS 2.2SE-01 3.04E-04 

RA224 1.77E-04 4.00E-07 3.S4E-OS O. 7.30E-06 7.91 E-02 3.42E-04 

RA22S 2.S7E-03 2.BBE-06 S.13E-04 O. S.31 E-OS 2.S7E-01 2.B7E-04 

RA226 2.4BE-01 1.46E-OS 2.0SE-01 O. 2.94E-04 7.B3E-01 3.0SE-04 

RA22B 1.60E-01 7.61 E-06 1.BOE-01 O. 1.S3E-04 1.09E-00 S.19E-OS 

AC22S 3.69E-03 4.72E-03 2.4BE-04 O. 3.49E-04 1.96E-01 2.71 E-04 

AC227 S.29E+00 B.76E-01 3.2BE-01 O. 1.B6E-01 1.62E+00 S.27E-OS 

TH227 1.B2E-03 3.03E-OS S.24E-OS O. 1.13E-04 3.27E-01 3.S3E-04 

TH22B B.46E-01 1.10E-02 2.B6E-02 O. S.61 E-02 4.6SE+00 3.62E-04 

TH229 1.34E+01 1.B2E-01 6.62E-01 O. B.99E-01 1.22E+01 3.29E-04 

TH230 3.46E+00 1.79E-01 9.6SE-02 O. B.B2E-01 2.1BE+00 3.B7E-OS 

TH232 3.B6E+00 1.S3E-01 2.29E-01 O. 7.S4E-01 2.09E+00 3.29E-OS 

TH234 1.33E-OS 7.17E-07 3.B4E-07 O. 2.70E-06 1.62E-03 7.40E-OS 

PA231 9.10E+00 3.00E-01 3.62E-01 O. 1.62E+00 3.BSE-01 4.61 E-OS 

PA233 6.B4E-06 1.32E-06 1.19E-06 O. 3.6BE-06 2.19E-04 9.04E-06 

U232 2.S7E-01 O. 2.13E-02 O. 2.40E-02 1.49E+00 4.36E-OS 

U233 S.44E-02 O. 3.B3E-03 O. 1.09E-02 3.S6E-01 4.03E-OS 

U234 S.22E-02 O. 3.7SE-03 O. 1.07E-02 3.49E-01 3.9SE-OS 

U23S S.01 E-02 O. 3.S2E-03 O. 1.01 E-02 3.2BE-01 S.02E-OS 

U236 S.01 E-02 O. 3.60E-03 O. 1.03E-02 3.3SE-01 3.71 E-OS 

U237 3.2SE-07 O. B.6SE-OB O. B.OBE-07 9.13E-OS 1.31 E-OS 

U23B 4.79E-02 O. 3.29E-03 O. 9.40E-03 3.06E-01 3.S4E-OS 

NP237 3.03E+00 2.32E-01 1.26E-01 O. 7.69E-01 3.49E-01 S.10E-OS 

NP23B 2.67E-06 6.73E-OB 4.16E-OB O. 1.47E-07 9.19E-OS 2.SBE-OS 

NP239 2.6SE-07 2.37E-OB 1.34E-OB O. 4.73E-OB 4.2SE-OS 1.7BE-OS 

PU23B S.02E+00 6.33E-01 1.27E-01 O. 4.64E-01 9.03E-01 4.69E-OS 

PU239 S.SOE+OO 6.72E-01 1.34E-01 O. 4.9SE-01 B.47E-01 4.2BE-OS 

PU240 6.49E+00 6.71E-01 1.34E-01 O. 4.94E-01 B.47E-01 4.36E-OS 

PU241 1.SSE-01 6.69E-03 3.11 E-03 O. 1.1SE-02 7.62E-04 B.97E-07 

PU242 S.09E+00 6.47E-01 1.29E-01 O. 4.77E-01 B.1SE-01 4.20E-OS 

PU244 S.9SE+00 7.40E-01 1.4BE-01 O. S.46E-01 9.33E-01 6.26E-OS 

AM241 1.B4E+00 B.44E-01 1.31 E-01 O. 7.94E-01 4.06E-01 4.7BE-OS 

AM242M 1.90E+00 B.24E-01 1.3SE-01 O. B.03E-01 1.64E-01 6.01 E-OS 

AM243 1.B2E+00 B.10E-01 1.27E-01 O. 7.72E-01 3.BSE-01 S.60E-OS 

CM242 B.SBE-02 7.44E-02 S.70E-03 O. 1.69E-02 2.97E-01 S.10E-OS 

CM243 1.73E+00 7.94E-01 1.06E-01 O. 3.91 E-01 4.24E-01 S.02E-OS 

CM244 1.43E+00 7.04E-01 B.B9E-02 O. 3.21 E-01 4.0BE-01 4.B6E-OS 

CM24S 2.26E+00 B.BOE-01 1.36E-01 O. S.23E-01 3.92E-01 4.S3E-OS 

CM246 2.24E+00 B.79E-01 1.36E-01 O. S.23E-01 3.99E-01 4.4SE-OS 

CM247 2.1BE+00 B.64E-01 1.33E-01 O. S.1SE-01 3.92E-01 S.BSE-OS 

CM24B 1.B2E+01 7.12E+00 1.10E+00 O. 4.24E+00 3.23E+00 9.43E-04 

CF2S2 4.26E+00 O. 1.01 E-01 O. O. 1.37E+00 1.BSE-04 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODCM 

Attachment 5 

Revision 26 

Page 5 of 16 

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3* O. 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 

BE10 B.43E-04 9.B3E-OS 2.12E-OS O. O. 7.41 E-04 1.72E-OS 

C14 9.70E-06 1.B2E-06 1.B2E-06 1.B2E-06 1.B2E-06 1.B2E-06 1.B2E-06 

N13 2.33E-OB 2.33E-OB 2.33E-OB 2.33E-OB 2.33E-OB 2.33E-OB 2.33E-OB 

F1B 1.BBE-06 O. 1.BSE-07 O. O. O. 3.37E-07 

NA22 4.41 E-OS 4.41 E-OS 4.41 E-OS 4.41 E-OS 4.41 E-OS 4.41 E-OS 4.41E-OS 

NA24 4.3SE-06 4.3SE-06 4.3SE-06 4.3SE-06 4.3SE-06 4.3SE-06 4.3SE-06 

P32 7.04E-04 3.09E-OS 2.67E-OS O. O. O. 1.14E-OS 

AR39 O. O. O. O. O. 4.B9E-09 O. 

AR41 O. O. O. O. O. 1.6BE-OB O. 

CA41 7.06E-OS O. 7.70E-06 O. O. 7.21 E-02 2.94E-07 

SC46 1.97E-04 2.70E-04 1.04E-04 O. 2.39E-04 O. 2.4SE-OS 

CRS1 O. O. 4.17E-OB 2.31 E-OB 6.S7E-09 4.S9E-06 2.93E-07 

MNS4 O. 1.16E-OS 2.S7E-06 O. 2.71 E-06 4.26E-04 6.19E-06 

MNS6 O. 4.4BE-10 B.43E-11 O. 4.S2E-10 3.SSE-06 3.33E-OS 

FESS 1.2BE-OS 6.BOE-06 2.10E-06 O. O. 3.00E-OS 7.7SE-07 

FES9 S.S9E-06 9.04E-06 4.S1 E-06 O. O. 3.43E-04 1.91 E-OS 

COS7 O. 2.44E-07 2.BBE-07 O. O. 1.37E-04 3.SBE-06 

COSB O. 4.79E-07 B.SSE-07 O. O. 2.99E-04 9.29E-06 

C060 O. 3.SSE-06 6.12E-06 O. O. 1.91 E-03 2.60E-OS 

NIS9 1.66E-OS 4.67E-06 2.B3E-06 O. O. 2.73E-OS 6.29E-07 

NI63 2.22E-04 1.2SE-OS 7.S6E-06 O. O. 7.43E-OS 1.71 E-06 

NI6S B.OBE-10 7.99E-11 4.44E-11 O. O. 2.21 E-06 2.27E-OS 

CU64 O. S.39E-10 2.90E-10 O. 1.63E-09 2.S9E-06 9.92E-06 

ZN6S 1.1SE-OS 3.06E-OS 1.90E-OS O. 1.93E-OS 2.69E-04 4.41 E-06 

ZN69M 4.26E-09 7.2BE-09 B.S9E-10 O. 4.22E-09 7.36E-06 2.71 E-OS 

ZN69 1.B1E-11 2.61 E-11 2.41E-12 O. 1.SBE-11 3.B4E-07 2.7SE-06 

SE79 O. 1.23E-06 2.60E-07 O. 1.71 E-06 1.49E-04 3.43E-06 

BRB2 O. O. S.66E-06 O. O. O. O. 

BRB3 O. O. 1.2BE-07 O. O. O. O. 

BRB4 O. O. 1.4BE-07 O. O. O. O. 

BRBS O. O. 6.B4E-09 O. O. O. O. 

KRB3M O. O. O. O. O. 1.22E-09 O. 

KRBSM O. O. O. O. O. 6.SBE-09 O. 

KRBS O. O. O. O. O. S.66E-09 O. 

KRB7 O. O. O. O. O. 3.3BE-OB O. 

KRBB O. O. O. O. O. 6.99E-OB O. 

KRB9 O. O. O. O. O. 4.SSE-OB O. 

RBB6 O. S.36E-OS 3.09E-OS O. O. O. 2.16E-06 

RBB7 O. 3.16E-OS 1.37E-OS O. O. O. 2.96E-07 

RBBB O. 1.S2E-07 9.90E-OB O. O. O. 4.66E-09 

RBB9 O. 9.33E-OB 7.B3E-OB O. O. O. S.11E-10 

SRB9 1.62E-04 O. 4.66E-06 O. O. S.B3E-04 4.S2E-OS 

SR90 2.73E-02 O. 1.74E-03 O. O. 3.99E-03 9.2BE-OS 

SR91 3.2BE-OB O. 1.24E-09 O. O. 1.44E-OS 4.70E-OS 

SR92 3.S4E-09 O. 1.42E-10 O. O. 6.49E-06 6.SSE-OS 

*Includes a SO% increase to account for percutaneous transpiration. 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODCM 

Attachment 5 

Revision 26 

Page 6 of 16 

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 1.11 E-06 O. 2.99E-OB O. O. 7.07E-OS 7.24E-OS 

Y91M 1.37E-10 O. 4.9BE-12 O. O. 7.60E-07 4.64E-07 

Y91 2.47E-04 O. 6.S9E-06 O. O. 7.10E-04 4.97E-OS 

Y92 S.SOE-09 O. 1.S7E-10 O. O. 6.46E-06 6.46E-OS 

Y93 S.04E-OB O. 1.3BE-09 O. O. 2.01E-OS 1.0SE-04 

ZR93 2.07E-04 7.BOE-OS S.SSE-OS O. 3.00E-04 7.10E-04 1.47E-OS 

ZR9S S.13E-OS 1.13E-OS 1.00E-OS O. 1.61 E-OS 6.03E-04 1.6SE-OS 

ZR97 S.07E-OB 7.34E-09 4.32E-09 O. 1.0SE-OB 3.06E-OS 9.49E-OS 

NB93M 1.27E-04 3.17E-OS 1.04E-OS O. 3.44E-OS 1.04E-04 2.4SE-06 

NB9S 6.3SE-06 2.4BE-06 1.77E-06 O. 2.33E-06 1.66E-04 1.00E-OS 

NB97 1.16E-10 2.0BE-11 9.74E-12 O. 2.31 E-11 9.23E-07 7.S2E-06 

M093 O. 3.76E-06 1.3SE-07 O. 1.06E-06 1.70E-04 3.7BE-06 

M099 O. 4.66E-OB 1.1SE-OB O. 1.06E-07 3.66E-OS 3.42E-OS 

TC99M 4.B1 E-13 9.41E-13 1.S6E-11 O. 1.37E-11 2.S7E-07 1.30E-06 

TC99 1.34E-07 1.49E-07 S.3SE-OB O. 1.7SE-06 3.37E-04 7.7SE-06 

TC101 2.19E-14 2.30E-14 2.91 E-13 O. 3.92E-13 1.SBE-07 4.41 E-09 

RU103 7.SSE-07 O. 2.90E-07 O. 1.90E-06 1.79E-04 1.21 E-OS 

RU10S 4.13E-10 O. 1.S0E-10 O. 3.63E-10 4.30E-06 2.69E-OS 

RU106 3.6BE-OS O. 4.S7E-06 O. 4.97E-OS 3.B7E-03 1.16E-04 

RH10S 3.91 E-09 2.10E-09 1.79E-09 O. B.39E-09 7.B2E-06 1.33E-OS 

PD107 O. 2.6SE-07 2.S1 E-OB O. 1.97E-06 3.16E-OS 7.26E-07 

PD109 O. 1.4BE-09 4.9SE-10 O. 7.06E-09 6.16E-06 2.S9E-OS 

AG110M 4.S6E-06 3.0BE-06 2.47E-06 O. S.74E-06 1.4BE-03 2.71E-OS 

AG111 1.B1 E-07 S.6BE-OB 3.7SE-OB O. 1.71 E-07 7.73E-OS 2.9BE-OS 

CD113M O. 4.93E-04 2.12E-OS O. S.13E-04 6.94E-04 1.63E-OS 

CD11SM O. 7.BBE-OS 3.39E-06 O. S.93E-OS S.B6E-04 4.97E-OS 

8N123 1.29E-04 2.14E-06 4.19E-06 2.27E-06 O. 9.S9E-04 4.0SE-OS 

8N12S 4.9SE-06 9.94E-OB 2.9SE-07 1.03E-07 O. 2.43E-04 7.17E-OS 

8N126 6.23E-04 1.04E-OS 2.36E-OS 2.B4E-06 O. 3.02E-03 1.63E-OS 

8B124 1.SSE-OS 2.00E-07 S.41 E-06 3.41 E-OB O. B.76E-04 4.43E-OS 

8B12S 2.66E-OS 2.0SE-07 S.S9E-06 2.46E-OB O. 6.27E-04 1.09E-OS 

8B126 1.72E-06 2.62E-OB 6.16E-07 1.00E-OB O. 2.B6E-04 S.67E-OS 

8B127 1.36E-07 2.09E-09 4.70E-OB 1.S1 E-09 O. 6.17E-OS 3.B2E-OS 

TE12SM 1.B2E-06 6.29E-07 2.47E-07 S.20E-07 O. 1.29E-04 9.13E-06 

TE127M 6.72E-06 2.31 E-06 B.16E-07 1.64E-06 1.72E-OS 4.00E-04 1.93E-OS 

TE127 7.49E-10 2.S7E-10 1.6SE-10 S.30E-10 1.91 E-09 2.71E-06 1.S2E-OS 

TE129M S.19E-06 1.BSE-06 B.22E-07 1.71 E-06 1.36E-OS 4.76E-04 4.91 E-OS 

TE129 2.64E-11 9.4SE-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.B9E-06 

TE131M 3.63E-OB 1.60E-OB 1.37E-OB 2.64E-OB 1.0BE-07 S.S6E-OS B.32E-OS 

TE131 S.87E-12 2.2BE-12 1.7BE-12 4.S9E-12 1.S9E-11 S.SSE-07 3.60E-07 

TE132 1.30E-07 7.36E-OB 7.12E-OB B.SBE-OB 4.79E-07 1.02E-04 3.72E-OS 

TE133M 2.93E-11 1.S1E-11 1.S0E-11 2.32E-11 1.01E-10 1.60E-06 4.77E-06 

TE134 1.S3E-11 B.B1 E-12 9.40E-12 1.24E-11 S.71E-11 1.23E-06 4.B7E-07 

1129 1.0SE-OS 6.40E-06 S.71E-06 4.2BE-03 1.0BE-OS O. 2.1SE-07 

1130 2.21 E-06 4.43E-06 2.2BE-06 4.99E-04 6.61 E-06 O. 1.3BE-06 

1131 1.30E-OS 1.30E-OS 7.37E-06 4.39E-03 2.13E-OS O. 7.6BE-07 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 7 of 16 

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 S.72E-07 1.10E-06 S.07E-07 S.23E-OS 1.69E-06 O. B.6SE-07 

1133 4.4BE-06 S.49E-06 2.0BE-06 1.04E-03 9.13E-06 O. 1.4BE-06 

1134 3.17E-07 S.B4E-07 2.69E-07 1.37E-OS B.92E-07 O. 2.SBE-07 

113S 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 O. 1.20E-06 

XE131M O. O. O. O. O. 3.30E-09 O. 

XE133M O. O. O. O. O. 4.36E-09 O. 

XE133 O. O. O. O. O. 3.66E-09 O. 

XE13SM O. O. O. O. O. 4.4BE-09 O. 

XE13S O. O. O. O. O. 9.09E-09 O. 

XE137 O. O. O. O. O. 4.07E-OB O. 

XE13B O. O. O. O. O. S.17E-OB O. 

CS134M 6.33E-OB B.92E-OB 6.12E-OB O. 4.94E-OB B.3SE-09 7.92E-OB 

CS134 1.76E-04 2.74E-04 6.07E-OS O. B.93E-OS 3.27E-OS 1.04E-06 

CS13S 6.23E-OS 4.13E-OS 4.4SE-06 O. 1.S3E-OS S.22E-06 2.17E-07 

CS136 1.76E-OS 4.62E-OS 3.14E-OS O. 2.SBE-OS 3.93E-06 1.13E-06 

CS137 2.4SE-04 2.23E-04 3.47E-OS O. 7.63E-OS 2.B1 E-OS 9.7BE-07 

CS13B 1.71 E-07 2.27E-07 1.S0E-07 O. 1.6BE-07 1.B4E-OB 7.29E-OB 

CS139 1.09E-07 1.1SE-07 S.BOE-OB O. 9.0BE-OB 9.36E-09 7.23E-12 

BA139 4.9BE-10 2.66E-13 1.4SE-11 O. 2.33E-13 1.S6E-06 1.S6E-OS 

BA140 2.00E-OS 1.7SE-OB 1.17E-06 O. S.71 E-09 4.71E-04 2.7SE-OS 

BA141 S.29E-11 2.9SE-14 1.72E-12 O. 2.S6E-14 7.B9E-07 7.44E-OB 

BA142 1.3SE-11 9.73E-1S 7.S4E-13 O. 7.B7E-1S 4.44E-07 7.41 E-10 

LA140 1.74E-07 6.0BE-OB 2.04E-OB O. O. 4.94E-OS 6.10E-OS 

LA141 2.2BE-09 S.31 E-1 0 1.1SE-10 O. O. 4.4BE-06 4.37E-OS 

LA142 3.S0E-10 1.11 E-1 0 3.49E-11 O. O. 2.3SE-06 2.0SE-OS 

CE141 1.06E-OS S.2BE-06 7.B3E-07 O. 2.31 E-06 1.47E-04 1.S3E-OS 

CE143 9.B9E-OB S.37E-OB 7.77E-09 O. 2.26E-OB 3.12E-OS 3.44E-OS 

CE144 1.B3E-03 S.72E-04 9.77E-OS O. 3.17E-04 3.23E-03 1.0SE-04 

PR143 4.99E-06 1.S0E-06 2.47E-07 O. B.11 E-07 1.17E-04 2.63E-OS 

PR144 1.61E-11 4.99E-12 B.10E-13 O. 2.64E-12 4.23E-07 S.32E-OB 

ND147 2.92E-06 2.36E-06 1.B4E-07 O. 1.30E-06 B.B7E-OS 2.22E-OS 

PM147 3.S2E-04 2.S2E-OS 1.36E-OS O. 4.4SE-OS 2.20E-04 S.70E-06 

PM14BM 3.31 E-OS 6.SSE-06 6.SSE-06 O. 9.74E-06 S.72E-04 3.SBE-OS 

PM14B 1.61 E-06 1.94E-07 1.2SE-07 O. 3.30E-07 1.24E-04 6.01 E-OS 

PM149 1.47E-07 1.S6E-OB B.4SE-09 O. 2.7SE-OB 2.40E-OS 2.92E-OS 

PM1S1 3.S7E-OB 4.33E-09 2.B2E-09 O. 7.3SE-09 1.24E-OS 2.S0E-OS 

SM1S1 3.14E-04 4.7SE-OS 1.49E-OS O. 4.B9E-OS 1.4BE-04 3.43E-06 

SM1S3 7.24E-OB 4.S1 E-OB 4.3SE-09 O. 1.37E-OB 1.37E-OS 1.B7E-OS 

EU1S2 7.42E-04 1.37E-04 1.61 E-04 O. S.73E-04 9.00E-04 1.14E-OS 

EU1S4 2.74E-03 2.49E-04 2.27E-04 O. 1.09E-03 1.66E-03 2.9BE-OS 

EU1SS S.60E-04 4.0SE-OS 3.1BE-OS O. 1.S1 E-04 2.79E-04 S.39E-OS 

EU1S6 7.B9E-06 4.23E-06 B.7SE-07 O. 2.72E-06 2.S4E-04 4.24E-OS 

TB160 7.79E-OS O. 9.67E-06 O. 2.32E-OS S.34E-04 2.2BE-OS 

H0166M 1.34E-03 2.B1 E-04 2.37E-04 O. 4.01 E-04 1.13E-03 1.63E-OS 

W1B1 2.66E-OB 6.S2E-09 B.99E-10 O. O. S.71E-06 2.61 E-07 

W1BS B.31 E-07 2.0BE-07 2.91 E-OB O. O. 1.B6E-04 1.11 E-OS 

W1B7 4.41 E-09 2.61 E-09 1.17E-09 O. O. 1.11 E-OS 2.46E-OS 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 8 of 16 

CHILD INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 8.03E-02 1.8SE-02 3.18E-03 O. 6.31 E-02 8.74E-02 3.7SE-OS 

BI210 O. S.11 E-06 S.6SE-07 O. S.76E-OS 3.70E-03 3.21 E-OS 

P0210 1.70E-03 2.76E-03 4.09E-04 O. 8.8SE-03 1.0SE-01 4.32E-OS 

RN222 O. O. O. O. O. 4.82E-06 O. 

RA223 7.69E-04 8.89E-07 1.S4E-04 O. 2.36E-OS 8.48E-02 3.00E-04 

RA224 8.44E-OS 1.S3E-07 1.69E-OS O. 4.06E-06 2.92E-02 3.34E-04 

RA22S 1.28E-03 1.14E-06 2.S6E-04 O. 3.02E-OS 9.74E-02 2.84E-04 

RA226 2.34E-01 7.66E-06 1.92E-01 O. 2.03E-04 3.90E-01 3.02E-04 

RA228 1.49E-01 3.94E-06 1.68E-01 O. 1.04E-04 S.37E-01 S.14E-OS 

AC22S 1.81 E-03 1.87E-03 1.21 E-04 O. 1.99E-04 7.37E-02 2.67E-04 

AC227 4.96E+00 8.0SE-01 3.07E-01 O. 1.77E-01 8.04E-01 S.22E-OS 

TH227 9.24E-04 1.26E-OS 2.67E-OS O. 6.67E-OS 1.26E-01 3.49E-04 

TH228 8.06E-01 1.04E-02 2.72E-02 O. S.41 E-02 3.34E+00 3.S9E-04 

TH229 1.28E+01 1.76E-01 6.31 E-01 O. 8.68E-01 1.04E+01 3.27E-04 

TH230 3.30E+00 1.73E-01 9.20E-02 O. 8.S2E-01 1.8SE+00 3.84E-OS 

TH232 3.68E+OO 1.47E-01 1.28E-01 O. 7.28E-01 1.77E+00 3.27E-OS 

TH234 6.94E-06 3.07E-07 2.00E-07 O. 1.62E-06 6.31 E-04 7.32E-OS 

PA231 8.62E+00 2.86E-01 3.43E-01 O. 1.S6E+00 1.92E-01 4.S7E-OS 

PA233 4.14E-06 6.48E-07 7.2SE-07 O. 2.38E-06 9.77E-OS 8.9SE-06 

U232 2.19E-01 O. 1.S6E-02 O. 1.67E-02 7.42E-01 4.33E-OS 

U233 4.64E-02 O. 2.82E-03 O. 7.62E-03 1.77E-01 4.00E-OS 

U234 4.46E-02 O. 2.76E-03 O. 7.47E-03 1.74E-01 3.92E-OS 

U23S 4.27E-02 O. 2.S9E-03 O. 7.01 E-03 1.63E-01 4.98E-OS 

U236 4.27E-02 O. 2.6SE-03 O. 7.16E-03 1.67E-01 3.67E-OS 

U237 1.S7E-07 O. 4.17E-08 O. 4.S3E-07 3.40E-OS 1.29E-OS 

U238 4.09E-02 O. 2.42E-03 O. 6.SSE-03 1.S3E-01 3.S1 E-OS 

NP237 2.88E+00 2.21 E-01 1.19E-01 O. 7.41E-01 1.74E-01 S.06E-OS 

NP238 1.26E-06 2.S6E-08 1.97E-08 O. 8.16E-08 3.39E-OS 2.S0E-OS 

NP239 1.26E-07 9.04E-09 6.3SE-09 O. 2.63E-08 1.S7E-OS 1.73E-OS 

PU238 4.77E+00 6.0SE-01 1.21 E-01 O. 4.47E-01 6.08E-01 4.6SE-OS 

PU239 S.24E+00 6.44E-01 1.28E-01 O. 4.78E-01 S.72E-01 4.24E-OS 

PU240 S.23E+00 6.43E-01 1.27E-01 O. 4.77E-01 S.71E-01 4.33E-OS 

PU241 1.46E-01 6.33E-03 2.93E-03 O. 1.10E-02 S.06E-04 8.90E-07 

PU242 4.8SE+00 6.20E-01 1.23E-01 O. 4.60E-01 S.SOE-01 4.16E-OS 

PU244 S.67E+00 7.10E-01 1.41 E-01 O. S.27E-01 6.30E-01 6.20E-OS 

AM241 1.74E+00 7.8SE-01 1.24E-01 O. 7.63E-01 2.02E-01 4.73E-OS 

AM242M 1.79E+00 7.6SE-01 1.27E-01 O. 7.71 E-01 8.14E-02 S.96E-OS 

AM243 1.72E+00 7.S3E-01 1.20E-01 O. 7.42E-01 1.92E-01 S.SSE-OS 

CM242 6.33E-02 4.84E-02 4.20E-03 O. 1.34E-02 1.31E-01 S.06E-OS 

CM243 1.61 E+OO 7.33E-01 9.9SE-02 O. 3.74E-01 2.10E-01 4.98E-OS 

CM244 1.33E+00 6.48E-01 8.31 E-02 O. 3.06E-01 2.02E-01 4.82E-OS 

CM24S 2.14E+00 8.16E-01 1.28E-01 O. S.03E-01 1.9SE-01 4.49E-OS 

CM246 2.13E+00 8.1SE-01 1.28E-01 O. S.03E-01 1.99E-01 4.41 E-OS 

CM247 2.07E+00 8.02E-01 1.26E-01 O. 4.9SE-01 1.9SE-01 S.80E-OS 

CM248 1.72E+01 6.61E+00 1.04E+00 O. 4.08E+00 1.61 E+OO 9.3SE-04 

CF2S2 3.92E+OO O. 9.33E-02 O. O. 6.62E-01 1.84E-04 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 9 of 16 

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3* O. 1.S9E-07 1.S9E-07 1.S9E-07 1.S9E-07 1.S9E-07 1.S9E-07 

BE10 2.7BE-04 4.33E-OS 7.09E-06 O. O. 3.B4E-04 1.77E-OS 

C14 3.2SE-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 

N13 B.6SE-09 B.6SE-09 B.6SE-09 B.6SE-09 B.6SE-09 B.6SE-09 B.6SE-09 

F1B 6.S2E-07 O. 7.10E-OB O. O. O. 3.B9E-OB 

NA22 1.76E-OS 1.76E-OS 1.76E-OS 1.76E-OS 1.76E-OS 1.76E-OS 1.76E-OS 

NA24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 

P32 2.36E-04 1.37E-OS B.9SE-06 O. O. O. 1.16E-OS 

AR39 O. O. O. O. O. 4.00E-09 O. 

AR41 O. O. O. O. O. 1.44E-OB O. 

CA41 4.0SE-OS O. 4.3BE-06 O. O. 1.01 E-01 3.03E-07 

SC46 7.24E-OS 1.41 E-04 4.1BE-OS O. 1.3SE-04 O. 2.9BE-OS 

CRS1 O. O. 1.69E-OB 9.37E-09 3.B4E-09 2.62E-06 3.7SE-07 

MNS4 O. 6.39E-06 1.0SE-06 O. 1.S9E-06 2.4BE-04 B.3SE-06 

MNS6 O. 2.12E-10 3.1SE-11 O. 2.24F-10 1.90E-06 7.1BE-06 

FESS 4.1BE-06 2.9BE-06 6.93E-07 O. O. 1.SSE-OS 7.99E-07 

FES9 1.99E-06 4.62E-06 1.79E-06 O. O. 1.91 E-04 2.23E-OS 

COS7 O. 1.1BE-07 1.1SE-07 O. O. 7.33E-OS 3.93E-06 

COSB O. 2.S9E-07 3.47E-07 O. O. 1.6BE-04 1.19E-OS 

C060 O. 1.B9E-06 2.4BE-06 O. O. 1.09E-03 3.24E-OS 

NIS9 S.44E-06 2.02E-06 9.24E-07 O. O. 1.41 E-OS 6.4BE-07 

NI63 7.2SE-OS S.43E-06 2.47E-06 O. O. 3.B4E-OS 1.77E-06 

NI6S 2.73E-10 3.66E-11 1.S9E-11 O. O. 1.17E-06 4.S9E-06 

CU64 O. 2.S4E-10 1.06E-10 O. B.01 E-10 1.39E-06 7.6BE-06 

ZN6S 4.B2E-06 1.67E-OS 7.BOE-06 O. 1.0BE-OS 1.SSE-04 S.B3E-06 

ZN69M 1.44E-09 3.39E-09 3.11E-10 O. 2.06E-09 3.92E-06 2.14E-OS 

ZN69 6.04E-12 1.1SE-11 B.07E-13 O. 7.S3E-12 1.9BE-07 3.S6E-OB 

SE79 O. S.43E-07 B.71 E-OB O. B.13E-07 7.71 E-OS 3.S3E-06 

BRB2 O. O. 2.2BE-06 O. O. O. O. 

BRB3 O. O. 4.30E-OB O. O. O. O. 

BRB4 O. O. S.41 E-OB O. O. O. O. 

BRBS O. O. 2.29E-09 O. O. O. O. 

KRB3M O. O. O. O. O. 9.97E-10 O. 

KRBSM O. O. O. O. O. S.46E-09 O. 

KRBS O. O. O. O. O. 4.63E-09 O. 

KRB7 O. O. O. O. O. 2.B2E-OB O. 

KRBB O. O. O. O. O. S.B1 E-OB O. 

KRB9 O. O. O. O. O. 3.BSE-OB O. 

RBB6 O. 2.3BE-OS 1.0SE-OS O. O. O. 2.21 E-06 

RBB7 O. 1.40E-OS 4.SBE-06 O. O. O. 3.0SE-07 

RBBB O. 6.B2E-OB 3.40E-OB O. O. O. 3.6SE-1S 

RBB9 O. 4.40E-OB 2.91 E-OB O. O. O. 4.22E-17 

SRB9 S.43E-OS O. 1.S6E-06 O. O. 3.02E-04 4.64E-OS 

SR90 1.3SE-02 O. B.3SE-04 O. O. 2.06E-03 9.S6E-OS 

SR91 1.10E-OB O. 4.39E-10 O. O. 7.S9E-06 3.24E-OS 

SR92 1.19E-09 O. S.OBE-11 O. O. 3.43E-06 1.49E-OS 

*/ncludes a SO% increase to account for percutaneous transpiration. 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 10 of 16 

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 3.73E-07 O. 1.00E-OB O. O. 3.66E-OS 6.99E-OS 

Y91M 4.63E-11 O. 1.77E-12 O. O. 4.00E-07 3.77E-09 

Y91 B.26E-OS O. 2.21 E-06 O. O. 3.67E-04 S.11 E-OS 

Y92 1.B4E-09 O. S.36E-11 O. O. 3.3SE-06 2.06E-OS 

Y93 1.69E-OB O. 4.6SE-10 O. O. 1.04E-OS 7.24E-OS 

ZR93 6.B3E-OS 3.3BE-OS 1.B4E-OS O. 1.16E-04 3.67E-04 1.60E-OS 

ZR9S 1.B2E-OS S.73E-06 3.94E-06 O. B.42E-06 3.36E-04 1.B6E-OS 

ZR97 1.72E-OB 3.40E-09 1.S7E-09 O. S.1SE-09 1.62E-OS 7.BBE-OS 

NB93M 4.14E-OS 1.36E-OS 3.41 E-06 O. 1.S9E-OS S.36E-OS 2.S2E-06 

NB9S 2.32E-06 1.29E-06 7.0BE-07 O. 1.2SE-06 9.39E-OS 1.21 E-OS 

NB97 3.92E-11 9.72E-12 3.SSE-12 O. 1.14E-11 4.91 E-07 2.71 E-07 

M093 O. 1.66E-06 4.S2E-OB O. S.06E-07 B.B1 E-OS 3.99E-06 

M099 O. 2.11 E-OB 4.03E-09 O. S.14E-OB 1.92E-OS 3.36E-OS 

TC99M 1.73E-13 4.B3E-13 6.24E-12 O. 7.20E-12 1.44E-07 7.66E-07 

TC99 4.4BE-OB 6.SBE-OB 1.79E-OB O. B.3SE-07 1.74E-04 7.99E-06 

TC101 7.40E-1S 1.0SE-14 1.03E-13 O. 1.90E-13 B.34E-OB 1.09E-16 

RU103 2.63E-07 O. 1.12E-07 O. 9.29E-07 9.79E-OS 1.36E-OS 

RU10S 1.40E-10 O. S.42E-11 O. 1.76E-10 2.27E-06 1.13E-OS 

RU106 1.23E-OS O. 1.SSE-06 O. 2.3BE-OS 2.01 E-03 1.20E-04 

RH10S 1.32E-09 9.4BE-10 6.24E-10 O. 4.04E-09 4.09E-06 1.23E-OS 

PD107 O. 1.17E-07 B.39E-09 O. 9.39E-07 1.63E-OS 7.49E-07 

PD109 O. 6.S6E-10 1.66E-10 O. 3.36E-09 3.19E-06 1.96E-OS 

AG110M 1.73E-06 1.64E-06 9.99E-07 O. 3.13E-06 B.44E-04 3.41 E-OS 

AG111 6.07E-OB 2.S2E-OB 1.26E-OB O. B.17E-OB 4.00E-OS 3.00E-OS 

CD113M O. 2.17E-04 7.10E-06 O. 2.43E-04 3.S9E-04 1.6BE-OS 

CD11SM O. 3.4BE-OS 1.14E-06 O. 2.B2E-OS 3.03E-04 S.10E-OS 

SN123 4.31 E-OS 9.44E-07 1.40E-06 7.SSE-07 O. 4.96E-04 4.16E-OS 

SN12S 1.66E-06 4.42E-OB 9.99E-OB 3.4SE-OB O. 1.26E-04 7.29E-OS 

SN126 2. 1 BE-04 S.39E-06 B.24E-06 1.42E-06 O. 1.72E-03 1.6BE-OS 

SB124 S.3BE-06 9.92E-OB 2.10E-06 1.22E-OB O. 4.B1 E-04 4.9BE-OS 

SB12S 9.23E-06 1.01 E-07 2.1SE-06 B.BOE-09 O. 3.42E-04 1.24E-OS 

SB126 6.19E-07 1.27E-OB 2.23E-07 3.S0E-09 O. 1.SSE-04 6.01 E-OS 

SB127 4.64E-OB 9.92E-10 1.7SE-OB S.21 E-10 O. 3.31 E-OS 3.94E-OS 

TE12SM 6.10E-07 2.BOE-07 B.34E-OB 1.7SE-07 O. 6.70E-OS 9.3BE-06 

TE127M 2.2SE-06 1.02E-06 2.73E-07 S.4BE-07 B.17E-06 2.07E-04 1.99E-OS 

TE127 2.S1E-10 1.14E-10 S.S2E-11 1.77E-10 9.10E-10 1.40E-06 1.01 E-OS 

TE129M 1.74E-06 B.23E-07 2.B1 E-07 S.72E-07 6.49E-06 2.47E-04 S.06E-OS 

TE129 B.B7E-12 4.22E-12 2.20E-12 6.4BE-12 3.32E-11 4.12E-07 2.02E-07 

TE131M 1.23E-OB 7.S1 E-09 S.03E-09 9.06E-09 S.49E-OB 2.97E-OS 7.76E-OS 

TE131 1.97E-12 1.04E-12 6.30E-13 1.SSE-12 7.72E-12 2.92E-07 1.B9E-09 

TE132 4.S0E-OB 3.63E-OB 2.74E-OB 3.07E-OB 2.44E-07 S.61 E-OS S.79E-OS 

TE133M 1.01E-11 7.33E-12 S.71E-12 B.1BE-12 S.07E-11 B.71 E-07 1.23E-07 

TE134 S.31E-12 4.3SE-12 3.64E-12 4.46E-12 2.91E-11 6.7SE-07 1.37E-09 

1129 3.S3E-06 2.94E-06 4.90E-06 3.66E-03 S.26E-06 O. 2.29E-07 

1130 7.BOE-07 2.24E-06 B.96E-07 1.B6E-04 3.44E-06 O. 1.14E-06 

1131 4.43E-06 6.14E-06 3.30E-06 1.B3E-03 1.0SE-OS O. B.11 E-07 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 11 of 16 

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 1.99E-07 S.47E-07 1.97E-07 1.B9E-OS B.6SE-07 O. 1.S9E-07 

1133 1.S2E-06 2.S6E-06 7.7BE-07 3.6SE-04 4.49E-06 O. 1.29E-06 

1134 1.11 E-07 2.90E-07 1.0SE-07 4.94E-06 4.SBE-07 O. 2.SSE-09 

113S 4.62E-07 1.1BE-06 4.36E-07 7.76E-OS 1.B6E-06 O. B.69E-07 

XE131M O. O. O. O. O. 2.70E-09 O. 

XE133M O. O. O. O. O. 3.S9E-09 O. 

XE133 O. O. O. O. O. 2.99E-09 O. 

XE13SM O. O. O. O. O. 3.BBE-09 O. 

XE13S O. O. O. O. O. 7.SSE-09 O. 

XE137 O. O. O. O. O. 3.33E-OB O. 

XE13B O. O. O. O. O. 4.3BE-OB O. 

CS134M 2.20E-OB 4.3SE-OB 2.3SE-OB O. 2.S4E-OB 4.S6E-09 2.02E-OB 

CS134 6.2BE-OS 1.41 E-04 6.B6E-OS O. 4.69E-OS 1.B3E-OS 1.22E-06 

CS13S 2.0BE-OS 1.B2E-OS 4.47E-06 O. 7.30E-06 2.70E-06 2.23E-07 

CS136 6.44E-06 2.42E-OS 1.71 E-OS O. 1.3BE-OS 2.22E-06 1.36E-06 

CS137 B.3BE-OS 1.06E-04 3.B9E-OS O. 3.BOE-OS 1.S1 E-OS 1.06E-06 

CS13B S.B2E-OB 1.07E-07 S.SBE-OB O. B.2BE-OB 9.B4E-09 3.3BE-11 

CS139 3.6SE-OB S.12E-OB 1.97E-OB O. 4.34E-OB 4.B6E-09 1.66E-23 

BA139 1.67E-10 1.1BE-13 4.B7E-12 O. 1.11 E-13 B.OBE-07 B.06E-07 

BA140 6.B4E-06 B.3BE-09 4.40E-07 O. 2.BSI=-09 2.S4E-04 2.B6E-OS 

BA141 1.7BE-11 1.32E-14 S.93E-13 O. 1.23E-14 4.11 E-07 9.33E-14 

BA142 4.62E-12 4.63E-1S 2.B4E-13 O. 3.92E-1S 2.39E-07 S.99E-20 

LA140 S.99E-OB 2.9SE-OB 7.B2E-09 O. O. 2.6BE-OS 6.09E-OS 

LA141 7.63E-10 2.3SE-10 3.B7E-11 O. O. 2.31 E-06 1.S4E-OS 

LA142 1.20E-10 S.31E-11 1.32E-11 O. O. 1.27E-06 1.S0E-06 

CE141 3.SSE-06 2.37E-06 2.71 E-07 O. 1.11 E-06 7.67E-OS 1.SBE-OS 

CE143 3.32E-OB 2.42E-OB 2.70E-09 O. 1.0BE-OB 1.63E-OS 3.19E-OS 

CE144 6.11 E-04 2.S3E-04 3.2BE-OS O. 1.S1E-04 1.67E-03 1.0BE-04 

PR143 1.67E-06 6.64E-07 B.2BE-OB O. 3.B6E-07 6.04E-OS 2.67E-OS 

PR144 S.37E-12 2.20E-12 2.72E-13 O. 1.26E-12 2.19E-07 2.94E-14 

ND147 9.B3E-07 1.07E-06 6.41 E-OB O. 6.2BE-07 4.6SE-OS 2.2BE-OS 

PM147 1.1SE-04 1.10E-OS 4.S0E-06 O. 2.10E-OS 1.14E-04 S.B7E-06 

PM14BM 1.32E-OS 3.3SE-06 2.62E-06 O. S.07E-06 3.20E-04 4.10E-OS 

PM14B S.44E-07 B.BBE-OB 4.4BE-OB O. 1.60E-07 6.S2E-OS 6.14E-OS 

PM149 4.91 E-OB 6.B9E-09 2.B4E-09 O. 1.31 E-OB 1.24E-OS 2.79E-OS 

PM1S1 1.20E-OB 1.99E-09 1.01 E-09 O. 3.S7E-09 6.S6E-06 2.27E-OS 

SM1S1 1.07E-04 2.10E-OS 4.B6E-06 O. 2.27E-OS 7.6BE-OS 3.S3E-06 

SM1S3 2.43E-OB 2.01 E-OB 1.47E-09 O. 6.S6E-09 7.11 E-06 1.77E-OS 

EU1S2 2.96E-04 7.19E-OS 6.30E-OS O. 3.34E-04 S.01 E-04 1.3SE-OS 

EU1S4 9.43E-04 1.23E-04 B.60E-OS O. S.44E-04 9.12E-04 3.34E-OS 

EU1SS 2.00E-04 1.96E-OS 1.21 E-OS O. 7.6SE-OS 1.S1 E-03 S.97E-OS 

EU1S6 2.70E-06 2.03E-06 3.30E-07 O. 1.36E-06 1.37E-04 4.S6E-OS 

TB160 3.04E-OS O. 3.79E-06 O. 1.20E-OS 2.97E-04 2.60E-OS 

H0166M 4.40E-04 1.36E-04 9.B7E-OS O. 2.00E-04 6.24E-04 1.6BE-OS 

W1B1 B.90E-09 2.BBE-09 3.01 E-1 0 O. O. 2.9SE-06 2.69E-07 

W1BS 2.7BE-07 9.17E-OB 9.73E-09 O. O. 9.60E-OS 1.14E-OS 

W1B7 1.S0E-09 1.22E-09 4.29E-10 O. O. S.92E-06 2.21 E-OS 
INHALATION DOSE COMMITMENT FACTORS 

Proc No aDeM 

Attachment 5 

Revision 26 

Page 12 of 16 

TEEN INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 3.09E-02 8.28E-03 1.07E-03 o. 2.9SE-02 4.S2E-02 3.87E-OS 

BI210 o. 2.26E-06 1.89E-07 o. 2.74E-OS 1.91 E-03 3.19E-OS 

P0210 S.68E-04 1.22E-03 1.37E-04 o. 4.21E-03 S.41 E-02 4.4SE-OS 

RN222 o. o. O. o. o. 3.94E-06 o. 

RA223 2.S7E-04 3.93E-07 S.14E-OS o. 1.12E-OS 4.39E-02 3.04E-04 

RA224 2.83E-OS 6.77E-08 S.6SE-06 o. 1.93E-06 1.S1 E-02 3.29E-04 

RA22S 4.28E-04 S.04E-07 8.S6E-OS o. 1.44E-OS S.04E-02 2.89E-04 

RA226 1.33E-01 3.38E-06 9.87E-02 o. 9.67E-OS 2.02E-01 3.11 E-04 

RA228 S.34E-02 1.74E-06 S.88E-02 o. 4.97E-OS 2.78E-01 S.30E-OS 

AC22S 6.04E-04 8.2SE-04 4.06E-OS o. 9.47E-OS 3.81 E-02 2.70E-04 

AC227 2.49E+00 3.69E-01 1.48E-01 o. 1.07E-01 4.16E-01 S.38E-OS 

TH227 3.09E-04 S.S6E-06 8.93E-06 o. 3.18E-OS 6.S0E-02 3.S7E-04 

TH228 2.60E-01 4.37E-03 8.78E-03 o. 2.4SE-02 1.69E+00 3.70E-04 

TH229 9.06E+00 1.36E-01 4.4SE-01 o. 6.67E-01 S.OSE+OO 3.36E-04 

TH230 2.34E+00 1.34E-01 6.49E-02 O. 6.SSE-01 8.98E-01 3.9SE-OS 

TH232 2.61E+00 1.14E-01 9.21 E-02 o. S.60E-01 8.60E-01 3.36E-OS 

TH234 2.32E-06 1.3SE-07 6.71E-08 o. 7.73E-07 3.26E-04 7.49E-OS 

PA231 S.32E+00 2.00E-01 2.07E-01 o. 1.12E+00 9.91 E-02 4.71 E-OS 

PA233 1.68E-06 3.24E-07 2.89E-07 O. 1.22E-06 S.39E-OS 1.00E-OS 

U232 7.31 E-02 O. S.23E-03 O. 7.94E-03 3.84E-01 4.46E-OS 

U233 1.SSE-02 O. 9.42E-04 O. 3.63E-03 9.18E-02 4.12E-OS 

U234 1.48E-02 O. 9.23E-04 O. 3.SSE-03 8.99E-02 4.04E-OS 

U23S 1.42E-02 O. 8.67E-04 O. 3.34E-03 8.44E-02 S.13E-OS 

U236 1.42E-02 O. 8.86E-04 O. 3.41 E-03 8.62E-02 3.79E-OS 

U237 S.2SE-08 o. 1.40E-08 o. 2.16E-07 1.76E-OS 1.29E-OS 

U238 1.36E-02 o. 8.10E-04 o. 3.12E-03 7.89E-02 3.62E-OS 

NP237 1.77E+00 1.S4E-01 7.21 E-02 o. S.3SE-01 8.99E-02 S.22E-OS 

NP238 4.23E-07 1.13E-08 6.S9E-09 o. 3.88E-08 1.7SE-OS 2.38E-OS 

NP239 4.23E-08 3.99E-09 2.21 E-09 o. 1.2SE-08 8.11 E-06 1.6SE-OS 

PU238 2.86E+00 4.06E-01 7.22E-02 o. 3.10E-01 3.12E-01 4.79E-OS 

PU239 3.31 E+OO 4.S0E-01 8.0SE-02 O. 3.44E-01 2.93E-01 4.37E-OS 

PU240 3.31E+00 4.49E-01 8.04E-02 O. 3.43E-01 2.93E-01 4.46E-OS 

PU241 6.97E-02 3.S7E-03 1.40E-03 O. 6.47E-03 2.60E-04 9.17E-07 

PU242 3.07E+00 4.33E-01 7.7SE-02 O. 3.31 E-01 2.82E-01 4.29E-OS 

PU244 3.S9E+00 4.96E-01 8.88E-02 O. 3.79E-01 3.23E-01 6.39E-OS 

AM241 1.06E+00 4.07E-01 7.10E-02 O. S.32E-01 1.0SE-01 4.88E-OS 

AM242M 1.07E+00 3.93E-01 7.1SE-02 O. S.30E-01 4.21 E-02 6.14E-OS 

AM243 1.06E+00 3.92E-01 6.9SE-02 o. S.21 E-01 9.91 E-02 S.72E-OS 

CM242 2.12E-02 2.14E-02 1.41 E-03 o. 6.40E-03 6.76E-02 S.21 E-OS 

CM243 8.4SE-01 3.S0E-01 S.00E-02 o. 2.34E-01 1.09E-01 S.13E-OS 

CM244 6.46E-01 3.03E-01 3.88E-02 o. 1.81 E-01 1.0SE-01 4.96E-OS 

CM24S 1.32E+00 4.11E-01 7.S3E-02 o. 3.S2E-01 1.01E-01 4.63E-OS 

CM246 1.31 E+OO 4.11E-01 7.S2E-02 O. 3.S1 E-01 1.03E-01 4.S4E-OS 

CM247 1.28E+00 4.04E-01 7.41 E-02 o. 3.46E-01 1.01 E-01 S.97E-OS 

CM248 1.06E+01 3.33E+00 6.11 E-01 o. 2.8SE+00 8.32E-01 9.63E-04 

CF2S2 1.29E+00 o. 3.07E-02 o. o. 3.43E-01 1.89E-04 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 13 of 16 

ADULT INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3* O. 1.SBE-07 1.SBE-07 1.SBE-07 1.SBE-07 1.SBE-07 1.SBE-07 

BE10 1.9BE-04 3.06E-OS 4.96E-06 O. O. 2.22E-04 1.67E-OS 

C14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 

N13 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09 6.27E-09 

F1B 4.71E-07 O. S.19E-OB O. O. O. 9.24E-09 

NA22 1.30E-OS 1.30E-OS 1.30E-OS 1.30E-OS 1.30E-OS 1.30E-OS 1.30E-OS 

NA24 1.2BE-06 1.2BE-06 1.2BE-06 1.2BE-06 1.2BE-06 1.2BE-06 1.2BE-06 

P32 1.6SE-04 9.64E-06 6.26E-06 O. O. O. 1.0BE-OS 

AR39 O. O. O. O. O. 2.0BE-09 O. 

AR41 O. O. O. O. O. B.06E-09 O. 

CA41 3.B3E-OS O. 4.13E-06 O. O. 3.B3E-06 2.B6E-07 

SC46 S.S1 E-OS 1.07E-04 3.11 E-OS O. 9.99E-OS O. 3.23E-OS 

CRS1 O. O. 1.2SE-OB 7.44E-09 2.BSE-09 1.BOE-06 4.1SE-07 

MNS4 O. 4.9SE-06 7.B7E-07 O. 1.23E-06 1.7SE-04 9.67E-06 

MNS6 O. 1.SSE-10 2.29E-11 O. 1.63E-10 1.1BE-06 2.S3E-06 

FESS 3.07E-06 2.12E-06 4.93E-07 O. O. 9.01 E-06 7.S4E-07 

FES9 1.47E-06 3.47E-06 1.32E-06 O. O. 1.27E-04 2.3SE-OS 

COS7 O. B.6SE-OB B.39E-OB O. O. 4.62E-OS 3.93E-06 

COSB O. 1.9BE-07 2.S9E-07 O. O. 1.16E-04 1.33E-OS 

C060 O. 1.44E-06 1.BSE-06 O. O. 7.46E-04 3.S6E-OS 

NIS9 4.06E-06 1.46E-06 6.77E-07 O. O. B.20E-06 6.11 E-07 

NI63 S.40E-OS 3.93E-06 1.B1 E-06 O. O. 2.23E-OS 1.67E-06 

NI6S 1.92E-10 2.62E-11 1.14E-11 O. O. 7.00E-07 1.S4E-06 

CU64 O. 1.B3E-10 7.69E-11 O. S.7BE-10 B.4BE-07 6.12E-06 

ZN6S 4.0SE-06 1.29E-OS S.B2E-06 O. B.62E-06 1.0BE-04 6.6BE-06 

ZN69M 1.02E-09 2.4SE-09 2.24E-10 O. 1.4BE-09 2.3BE-06 1.71 E-OS 

ZN69 4.23E-12 B.14E-12 S.6SE-13 O. S.27E-12 1.1SE-07 2.04E-09 

SE79 O. 3.B3E-07 6.09E-OB O. S.69E-07 4.47E-OS 3.33E-06 

BRB2 O. O. 1.69E-06 O. O. O. 1.30E-06 

BRB3 O. O. 3.01 E-OB O. O. O. 2.90E-OB 

BRB4 O. O. 3.91 E-OB O. O. O. 2.0SE-13 

BRBS O. O. 1.60E-09 O. O. O. O. 

KRB3M O. O. O. O. O. S.19E-10 O. 

KRBSM O. O. O. O. O. 2.91 E-09 O. 

KRBS O. O. O. O. O. 2.41 E-09 O. 

KRB7 O. O. O. O. O. 1.S3E-OB O. 

KRBB O. O. O. O. O. 3.13E-OB O. 

KRB9 O. O. O. O. O. 2.13E-OB O. 

RBB6 O. 1.69E-OS 7.37E-06 O. O. O. 2.0BE-06 

RBB7 O. 9.B6E-06 3.21 E-06 O. O. O. 2.BBE-07 

RBBB O. 4.B4E-OB 2.41 E-OB O. O. O. 4.1BE-19 

RBB9 O. 3.20E-OB 2.12E-OB O. O. O. 1.16E-21 

SRB9 3.BOE-OS O. 1.09E-06 O. O. 1.7SE-04 4.37E-OS 

SR90 1.24E-02 O. 7.62E-04 O. O. 1.20E-03 9.02E-OS 

SR91 7.74E-09 O. 3.13E-10 O. O. 4.S6E-06 2.39E-OS 

SR92 B.43E-10 O. 3.64E-11 O. O. 2.06E-06 S.3BE-06 

*Includes a SO% increase to account for percutaneous transpiration. 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODCM 

Attachment 5 

Revision 26 

Page 14 of 16 

ADUL T INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 2.61 E-07 O. 7.01 E-09 O. O. 2.12E-OS 6.32E-OS 

Y91M 3.26E-11 O. 1.27E-12 O. O. 2.40E-07 1.66E-10 

Y91 S.7BE-OS O. 1.SSE-06 O. O. 2.13E-04 4.B1 E-OS 

Y92 1.29E-09 O. 3.77E-11 O. O. 1.96E-06 9.19E-06 

Y93 1.1BE-OB O. 3.26E-10 O. O. 6.06E-06 S.27E-OS 

ZR93 S.22E-OS 2.92E-06 1.37E-06 O. 1.11 E-OS 2.13E-OS 1.S1 E-06 

ZR9S 1.34E-OS 4.30E-06 2.91 E-06 O. 6.77E-06 2.21 E-04 1.BBE-OS 

ZR97 1.21 E-OB 2.4SE-09 1.13E-09 O. 3.71 E-09 9.B4E-06 6.S4E-OS 

NB93M 3.10E-OS 1.01 E-OS 2.49E-06 O. 1.16E-OS 3.11 E-OS 2.3BE-06 

NB9S 1.76E-06 9.77E-07 S.26E-07 O. 9.67E-07 6.31 E-OS 1.30E-OS 

NB97 2.7BE-11 7.03E-12 2.S6E-12 O. B.1BE-12 3.00E-07 3.02E-OB 

M093 O. 1.17E-06 3.17E-OB O. 3.SSE-07 S.11 E-OS 3.79E-06 

M099 O. 1.S1 E-OB 2.B7E-09 O. 3.64E-OB 1.14E-OS 3.10E-OS 

TC99M 1.29E-13 3.64E-13 4.63E-12 O. S.S2E-12 9.SSE-OB S.20E-07 

TC99 3.13E-OB 4.64E-OB 1.2SE-OB O. S.BSE-07 1.01 E-04 7.S4E-06 

TC101 S.22E-1S 7.S2E-1S 7.3BE-14 O. 1.3SE-13 4.99E-OB 1.36E-21 

RU103 1.91 E-07 O. B.23E-OB O. 7.29E-07 6.31 E-OS 1.3BE-OS 

RU10S 9.BBE-11 O. 3.B9E-11 O. 1.27E-10 1.37E-06 6.02E-06 

RU106 B.64E-06 O. 1.09E-06 O. 1.67E-OS 1.17E-03 1.14E-04 

RH10S 9.24E-10 6.73E-10 4.43E-10 O. 2.B6E-09 2.41 E-06 1.09E-OS 

PD107 O. B.27E-OB S.B7E-09 O. 6.S7E-07 9.47E-06 7.06E-07 

PD109 O. 4.63E-10 1.16E-10 O. 2.3SE-09 1.BSE-06 1.S2E-OS 

AG110M 1.3SE-06 1.2SE-06 7.43E-07 O. 2.46E-06 S.79E-04 3.7BE-OS 

AG111 4.2SE-OB 1.7BE-OB B.B7E-09 O. S.74E-OB 2.33E-OS 2.79E-OS 

CD113M O. 1.S4E-04 4.97E-06 O. 1.71 E-04 2.0BE-04 1.S9E-OS 

CD11SM O. 2.46E-OS 7.9SE-07 O. 1.9BE-OS 1.76E-04 4.BOE-OS 

8N123 3.02E-OS 6.67E-07 9.B2E-07 S.67E-07 O. 2.BBE-04 3.92E-OS 

8N12S 1.16E-06 3.12E-OB 7.03E-OB 2.S9E-OB O. 7.37E-OS 6.B1 E-OS 

8N126 1.SBE-04 4.1BE-06 6.00E-06 1.23E-06 O. 1.17E-03 1.S9E-OS 

8B124 3.90E-06 7.36E-OB 1.SSE-06 9.44E-09 O. 3.10E-04 S.OBE-OS 

8B12S 6.67E-06 7.44E-OB 1.SBE-06 6.7SE-09 O. 2.1BE-04 1.26E-OS 

8B126 4.S0E-07 9.13E-09 1.62E-07 2.7SE-09 O. 9.S7E-OS 6.01 E-OS 

8B127 3.30E-OB 7.22E-10 1.27E-OB 3.97E-10 O. 2.0SE-OS 3.77E-OS 

TE12SM 4.27E-07 1.9BE-07 S.B4E-OB 1.31 E-07 1.SSE-06 3.92E-OS B.B3E-06 

TE127M 1.SBE-06 7.21E-07 1.96E-07 4.11 E-07 S.72E-06 1.20E-04 1.B7E-OS 

TE127 1.7SE-10 B.03E-11 3.B7E-11 1.32E-10 6.37E-10 B.14E-07 7.17E-06 

TE129M 1.22E-06 S.B4E-07 1.9BE-07 4.30E-07 4.S7E-06 1.4SE-04 4.79E-OS 

TE129 6.22E-12 2.99E-12 1.SSE-12 4.B7E-12 2.34E-11 2.42E-07 1.96E-OB 

TE131M B.74E-09 S.4SE-09 3.63E-09 6.BBE-09 3.B6E-OB 1.B2E-OS 6.9SE-OS 

TE131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 S.46E-12 1.74E-07 2.30E-09 

TE132 3.2SE-OB 2.69E-OB 2.02E-OB 2.37E-OB 1.B2E-07 3.60E-OS 6.37E-OS 

TE133M 7.24E-12 S.40E-12 4.17E-12 6.27E-12 3.74E-11 S.S1 E-07 S.49E-OB 

TE134 3.B4E-12 3.22E-12 1.S7E-12 3.44E-12 2.1BE-11 4.343-07 2.97E-11 

1129 2.4BE-06 2.11 E-06 6.91 E-06 S.S4E-03 4.S3E-06 O. 2.22E-07 

1130 S.72E-07 1.6BE-06 6.60E-07 1.42E-04 2.61 E-06 O. 9.61 E-07 

1131 3.1SE-06 4.47E-06 2.S6E-06 1.49E-03 7.66E-06 O. 7.BSE-07 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODeM 

Attachment 5 

Revision 26 

Page 15 of 16 

ADUL T INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.4BE-07 o. 5.OBE-OB 

1133 1.0BE-06 1.B5E-06 5.65E-07 2.69E-04 3.23E-06 o. 1.11 E-06 

1134 8.05E-OB 2.16E-07 7.69E-OB 3.73E-06 3.44E-07 o. 1.26E-10 

1135 3.35E-07 B.73E-07 3.21 E-07 5.60E-05 1.39E-06 o. 6.56E-07 

XE131M o. o. o. o. o. 1.40E-09 o. 

XE133M o. o. o. o. o. 1.B9E-09 o. 

XE133 o. o. o. o. o. 1.57E-09 o. 

XE135M o. O. o. o. o. 2.22E-09 o. 

XE135 o. o. o. o. O. 4.05E-09 o. 

XE137 o. o. o. o. o. 1.74E-OB o. 

XE13B o. o. o. o. o. 2.44E-OB o. 

CS134M 1.59E-OB 3.20E-OB 1.72E-OB o. 1.B3E-OB 2.93E-09 7.92E-09 

CS134 4.66E-05 1.06E-04 9.10E-05 o. 3.59E-05 1.22E-05 1.30E-06 

CS135 1.46E-05 1.29E-05 5.99E-06 o. 5.11 E-06 1.57E-06 2.11 E-07 

CS136 4.BBE-06 1.B3E-05 1.3BE-05 o. 1.07E-05 1.50E-06 1.46E-06 

CS137 5.9BE-05 7.76E-05 5.35E-05 o. 2.7BE-05 9.40E-06 1.D5E-06 

CS13B 4.14E-OB 7.76E-OB 4.05E-OB o. 6.00E-OB 6.07E-09 2.33E-13 

CS139 2.56E-OB 3.63E-OB 1.39E-OB o. 3.05E-OB 2.B4E-09 5.49E-31 

BA139 1.17E-10 B.32E-14 3.42E-12 o. 7.7BE-14 4.70E-07 1.12E-07 

BA140 4.BBE-06 6.13E-09 3.21 E-07 o. 2.09E-09 1.59E-04 2.73E-05 

BA141 1.25E-11 9.41E-15 4.20E-13 o. B.75E-15 2.42E-07 1.45E-17 

BA142 3.29E-12 3.3BE-15 2.07E-13 o. 2.B6E-15 1.49E-07 1.96E-26 

LA140 4.30E-OB 2.17E-OB 5.73E-09 o. o. 1.70E-05 5.73E-05 

LA141 5.34E-10 1.66E-10 2.71E-11 o. o. 1.35E-06 7.31 E-06 

LA142 B.54E-11 3.BBE-11 9.65E-12 o. o. 7.91 E-07 2.64E-07 

CE141 2.49E-06 1.69E-06 1.91 E-07 o. 7.B3E-07 4.52E-05 1.50E-05 

CE143 2.33E-OB 1.72E-OB 1.91 E-09 o. 7.60E-09 9.97E-06 2.B3E-05 

CE144 4.29E-04 1.79E-04 2.30E-05 o. 1.06E-04 9.72E-04 1.02E-04 

PR143 1.17E-06 4.69E-07 5.BOE-OB o. 2.70E-07 3.51 E-05 2.50E-05 

PR144 3.76E-12 1.56E-12 1.91E-13 o. B.B1 E-13 1.27E-07 2.69E-1B 

ND147 6.59E-07 7.62E-07 4.56E-OB o. 4.45E-07 2.76E-05 2.16E-05 

PM147 B.37E-05 7.B7E-06 3.19E-06 O. 1.49E-05 6.60E-05 5.54E-06 

PM14BM 9.B2E-06 2.54E-06 1.94E-06 o. 3.B5E-06 2.14E-04 4.1BE-05 

PM14B 3.B4E-07 6.37E-OB 3.20E-OB o. 1.20E-07 3.91 E-05 5.BOE-05 

PM149 3.44E-OB 4.B7E-09 1.99E-09 o. 9.19E-09 7.21 E-06 2.50E-05 

PM151 B.50E-09 1.42E-09 7.21E-10 O. 2.55E-09 3.94E-06 2.00E-05 

SM151 B.59E-05 1.4BE-05 3.55E-06 o. 1.66E-05 4.45E-05 3.25E-06 

SM153 1.70E-OB 1.42E-OB 1.04E-09 o. 4.59E-09 4.14E-06 1.5BE-05 

EU152 2.3BE-04 5.41 E-05 4.76E-05 o. 3.35E-04 3.43E-04 1.59E-05 

EU154 7.40E-04 9.1 DE-05 6.4BE-05 o. 4.36E-04 5.B4E-04 3.40E-05 

EU155 1.01 E-04 1.43E-05 9.21 E-06 o. 6.59E-05 9.46E-05 5.95E-06 

EU156 1.93E-06 1.4BE-06 2.40E-07 o. 9.95E-07 B.56E-05 4.50E-05 

TB160 2.21 E-05 o. 2.75E-06 o. 9.10E-06 1.92E-04 2.6BE-05 

H0166M 3.37E-04 1.05E-04 B.00E-05 o. 1.57E-04 3.94E-04 1.59E-05 

W1B1 6.23E-09 2.03E-09 2.17E-10 o. o. 1.71 E-06 2.53E-07 

W1B5 1.95E-07 6.47E-OB 6.B1 E-09 o. o. 5.57E-05 1.07E-05 

W1B7 1.06E-09 B.B5E-10 3.10E-10 O. o. 3.63E-06 1.94E-05 
INHALATION DOSE COMMITMENT FACTORS 

Proc No ODCM 

Attachment 5 

Revision 26 

Page 16 of 16 

ADUL T INHALATION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINHALED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 2.64E-02 6.73E-03 B.37E-04 o. 2.12E-02 2.62E-02 3.6SE-OS 

BI210 o. 1.S9E-06 1.32E-07 o. 1.92E-OS 1.11 E-03 2.9SE-OS 

P0210 3.97E-04 B.60E-04 9.SBE-OS o. 2.9SE-03 3.14E-02 4.19E-OS 

RN222 o. o. o. o. o. 2.0SE-06 o. 

RA223 1.BOE-04 2.77E-07 3.60E-OS o. 7.BSE-06 2.SSE-02 2.B4E-04 

RA224 1.9BE-OS 4.7BE-OB 3.96E-06 o. 1.3SE-06 B.77E-03 3.01 E-04 

RA22S 3.00E-04 3.S6E-07 S.99E-OS o. 1.01 E-OS 2.92E-02 2.71 E-04 

RA226 1.2SE-01 2.39E-06 9.14E-02 o. 6.77E-OS 1.17E-01 2.94E-04 

RA22B 4.41 E-02 1.23E-06 4.7BE-02 o. 3.4BE-OS 1.61 E-01 S.OOE-OS 

AC22S 4.23E-04 S.B2E-04 2.B4E-OS O. 6.63E-OS 2.21 E-02 2.S2E-04 

AC227 2.30E+00 3.0SE-01 1.36E-01 o. 9.B2E-02 2.41 E-01 S.OBE-OS 

TH227 2.17E-04 3.92E-06 6.2SE-06 o. 2.22E-OS 3.77E-02 3.34E-04 

TH226 2.00E-01 3.39E-03 6.77E-03 o. 1.B9E-02 1.01 E+OO 3.49E-04 

TH229 B.BBE+OO 1.33E-01 4.36E-01 o. 6.S2E-01 3.49E+00 3.17E-04 

TH230 2.29E+00 1.31 E-01 6.36E-02 o. 6.40E-01 6.21 E-01 3.73E-OS 

TH232 2.S6E+00 1.12E-01 9.04E-02 o. S.47E-01 S.96E-01 3.17E-OS 

TH234 1.63E-06 9.S6E-OB 4.70E-OB o. S.41 E-07 1.B9E-04 7.03E-OS 

PA231 S.OBE+OO 1.91 E-01 1.9BE-01 o. 1.07E+00 S.7SE-02 4.44E-OS 

PA233 1.21 E-06 2.42E-07 2.09E-07 o. 9.1SE-07 3.S2E-OS 1.02E-OS 

U232 S.14E-02 o. 3.66E-03 o. S.S6E-03 2.22E-01 4.21 E-OS 

U233 1.09E-02 o. 6.60E-04 O. 2.S4E-03 S.32E-02 3.B9E-OS 

U234 1.04E-02 o. 6.46E-04 o. 2.49E-03 S.22E-02 3.B1 E-OS 

U23S 1.00E-02 o. 6.07E-04 o. 2.34E-03 4.90E-02 4.B4E-OS 

U236 1.00E-02 o. 6.20E-04 o. 2.39E-03 S.00E-02 3.S7E-OS 

U237 3.67E-OB o. 9.77E-09 o. 1.S1 E-07 1.02E-OS 1.20E-OS 

U23B 9.SBE-03 o. S.67E-04 O. 2.1BE-03 4.SBE-02 3.41 E-OS 

NP237 1.69E+00 1.47E-01 6.B7E-02 o. S.10E-01 S.22E-02 4.92E-OS 

NP23B 2.96E-07 B.00E-09 4.61 E-09 o. 2.72E-OB 1.02E-OS 2.13E-OS 

NP239 2.B7E-OB 2.B2E-09 1.SSE-09 o. B.7SE-09 4.70E-06 1.49E-OS 

PU23B 2.74E+00 3.B7E-01 6.90E-02 o. 2.96E-01 1.B2E-01 4.S2E-OS 

PU239 3.19E+00 4.31 E-01 7.7SE-02 O. 3.30E-01 1.72E-01 4.13E-OS 

PU240 3.1BE+00 4.30E-01 7.73E-02 O. 3.29E-01 1.72E-01 4.21 E-OS 

PU241 6.41 E-02 3.2BE-03 1.29E-03 o. S.93E-03 1.S2E-04 B.6SE-07 

PU242 2.9SE+00 4.1SE-01 7.46E-02 o. 3.17E-01 1.6SE-01 4.0SE-OS 

PU244 3.4SE+00 4.76E-01 B.S4E-02 o. 3.64E-01 1.B9E-01 6.03E-OS 

AM241 1.01 E+OO 3.S9E-01 6.71 E-02 O. S.04E-01 6.06E-02 4.60E-OS 

AM242M 1.02E+00 3.46E-01 6.73E-02 o. S.01 E-01 2.44E-02 S.79E-OS 

AM243 1.01 E+OO 3.47E-01 6.S7E-02 o. 4.9SE-01 S.7SE-02 S.40E-OS 

CM242 1.4BE-02 1.S1 E-02 9.B4E-04 o. 4.4BE-03 3.92E-02 4.91 E-OS 

CM243 7.B6E-01 2.97E-01 4.61 E-02 O. 2.1SE-01 6.31 E-02 4.B4E-OS 

CM244 S.90E-01 2.S4E-01 3.S1 E-02 O. 1.64E-01 6.06E-02 4.6BE-OS 

CM24S 1.26E+00 3.S9E-01 7.14E-02 o. 3.33E-01 S.BSE-02 4.36E-OS 

CM246 1.2SE+00 3.S9E-01 7.13E-02 o. 3.33E-01 S.96E-02 4.29E-OS 

CM247 1.22E+00 3.S3E-01 7.03E-02 o. 3.2BE-01 S.BSE-02 S.63E-OS 

CM24B 1.01 E+01 2.91 E+OO S.79E-01 o. 2.70E+00 4.B2E-01 9.09E-04 

CF2S2 9.7BE-01 o. 2.33E-02 o. o. 1.99E-01 1.7BE-04 
Proc No aDeM 

Attachment 6 

Revision 26 

Page 1 of2 

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND (DFG,l 

(mrem/hr per pCi/m2) 

ELEMENT TOTAL BODY SKIN 

H-3 0.0 0.0 

C-14 0.0 0.0 

Na-24 2.50E-08 2.90E-08 

P-32 0.0 0.0 

Cr-51 2.20E-10 2.60E-10 

Mn-54 5.80E-09 6.80E-09 

Mn-56 1.10E-08 1.30E-08 

Fe-55 0.0 0.0 

Fe-59 8.00E-09 9.40E-09 

Co-58 7.00E-09 8.20E-09 

Co-60 1.70E-08 2.00E-08 

Ni-63 0.0 0.0 

Ni-65 3.70E-09 4.30E-09 

Cu-64 1.50E-09 1.70E-09 

Zn-65 4.00E-09 4.60E-09 

Zn-69 0.0 0.0 

Br-83 6.40E-11 9.30E-11 

Br-84 1.20E-08 1.40E-08 

Br-85 0.0 0.0 

Rb-86 6.30E-10 7.20E-10 

Rb-88 3.50E-09 4.00E-09 

Rb-89 1.50E-08 1.80E-08 

Sr-89 5.60E-13 6.50E-13 

Sr-91 7.10E-09 8.30E-09 

Sr-92 9.00E-09 1.00E-08 

Y-90 2.20E-12 2.60E-12 

Y-91m 3.80E-09 4.40E-09 

Y-91 2.40E-11 2.70E-11 

Y-92 1.60E-09 1.90E-09 

Y-93 5.70E-10 7.80E-10 

Zr-95 5.00E-09 5.80E-09 

Zr-97 5.50E-09 6.40E-09 

Nb-95 5.10E-09 6.00E-09 

Mo-99 1.90E-09 2.20E-09 

Tc-99m 9.60E-10 1.10E-09 

Tc-101 2.70E-09 3.00E-09 
Proc No ODeM 

Attachment 6 

Revision 26 

Page 2 of2 

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND (DFG,l 

(mrem/hr per pCi/m2) 

ELEMENT TOTAL BODY SKIN 

Ru-103 3.60E-09 4.20E-09 

Ru-105 4.50E-09 5.10E-09 

Ru-106 1.50E-09 1.BOE-09 

Ag-110m 1.BOE-OB 2.10E-OB 

Te-125m 3.50E-11 4.BOE-11 

Te-127m 1.10E-12 1.30E-12 

Te-127 1.00E-11 1.10E-11 

Te-129m 7.70E-10 9.00E-10 

Te-129 7.10E-10 B.40E-10 

Te-131m B.40E-09 9.90E-09 

Te-131 2.20E-09 2.60E-06 

Te-132 1.70E-09 2.00E-09 

1-130 1.40E-OB 1.70E-OB 

1-131 2.BOE-09 3.40E-09 

1-132 1.70E-OB 2.00E-OB 

1-133 3.70E-09 4.50E-09 

1-134 1.60E-OB 1.90E-OB 

1-135 1.20E-OB 1.40E-OB 

Cs-134 1.20E-OB 1.40E-OB 

Cs-136 1.50E-OB 1.70E-OB 

Cs-137 4.20E-09 4.90E-09 

Cs-13B 2.10E-OB 2.40E-OB 

Ba-139 2.40E-09 2.70E-09 

Ba-140 2. 1 OE-09 2.40E-09 

Ba-141 4.30E-09 4.90E-09 

Ba-142 7.90E-09 9.00E-09 

La-140 1.50E-OB 1.70E-OB 

La-142 1.50E-OB 1.BOE-OB 

Ce-141 5.50E-10 6.20E-10 

Ce-143 2.20E-09 2.50E-09 

Ce-144 3.20E-10 3.70E-10 

Pr-143 0.0 0.0 

Pr-144 2.00E-10 2.30E-10 

Nd-147 1.00E-09 1.20E-09 

W-1B7 3.10E-09 3.60E-09 

Np-239 9.50E-10 1.10E-09 
ELEMENT 

H 

C 

NA 

P 

CR 

MN 

FE 

CO 

NI 

CU 

ZN 

BR 

RB 

SR 

Y 

ZR 

NB 

MO 

TC 

RU 

RH 

TE 

I 

CS 

BA 

LA 

CE 

PR 

NO 

W 

NP 

BIOACCUMULATION FACTORS 

uCi/gm per uCi/ml 

Proc No aDeM 

Attachment 7 

Revision 26 

Page 1 of 1 

FRESHWATER 

FISH 

9.0E-01 

4.6E 03 

1.0E 02 

1.0E OS 

2.0E 02 

4.0E 02 

1.0E 02 

S.OE 01 

1.0E 02 

S.OE 01 

2.0E 03 

4.2E 02 

2.0E 03 

3.0E 01 

2.SE 01 

3.3E 00 

3.0E 04 

1.0E 01 

1.SE 01 

1.0E 01 

1.0E 01 

4.0E 02 

1.SE 01 

2.0E 03 

4.0E 00 

2.SE 01 

1.0E 00 

2.SE 01 

2.SE 01 

1.2E 03 

1.0E 01 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 1 of 16 

INGESTION DOSE COMMITMENT FACTORS 

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3 o. 3.0BE-07 3.0BE-07 3.0BE-07 3.0BE-07 3.0BE-07 3.0B3-07 

BE10 1.71 E-OS 2.49E-06 S.16E-07 O. 1.64E-06 O. 2.7BE-OS 

C14 2.37E-OS S.06E-06 S.06E-06 S.06E-06 S.06E-06 S.06E-06 S.06E-06 

N13 S.BSE-OB S.BSE-OB S.BSE-OB S.B3SE-OB S.BSE-OB S.BSE-OB S.BSE-OB 

F1B S.19E-06 O. 4.43E.07 O. O. O. 1.22E-06 

NA22 9.B3E-OS 9.B3E-OS 9.B3E-OS 9.B3E-OS 9.B3E-OS 9.B3E-OS 9.B3E-OS 

NA24 1.01 E-OS 1.01 E-OS 1.01 E-OS 1.01 E-OS 1.01 E-OS 1.01 E-OS 1.01 E-OS 

P32 1.70E-03 1.00E-04 6.S9E-OS O. o. O. 2.30E-OS 

AR39 O. O. O. O. O. o. O. 

AR41 O. O. o. O. o. O. O. 

CA41 3.74E-04 O. 4.0BE-OS o. O. o. 1.91 E-07 

SC46 3.7SE-OB S.41 E-OB 1.69E-OB O. 3.S6E-OB O. 3.S3E-OS 

CRS1 O. O. 1.41 E-OB 9.20E-09 2.01 E-09 1.79E-OB 4.11 E-07 

MNS4 O. 1.99E-OS 4.S1 E-06 O. 4.41 E-06 o. 7.31 E-06 

MNS6 o. B.1BE-07 1.41 E-07 O. 7.03E-07 O. 7.43E-OS 

FESS 1.39E-OS B.9BE-06 2.40E-06 O. O. 4.39E-06 1.14E-06 

FES9 3.0BE-OS S.3BE-OS 2.12E-OS O. o. 1.S9E-OS 2.S7E-OS 

COS7 O. 1.1SE-06 1.B7E-06 O. O. o. 3.92E-06 

COSB O. 3.60E-06 B.9BE-06 O. o. O. B.97E-06 

C060 o. 1.0BE-OS 2.SSE-OS O. O. O. 2.S7E-OS 

NIS9 4.7BE-OS 1.4SE-OS B.17E-06 O. o. O. 7.16E-07 

NI63 6.34E-04 3.92E-OS 2.20E-OS O. O. O. 1.9SE-06 

NI6S 4.70E-06 S.32E-07 2.42E-07 o. O. o. 4.0SE-OS 

CU64 o. 6.09E-07 2.B2E-07 O. 1.03E-06 O. 1.2SE-OS 

ZN6S 1.B4E-OS 6.31 E-OS 2.91 E-OS o. 3.06E-OS O. S.33E-OS 

ZN69M 1.S0E-06 3.06E-06 2.79E-07 O. 1.24E-06 O. 4.24E-OS 

ZN69 9.33E-OB 1.6BE-07 1.2SE-OB O. 6.9BE-OB O. 1.37E-OS 

SE79 O. 2.10E-OS 3.90E-06 O. 2.43E-OS o. S.SBE-07 

BRB2 O. O. 1.27E-OS O. o. O. o. 

BRB3 o. o. 3.63E-07 o. O. o. O. 

BRB4 O. O. 3.B2E-07 O. O. O. O. 

BRBS o. O. 1.94E-OB O. O. O. O. 

KRB3M o. O. O. o. O. O. O. 

KRBSM O. o. O. O. O. o. O. 

KRBS O. O. o. O. o. O. o. 

KRB7 o. O. o. O. o. O. o. 

KRBB o. o. O. O. O. o. O. 

KRB9 O. o. O. O. O. o. O. 

RBB6 O. 1.70E-04 B.40E-OS O. O. o. 4.3SE-06 

RBB7 O. B.BBE-OS 3.S2E-OS O. O. O. S.9BE-07 

RBBB O. 4.9BE-07 2.73E-07 O. O. O. 4.BSE-07 

RBB9 O. 2.B6E-07 1.97E-07 O. O. O. 9.74E-OB 

SRB9 2.S1 E-03 o. 7.20E-OS O. O. O. S.16E-OS 

SR90 1.BSE-02 O. 4.71 E-03 O. O. O. 2.31 E-04 

SR91 S.OOE-OS O. 1.B1 E-06 O. O. o. S.92E-OS 

SR92 1.92E-OS O. 7.13E-07 O. O. o. 2.07E-04 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 2 of 16 

INGESTION DOSE COMMITMENT FACTORS 

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 B.69E-OB O. 2.33E-09 O. O. O. 1.20E-04 

Y91M B.10E-10 O. 2.76E-11 O. O. o. 2.70E-06 

Y91 1.13E-06 O. 3.01 E-OB O. o. O. B.10E-OS 

Y92 7.6SE-09 O. 2.1SE-10 O. O. o. 1.46E-04 

Y93 2.43E-OB o. 6.62E-10 O. O. o. 1.92E-04 

ZR93 1.93E-07 9.1BE-OB S.S4E-OB O. 2.71 E-07 O. 2.39E-OS 

ZR9S 2.06E-07 S.02E-OB 3.S6E-OB O. S.41 E-OB O. 2.S0E-OS 

ZR97 1.4BE-OB 2.S4E-09 1.16E-09 O. 2.S6E-09 O. 1.62E-04 

NB93M 1.23E-07 3.33E-OB 1.04E-OB O. 3.2SE-OB O. 3.9BE-06 

NB9S 4.20E-OB 1.73E-OB 1.00E-OB O. 1.24E-OB O. 1.46E-OS 

NB97 4.S9E-10 9.79E-11 3.S3E-11 O. 7.6SE-11 O. 3.09E-OS 

M093 O. S.6SE-OS 1.B2E-06 O. 1.13E-OS O. 1.21 E-06 

M099 O. 3.40E-OS 6.63E-06 O. S.OBE-OS O. 1.12E-OS 

TC99M 1.92E-09 3.96E-09 S.10E-OB O. 4.26E-OB 2.07E-09 1.1SE-06 

TC99 1.0BE-06 1.46E-06 4.SSE-07 O. 1.23E-OS 1.42E-07 6.31 E-06 

TC101 2.27E-09 2.B6E-09 2.B3E-OB o. 3.40E-OB 1.S6E-09 4.B6E-07 

RU103 1.4BE-06 o. 4.9SE-07 O. 3.0BE-06 O. 1.BOE-OS 

RU10S 1.36E-07 O. 4.SBE-OB o. 1.00E-06 O. S.41 E-OS 

RU106 2.41 E-OS O. 3.01 E-06 O. 2.BSE-OS O. 1.B3E-04 

RH10S 1.09E-06 7.13E-07 4.79E-07 o. 1.9BE-06 O. 1.77E-OS 

PD107 O. 1.19E-06 B.4SE-OB O. 6.79E-06 O. 9.46E-07 

PD109 O. 1.S0E-06 3.62E-07 O. S.S1 E-06 O. 3.6BE-OS 

AG110M 9.96E-07 7.27E-07 4.B1 E-07 O. 1.04E-06 o. 3.77E-OS 

AG111 S.20E-07 2.02E-07 1.07E-07 O. 4.22E-07 O. 4.B2E-OS 

CD113M O. 1.77E-OS 6.S2E-07 O. 1.34E-OS o. 2.66E-OS 

CD11SM O. 1.42E-OS 4.93E-07 O. 7.41 E-06 O. B.09E-OS 

SN123 2.49E-04 3.B9E-06 6.S0E-06 3.91 E-06 O. O. 6.SBE-OS 

SN12S 7.41 E-OS 1.3BE-06 3.29E-06 1.36E-06 O. O. 1.11 E-04 

SN126 S.S3E-04 7.26E-06 1.BOE-OS 1.91 E-06 O. O. 2.S2E-OS 

SB124 2.14E-OS 3.1SE-07 6.63E-06 S.6BE-OB O. 1.34E-OS 6.60E-OS 

SB12S 1.23E-OS 1.19E-07 2.S3E-06 1.S4E-OB O. 7.72E-06 1.64E-OS 

SB126 B.06E-06 1.SBE-07 2.91 E-06 6.19E-OB O. S.07E-06 B.3SE-OS 

SB127 2.23E-06 3.9BE-OB 6.90E-07 2.B4E-OB O. 1.1SE-06 S.91 E-OS 

TE12SM 2.33E-OS 7.79E-06 3.1SE-06 7.B4E-06 O. O. 1.11 E-OS 

TE127M S.BSE-OS 1.94E-OS 7.0BE-06 1.69E-OS 1.44E-04 O. 2.36E-OS 

TE127 1.00E-06 3.3SE-07 2.1SE-07 B.14E-07 2.44E-06 O. 2.10E-OS 

TE129M 1.00E-04 3.43E-OS 1.S4E-OS 3.B4E-OS 2.S0E-04 O. S.97E-OS 

TE129 2.B4E-07 9.79E-OB 6.63E-OB 2.3BE-07 7.07E-07 O. 2.27E-OS 

TE131M 1.S2E-OS 6.12E-06 S.OSE-06 1.24E-OS 4.21 E-OS O. 1.03E-04 

TE131 1.76E-07 6.S0E-OB 4.94E-OB 1.S7E-07 4.S0E-07 O. 7.11 E-06 

TE132 2.0BE-OS 1.03E-OS 9.61 E-06 1.S2E-OS 6.44E-OS O. 3.B1 E-OS 

TE133M 3.91 E-07 1.79E-07 1.71 E-07 3.4SE-07 1.22E-06 O. 1.93E-OS 

TE134 2.67E-07 1.34E-07 1.3BE-07 2.39E-07 9.03E-07 O. 3.06E-06 

1129 2.B6E-OS 2.12E-OS 1.SSE-OS 1.36E-02 2.S1 E-OS O. 4.24E-07 

1130 6.00E-06 1.32E-OS S.30E-06 1.4BE-03 1.4SE-OS O. 2.B3E-06 

1131 3.S9E-OS 4.23E-OS 1.B6E-OS 1.39E-02 4.94E-OS O. 1.S1 E-06 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 3 of 16 

INGESTION DOSE COMMITMENT FACTORS 

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI·LLI 

1132 1.66E-06 3.37E-06 1.20E-06 1.SBE-04 3.76E-06 O. 2.73E.06 

1133 1.2SE-OS 1.B2E-OS S.33E-06 3.31 E-03 2.14E-OS O. 3.OBE-06 

1134 B.69E-07 1.7BE-06 6.33E-07 4.1SE-OS 1.99E-06 O. 1.B4E-06 

113S 3.64E-06 7.24E-06 2.64E-06 6.49E-04 B.07E-06 O. 2.62E-06 

XE131M O. O. O. O. O. O. O. 

XE133M O. O. O. O. O. O. O. 

XE133 O. O. O. O. O. O. O. 

XE13SM O. O. O. O. O. O. O. 

XE13S O. O. O. O. O. O. O. 

XE137 O. O. O. O. O. O. O. 

XE13B O. O. O. O. O. O. O. 

CS134M 1.76E-07 2.93E-07 1.4BE-07 O. 1.13E-07 2.60E-OB 2.32E-07 

CS134 3.77E-04 7.03E-04 7.10E-OS O. 1.B1 E-04 7.42E-OS 1.91 E-06 

CS13S 1.33E-04 1.21 E-04 6.30E-06 O. 3.44E-OS 1.31 E-OS 4.37E-07 

CS136 4.S9E-OS 1.3SE-04 S.04E-OS O. S.3BE-OS 1.10E-OS 2.0SE-06 

CS137 S.22E-04 6.11 E-04 4.33E-OS O. 1.64E-04 6.64E-OS 1.91 E-06 

CS13B 4.B1 E-07 7.B2E-07 3.79E-07 O. 3.90E-07 6.09E-OB 1.2SE-06 

CS139 3.10E-07 4.24E-07 1.62E-07 O. 2.19E-07 3.30E-OB 2.66E-OB 

BA139 B.B1 E-07 S.B4E-10 2.SSE-OB O. 3.S1E-10 3.S4E-10 S.SBE-OS 

BA140 1.71 E-04 1.71 E-07 B.B1 E-06 O. 4.06E-OB 1.0SE-07 4.20E-OS 

BA141 4.2SE-07 2.91E-10 1.34E-OB O. 1.7SE-10 1.77E-10 S.19E-06 

BA142 1.B4E-07 1.S3E-10 9.06E-09 O. B.B1 E-11 9.26E-11 7.S9E-07 

LA140 2.11E-OB B.32E-09 2.14E-09 O. O. O. 9.77E-OS 

LA141 2.B9E-09 B.3BE-10 1.46E-10 O. O. O. 9.61 E-OS 

LA142 1.10E-09 4.04E-10 9.67E-11 O. O. O. 6.B6E-OS 

CE141 7.B7E-OB 4.BOE-OB S.6SE-09 O. 1.4BE-OB O. 2.4BE-OS 

CE143 1.4BE-OB 9.B2E-06 1.12E-09 O. 2.B6E-09 O. S.73E-OS 

CE144 2.9BE-06 1.22E-06 1.67E-07 O. 4.93E-07 O. 1.71 E-04 

PR143 B.1BE-OB 3.04E-OB 4.03E-09 O. 1.13E-OB O. 4.29E-OS 

PR144 2.74E-10 1.06E-10 1.3BE-11 O. 3.B4E-11 O. 4.93E-06 

ND147 S.S3E-OB S.6BE-OB 3.4BE-09 O. 2.19E-OB O. 3.60E-OS 

PM147 3.BBE-07 3.27E-OB 1.S9E-OB O. 4.BBE-OB O. 9.27E-06 

PM14BM 1.6SE-07 4.1BE-OB 3.2BE-OB O. 4.BOE-OB O. S.443-0S 

PM14B 6.32E-OB 9.13E-09 4.60E-09 O. 1.09E-OB O. 9.74E-OS 

PM149 1.3BE-OB 1.B1 E-09 7.90E-10 O. 2.20E-09 O. 4.B6E-OS 

PM1S1 6.1BE-09 9.01 E-10 4.S6E-10 O. 1.07E-09 O. 4.17E-OS 

SM1S1 2.90E-07 6.67E-OB 1.44E-OB O. 4.S3E-OB O. S.SBE-06 

SM1S3 7.72E-09 S.97E-09 4.SBE-10 O. 1.2SE-09 O. 3.12E-OS 

EU1S2 6.74E-07 1.79E-07 1.S1 E-07 O. S.02E-07 O. 1.S9E-OS 

EU1S4 2.64E-06 3.67E-07 2.20E-07 O. 9.9SE-07 O. 4.SBE-OS 

EU1SS S.42E-07 6.2SE-OB 3.23E-OB O. 1.40E-07 O. B.37E-OS 

EU1S6 1.14E-07 7.06E-OB 1.12E-OB O. 3.26E-OB O. 6.67E-OS 

TB160 2.S9E-07 O. 3.24E-OB O. 7.37E-OB O. 3.4SE-OS 

H0166M 1.2SE-06 2.69E-07 2.13E-07 O. 3.S7E-07 O. O. 

W1B1 B.BSE-OB 2.72E-OB 3.04E-09 O. O. O. 3.B2E-07 

W1BS 3.62E-06 1.13E-06 1.29E-07 O. O. O. 1.62E-OS 

W1B7 9.03E-07 6.2BE-07 2.17E-07 O. O. O. 3.69E-OS 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 4 of 16 

INGESTION DOSE COMMITMENT FACTORS 

INFANT INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 S.28E-02 1.42E-02 2.38E-03 O. 4.33E-02 O. S.62E-OS 

BI210 4.16E-06 2.68E-OS 3.S8E-07 O. 2.08E-04 O. S.27E-OS 

P0210 3.10E-03 S.93E-03 7.41 E-04 O. 1.26E-02 O. 6.61 E-OS 

RN222 O. O. O. O. O. o. O. 

RA223 4.41 E-02 6.42E-OS 8.82E-03 O. 1.17E-03 O. 3.43E-04 

RA224 1.46E-02 3.29E-OS 2.91 E-03 O. 6.00E-04 O. 3.86E-04 

RA22S S.78E-02 6.42E-OS 1.1SE-02 O. 1.19E-03 O. 3.24E-04 

RA226 6.20E-01 4.76E-OS S.14E-01 O. 8.71 E-04 O. 3.44E-04 

RA228 4.32E-01 2.S8E-OS 4.86E-01 O. 4.73E-04 O. S.86E-OS 

AC22S 3.92E-OS S.03E-OS 2.63E-06 O. 3.69E-06 O. 4.36E-04 

AC227 4.49E-03 7.67E-04 2.79E-04 O. 1.S6E-04 O. 8.S0E-OS 

TH227 1.20E-04 2.01 E-06 3.4SE-06 O. 7.41 E-06 O. S.70E-04 

TH228 2.47E-03 3.38E-OS 8.36E-OS O. 1.S8E-04 O. S.84E-04 

TH229 1.48E-02 1.94E-04 7.29E-04 O. 9.29E-04 O. S.31 E-04 

TH230 3.80E-03 1.90E-04 1.06E-04 O. 9.12E-04 O. 6.24E-OS 

TH232 4.24E-03 1.63E-04 1.6SE-04 O. 7.79E-04 O. S.31 E-OS 

TH234 6.92E-07 3.77E-08 2.00E-08 O. 1.39E-07 O. 1.19E-04 

PA231 7.S7E-03 2.S0E-04 3.02E-04 O. 1.34E-03 O. 7.44E-OS 

PA233 3.11 E-08 6.09E-09 S.43E-09 O. 1.67E-08 O. 1.46E-OS 

U232 2.42E-02 O. 2.16E-03 O. 2.37E-03 O. 7.04E-OS 

U233 S.08E-03 O. 3.87E-04 O. 1.08E-03 O. 6.S1 E-OS 

U234 4.88E-03 O. 3.80E-04 O. 1.06E-03 O. 6.37E-OS 

U23S 4.67E-03 O. 3.S6E-04 O. 9.93E-04 O. 8.10E-OS 

U236 4.67E-03 O. 3.64E-04 O. 1.01 E-03 O. S.98E-OS 

U237 4.9SE-07 O. 1.32E-07 O. 1.23E-06 O. 2.11 E-OS 

U238 4.47E-03 O. 3.33E-04 O. 9.28E-04 O. S.71 E-OS 

NP237 2.S3E-03 1.93E-04 1.0SE-04 O. 6.34E-04 O. 8.23E-OS 

NP238 1.24E-07 3.12E-09 1.92E-09 O. 6.81 E-09 O. 4.17E-OS 

NP239 1.11 E-08 9.93E-10 S.61 E-1 0 O. 1.98E-09 O. 2.87E-OS 

PU238 1.34E-03 1.69E-04 3.40E-OS O. 1.21 E-04 O. 7.S7E-OS 

PU239 1.4SE-03 1.77E-04 3.S4E-OS O. 1.28E-04 O. 6.91 E-OS 

PU240 1.4SE-03 1.77E-04 3.S4E-OS O. 1.28E-04 O. 7.04E-OS 

PU241 4.38E-OS 1.90E-06 8.82E-07 O. 3.17E-06 O. 1.4SE-06 

PU242 1.3SE-03 1.70E-04 3.41 E-OS O. 1.23E-04 O. 6.77E-OS 

PU244 1.S7E-03 1.9SE-04 3.91 E-OS O. 1.41 E-04 O. 1.01 E-04 

AM241 1.S3E-03 7.18E-04 1.09E-04 O. 6.SSE-04 O. 7.70E-OS 

AM242M 1.S8E-03 7.02E-04 1.13E-04 O. 6.64E-04 O. 9.69E-OS 

AM243 1.S1 E-03 6.88E-04 1.06E-04 O. 6.36E-04 O. 9.03E-OS 

CM242 1.37E-04 1.24E-04 9.10E-06 O. 2.62E-OS O. 8.23E-OS 

CM243 1.4SE-03 6.88E-04 8.98E-OS O. 3.27E-04 O. 8.10E-OS 

CM244 1.22E-03 6.16E-04 7.S9E-OS O. 2.71E-04 O. 7.84E-OS 

CM24S 1.88E-03 7.49E-04 1.13E-04 O. 4.32E-04 O. 7.30E-OS 

CM246 1.87E-03 7.49E-04 1.13E-04 O. 4.31E-04 O. 7.17E-OS 

CM247 1.82E-03 7.36E-04 1.11 E-04 O. 4.24E-04 O. 9.43E-OS 

CM248 1.S1 E-02 6.07E-03 9.16E-04 O. 3.S0E-03 O. 1.S2E-03 

CF2S2 1.24E-03 O. 2.9SE-OS 0 O. O. 2.99E-04 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 5 of 16 

INGESTION DOSE COMMITMENT FACTORS 

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3 O. 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 

BE10 1.3SE-OS 1.S7E-06 3.39E-07 O. 1.11 E-06 O. 2.7SE-OS 

C14 1.21 E-OS 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 

N13 3.10E-OB 3.10E-OB 3.10E-OB 3.10E-OB 3.10E-OB 3.10E-OB 3.10E-OB 

F1B 2.49E-06 O. 2.47E-07 O. O. O. 6.74E-07 

NA22 S.BBE-OS S.BBE-OS S.BBE-OS S.BBE-OS S.BBE-OS S.BBE-OS S.BBE-OS 

NA24 S.BOE-06 S.BOE-06 S.BOE-06 S.BOE-06 S.BOE-06 S.BOE-06 S.BOE-06 

P32 B.2SE-04 3.B6E-OS 3.1BE-OS O. O. O. 2.2BE-OS 

AR39 O. O. O. O. O. o. O. 

AR41 O. O. o. O. O. O. O. 

CA41 3.47E-04 O. 3.79E-OS O. O. O. 1.90E-07 

SC46 1.97E-OB 2.70E-OB 1.04E-OB O. 2.30E-OB O. 3.9SE-OS 

CRS1 O. O. B.90E-09 4.94E-09 1.3SE-09 9.02E-09 4.72E-07 

MNS4 O. 1.07E-OS 2.BSE-06 O. 3.00E-06 O. B.9BE-06 

MNS6 O. 3.34E-07 7.S4E-OB O. 4.04E-07 O. 4.B4E-OS 

FESS 1.1SE-OS 6.10E-06 1.B9E-06 O. O. 3.4SE-06 1.13E-06 

FES9 1.6SE-OS 2.67E-OS 1.33E-OS O. O. 7.74E-06 2.7BE-OS 

COS7 O. 4.93E-07 9.9BE-07 O. O. O. 4.04E-06 

COSB O. 1.BOE-06 S.S1 E-06 O. O. O. 1.0SE-OS 

C060 O. S.29E-06 1.S6E-OS O. O. O. 2.93E-OS 

NIS9 4.02E-OS 1.07E-OS 6.B2E-06 O. O. O. 7.10E-07 

NI63 S.3BE-04 2.BBE-OS 1.B3E-OS O. O. O. 1.94E-06 

NI6S 2.22E-06 2.09E-07 1.22E-07 O. O. O. 2.S6E-OS 

CU64 O. 2.4SE-07 1.4BE-07 O. S.92E-07 O. 1.1SE-OS 

ZN6S 1.37E-OS 3.6SE-OS 2.27E-OS O. 2.30E-OS O. 6.41 E-06 

ZN69M 7.10E-07 1.21 E-06 1.43E-07 O. 7.03E-07 O. 3.94E-OS 

ZN69 4.3BE-OB 6.33E-OB S.BSE-09 O. 3.B4E-OB O. 3.99E-06 

SE79 O. B.43E-06 1.B7E-06 O. 1.37E-OS O. S.S3E-07 

BRB2 O. O. 7.SSE-06 O. O. O. O. 

BRB3 O. O. 1.71 E-07 O. O. O. O. 

BRB4 O. O. 1.9BE-07 O. O. O. O. 

BRBS 0 O. 9.12E-09 O. O. O. O. 

KRB3M O. O. O. O. O. O. O. 

KRBSM O. O. O. O. O. O. O. 

KRBS O. O. O. O. O. O. O. 

KRB7 O. O. O. O. O. O. O. 

KRBB O. O. O. O. O. O. O. 

KRB9 O. O. O. O. O. O. O. 

RBB6 O. 6.70E-OS 4.12E-OS O. O. O. 4.31 E-06 

RBB7 O. 3.9SE-OS 1.B3E-OS O. O. O. S.92E-07 

RBBB O. 1.90E-07 1.32E-07 O. O. O. 9.32E-09 

RBB9 O. 1.17E-07 1.04E-07 O. O. O. 1.02E-09 

SRB9 1.32E-03 O. 3.77E-OS O. O. O. S.11 E-OS 

SR90 1.70E-02 O. 4.31 E-03 O. O. O. 2.29E-04 

SR91 2.40E-OS O. 9.06E-07 O. O. O. S.30E-OS 

SR92 9.03E-06 O. 3.62E-07 O. O. O. 1.71 E-04 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 6 of 16 

INGESTION DOSE COMMITMENT FACTORS 

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 4.11 E-OB O. 1.10E-09 O. O. O. 1.17E-04 

Y91M 3.B2E-10 O. 1.39E-11 O. O. O. 7.4BE-07 

Y91 6.02E-07 O. 1.61 E-OB O. O. O. B.02E-OS 

Y92 3.60E-09 O. 1.03E-10 O. O. O. 1.04E-04 

Y93 1.14E-OB O. 3.13E-10 O. O. O. 1.70E-04 

ZR93 1.67E-07 6.2SE-OB 4.4SE-OB O. 2.42E-07 O. 2.37E-OS 

ZR9S 1.16E-07 2.SSE-OB 2.27E-OB O. 3.6SE-OB O. 2.66E-OS 

ZR97 6.99E-09 1.01 E-09 S.96E-10 O. 1.4SE-09 O. 1.S3E-04 

NB93M 1.0SE-07 2.62E-OB B.61 E-09 O. 2.B3E-OB O. 3.9SE-06 

NB9S 2.2SE-OB B.76E-09 6.26E-09 O. B.23E-09 O. 1.62E-OS 

NB97 2.17E-10 3.92E-11 1.B3E-11 O. 4.3SE-11 O. 1.21 E-OS 

M093 O. 2.41 E-OS B.6SE-07 O. 6.3SE-06 O. 1.22E-06 

M099 O. 1.33E-OS 3.29E-06 O. 2.B4E-OS O. 1.10E-OS 

TC99M 9.23E-10 1.B1 E-09 3.00E-OB O. 2.63E-OB 9.19E-10 1.03E-06 

TC99 S.3SE-07 S.96E-07 2.14E-07 O. 7.02E-06 S.27E-OB 6.2SE-06 

TC101 1.07E-09 1.12E-09 1.42E-OB O. 1.91 E-OB S.92E-10 3.S6E-09 

RU103 7.31 E-07 O. 2.B1 E-07 O. 1.B4E-06 O. 1.B9E-OS 

RU10S 6.4SE-OB O. 2.34E-OB O. S.67E-07 O. 4.21 E-OS 

RU106 1.17E-OS O. 1.46E-06 O. 1.SBE-OS O. 1.B2E-04 

RH10S S.14E-07 2.76E-07 2.36E-07 O. 1.10E-06 O. 1.71 E-OS 

PD107 O. 4.72E-07 4.01 E-OB O. 3.9SE-06 O. 9.37E-07 

PD109 O. S.67E-07 1.70E-07 O. 3.04E-06 O. 3.3SE-OS 

AG110M S.39E-07 3.64E-07 2.91 E-07 O. 6.7BE-07 O. 4.33E-OS 

AG111 2.4BE-07 7.76E-OB S.12E-OB O. 2.34E-07 O. 4.7SE-OS 

CD113M O. 1.02E-OS 4.34E-07 O. 1.0SE-OS O. 2.63E-OS 

CD11SM O. S.B9E-06 2.S1 E-07 O. 4.3BE-06 O. B.01 E-OS 

SN123 1.33E-04 1.6SE-06 3.24E-06 1.7SE-06 O. O. 6.S2E-OS 

SN12S 3.SSE-OS S.3SE-07 1.S9E-06 S.SSE-07 O. O. 1.10E-04 

SN126 3.33E-04 4.1SE-06 9.46E-06 1.14E-06 O. O. 2.S0E-OS 

SB124 1.11 E-OS 1.44E-07 3.B9E-06 2.4SE-OB O. 6.16E-06 6.94E-OS 

SB12S 7.16E-06 S.S2E-OB 1.S0E-06 6.63E-09 O. 3.99E-06 1.71 E-OS 

SB126 4.40E-06 6.73E-OB 1.SBE-06 2.SBE-OB O. 2.10E-06 B.B7E-OS 

SB127 1.06E-06 1.64E-OB 3.6BE-07 1.1BE-OB O. 4.60E-07 S.97E-OS 

TE12SM 1.14E-OS 3.09E-06 1.S2E-06 3.20E-06 O. O. 1.10E-OS 

TE127M 2.B9E-OS 7.7BE-06 3.43E-06 6.91 E-06 B.24E-OS O. 2.34E-OS 

TE127 4.71 E-07 1.27E-07 1.01 E-07 3.26E-07 1.34E-06 O. 1.B4E-OS 

TE129M 4.B7E-OS 1.36E-OS 7.S6E-06 1.S7E-OS 1.43E-04 O. S.94E-OS 

TE129 1.34E-07 3.74E-OB 3.1BE-OB 9.S6E-OB 3.92E-07 O. B.34E-06 

TE131M 7.20E-06 2.49E-06 2.6SE-06 S.12E-06 2.41 E-OS O. 1.01 E-04 

TE131 B.30E-OB 2.S3E-OB 2.47E-OB 6.3SE-OB 2.S1 E-07 O. 4.36E-07 

TE132 1.01 E-OS 4.47E-06 S.40E-06 6.S1 E-06 4.1SE-OS O. 4.S0E-OS 

TE133M 1.B7E-07 7.S6E-OB 9.37E-OB 1.4SE-07 7.1BE-07 O. S.77E-06 

TE134 1.29E-07 S.BOE-OB 7.74E-OB 1.02E-07 S.37E-07 O. S.B9E-07 

1129 1.39E-OS B.S3E-06 7.62E-06 S.SBE-03 1.44E-OS O. 4.29E-07 

1130 2.92E-06 S.90E-06 3.04E-06 6.S0E-04 B.B2E-06 O. 2.76E-06 

1131 1.72E-OS 1.73E-OS 9.B3E-06 S.72E-03 2.B4E-OS O. 1.S4E-06 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 7 of 16 

INGESTION DOSE COMMITMENT FACTORS 

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 B.00E-07 1.47E-06 6.76E-07 6.B2E-OS 2.2SE-06 O. 1.73E-06 

1133 S.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-OS O. 2.9SE-06 

1134 4.19E-07 7.7BE-07 3.SBE-07 1.79E-OS 1.19E-06 O. S.16E-07 

113S 1.7SE-06 3.1SE-06 1.49E-06 2.79E-04 4.B3E-06 O. 2.40E-06 

XE131M O. O. O. O. O. O. O. 

XE133M O. O. O. O. O. O. 0: 

XE133 O. O. O. O. O. O. O. 

XE13SM O. O. O. O. O. O. O. 

XE13S O. O. O. O. O. O. O. 

XE137 O. O. O. O. O. O. O. 

XE13B O. O. O. O. O. O. O. 

CS134M B.44E-OB 1.2SE-07 B.16E-OB O. 6.S9E-OB 1.09E-OB 1.SBE-07 

CS134 2.34E-04 3.B4E-04 B.10E-OS O. 1.19E-04 4.27E-OS 2.07E-06 

CS13S B.30E-OS S.7BE-OS S.93E-06 O. 2.04E-OS 6.B1 E-06 4.33E-07 

CS136 2.3SE-OS 6.46E-OS 4.1BE-OS O. 3.44E-OS S.13E-06 2.27E-06 

CS137 3.27E-04 3.13E-04 4.62E-OS O. 1.02E-04 3.67E-OS 1.96E-06 

CS13B 2.2BE-07 3.17E-07 2.01 E-07 O. 2.23E-07 2.40E-OB 1.46E-07 

CS139 1.4SE-07 1.61 E-07 7.74E-OB O. 1.21 E-07 1.22E-OB 1.4SE-11 

BA139 4.14E-07 2.21 E-1 0 1.20E-OB O. 1.93E-10 1.30E-10 2.39E-OS 

BA140 B.31 E-OS 7.2BE-OB 4.BSE-06 O. 2.37E-OB 4.34E-OB 4.21 E-OS 

BA141 2.00E-07 1.12E-10 6.S1 E-09 O. 9.69E-11 6.SBE-10 1.14E-07 

BA142 B.74E-OB 6.29E-11 4.BBE-09 O. S.09E-11 3.70E-11 1.14E-09 

LA140 1.01 E-OB 3.S3E-09 1.19E-09 O. O. O. 9.B4E-OS 

LA141 1.3SE-09 3.17E-10 6.BBE-11 O. O. O. 7.0SE-OS 

LA142 S.24E-10 1.67E-10 S.23E-11 O. O. O. 3.31 E-OS 

CE141 3.97E-OB 1.9BE-OB 2.94E-09 O. B.6BE-09 O. 2.47E-OS 

CE143 6.99E-09 3.79E-06 S.49E-10 O. 1.S9E-09 O. S.SSE-OS 

CE144 2.0BE-06 6.S2E-07 1.11 E-07 O. 3.61 E-07 O. 1.70E-04 

PR143 3.93E-OB 1.1BE-OB 1.9SE-09 O. 6.39E-09 O. 4.24E-OS 

PR144 1.29E-10 3.99E-11 6.49E-12 O. 2.11E-11 O. B.S9E-OB 

ND147 2.79E-OB 2.26E-OB 1.7SE-09 O. 1.24E-OB O. 3.SBE-OS 

PM147 3.1BE-07 2.27E-OB 1.22E-OB O. 4.01 E-OB O. 9.19E-06 

PM14BM 1.03E-07 2.0SE-OB 2.0SE-OB O. 3.04E-OB O. S.7BE-OS 

PM14B 3.02E-OB 3.63E-09 2.3SE-09 O. 6.17E-09 O. 9.70E-OS 

PM149 6.49E-09 6.90E-10 3.74E-10 O. 1.22E-09 O. 4.71 E-OS 

PM1S1 2.92E-09 3.SSE-10 2.31 E-1 0 O. 6.02E-10 O. 4.03E-OS 

SM1S1 2.S6E-07 3.B1 E-OB 1.20E-OB O. 3.94E-OB O. S.S3E-06 

SM1S3 3.6SE-09 2.27E-09 2.19E-10 O. 6.91 E-10 O. 3.02E-OS 

EU1S2 6.1SE-07 1.12E-07 1.33E-07 O. 4.73E-07 O. 1.B4E-OS 

EU1S4 2.30E-06 2.07E-07 1.B9E-07 O. 9.09E-07 O. 4.B1 E-OS 

EU1SS 4.B2E-07 3.47E-OB 2.72E-OB O. 1.30E-07 O. B.69E-OS 

EU1S6 S.62E-OB 3.01 E-OB 6.23E-09 O. 1.94E-OB O. 6.B3E-OS 

TB160 1.66E-07 O. 2.06E-OB O. 4.94E-OB O. 3.6BE-OS 

H0166M 1.0BE-06 2.26E-07 1.91 E-07 O. 3.22E-07 O. O. 

W1B1 4.23E-06 1.04E-OB 1.43E-09 O. O. O. 3.79E-07 

W1BS 1.73E-06 4.32E-07 6.0SE-OB O. O. O. 1.61 E-OS 

W1B7 4.29E-07 2.S4E-07 1.14E-07 O. O. O. 3.S7E-OS 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 8 of 16 

INGESTION DOSE COMMITMENT FACTORS 

CHILD INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 4.7SE-02 1.22E-02 2.09E-03 O. 3.67E-02 O. S.S7E-OS 

BI210 1.97E-06 1.02E-OS 1.69E-07 O. 1.1SE-04 o. S.17E-OS 

P0210 1.S2E-03 2.43E-03 3.67E-04 o. 7.S6E-03 O. 6.SSE-OS 

RN222 o. O. O. O. O. O. o. 

RA223 2.12E-02 2.4SE-OS 4.24E-03 O. 6.S0E-04 o. 3.3BE-04 

RA224 6.B9E-03 1.2SE-OS 1.3BE-03 O. 3.31 E-04 O. 3.7BE-04 

RA22S 2.BOE-02 2.S0E-OS S.S9E-03 O. 6.62E-04 O. 3.21 E-04 

RA226 S.7SE-01 1.B4E-OS 4.72E-01 O. 4.BBE-04 O. 3.41 E-04 

RA22B 3.BSE-01 9.99E-06 4.32E-01 O. 2.6SE-04 O. S.B1E-OS 

AC22S 1.BBE-OS 1.94E-OS 1.26E-06 O. 2.07E-06 O. 4.31 E-04 

AC227 4.12E-03 6.63E-04 2.SSE-04 O. 1.46E-04 O. B.43E-OS 

TH227 S.BSE-OS 7.96E-07 1.69E-06 O. 4.22E-06 O. S.63E-04 

TH22B 2.07E-03 2.6SE-OS 7.00E-OS O. 1.3BE-04 O. S.79E-04 

TH229 1.3BE-02 1.B1 E-04 6.BOE-04 O. B.B4E-04 O. S.27E-04 

TH230 3.SSE-03 1.7BE-04 9.91 E-OS O. B.67E-04 O. 6.19E-OS 

TH232 3.96E-03 1.S2E-04 3.01 E-04 O. 7.41E-04 O. S.27E-OS 

TH234 3.42E-07 1.S1 E-OB 9.BBE-09 O. B.01 E-OB O. 1.1BE-04 

PA231 7.07E-03 2.34E-04 2.B1 E-04 O. 1.2BE-03 O. 7.37E-OS 

PA233 1.B1 E-OB 2.B2E-09 3.16E-09 O. 1.04E-OB O. 1.44E-OS 

U232 1.76E-02 O. 1.26E-03 O. 1.34E-03 O. 6.9BE-OS 

U233 3.72E-03 O. 2.2SE-04 O. 6.10E-04 O. 6.4SE-OS 

U234 3.S7E-03 O. 2.21 E-04 O. S.9BE-04 O. 6.32E-OS 

U23S 3.42E-03 O. 2.07E-04 O. S.61 E-04 O. B.03E-OS 

U236 3.42E-03 O. 2.12E-04 O. S.73E-04 O. S.92E-OS 

U237 2.36E-07 O. 6.27E-OB O. 6.B1 E-07 O. 2.0BE-OS 

U23B 3.27E-03 O. 1.94E-04 O. S.24E-04 O. S.66E-OS 

NP237 2.36E-03 1.B1 E-04 9.79E-OS O. 6.0SE-04 O. B.16E-OS 

NP23B S.B3E-OB 1.1BE-09 9.0BE-10 O. 3.76E-09 O. 4.04E-OS 

NP239 S.2SE-09 3.77E-10 2.6SE-10 O. 1.09E-09 O. 2.79E-OS 

PU23B 1.2SE-03 1.S6E-04 3.16E-OS O. 1.1SE-04 O. 7.S0E-OS 

PU239 1.36E-03 1.6SE-04 3.31 E-OS O. 1.22E-04 O. 6.BSE-OS 

PU240 1.36E-03 1.6SE-04 3.31 E-OS O. 1.22E-04 O. 6.9BE-OS 

PU241 4.00E-OS 1.72E-06 B.04E-07 O. 2.96E-06 O. 1.44E-06 

PU242 1.26E-03 1.S9E-04 3.19E-OS O. 1.17E-04 O. 6.71 E-OS 

PU244 1.47E-03 1.B2E-04 3.6SE-OS O. 1.3SE-04 O. 1.00E-04 

AM241 1.43E-03 6.40E-04 1.02E-04 O. 6.23E-04 O. 7.64E-OS 

AM242M 1.47E-03 6.2SE-04 1.04E-04 O. 6.30E-04 O. 9.61 E-OS 

AM243 1.41 E-03 6.14E-04 9.B3E-OS O. 6.06E-04 O. B.9SE-OS 

CM242 B.BOE-OS 6.73E-OS S.B4E-06 O. 1.B7E-OS O. B.16E-OS 

CM243 1.33E-03 6.03E-04 B.24E-OS O. 3.0BE-04 O. B.03E-OS 

CM244 1.11 E-03 S.36E-04 6.93E-OS O. 2.S4E-04 O. 7.77E-OS 

CM24S 1.76E-03 6.64E-04 1.0SE-04 O. 4.11 E-04 O. 7.24E-OS 

CM246 1.74E-03 6.64E-04 1.0SE-04 O. 4.10E-04 O. 7.11 E-OS 

CM247 1.70E-03 6.S3E-04 1.03E-04 O. 4.04E-04 O. 9.3SE-OS 

CM24B 1.41 E-02 S.3BE-03 B.S2E-04 O. 3.33E-03 O. 1.S1 E-03 

CF2S2 1.07E-03 O. 2.S4E-OS O. O. O. 2.96E-04 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 9 of 16 

INGESTION DOSE COMMITMENT FACTORS 

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3 O. 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 

BE10 4.4BE-06 6.94E-07 1.13E-07 O. S.30E-07 O. 2.B4E-OS 

C14 4.06E-06 B.12E-07 B.12E-07 B.12E-07 B.12E-07 B.12E-07 B.12E-07 

N13 1.1SE-OB 1.1SE-OB 1.1SE-OB 1.1SE-OB 1.1SE-OB 1.1SE-OB 1.1SE-OB 

F1B B.64E-07 O. 9.47E-OB O. O. O. 7.7BE-OB 

NA22 2.34E-OS 2.34E-OS 2.34E-OS 2.34E-OS 2.34E-OS 2.34E-OS 2.34E-OS 

NA24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 

P32 2.76E-04 1.71 E-OS 1.07E-OS O. O. O. 2.32E-OS 

AR39 O. O. O. O. O. O. O. 

AR41 O. O. O. O. O. O. O. 

CA41 1.97E-04 O. 2.13E-OS O. O. O. 1.9SE-07 

SC46 7.24E-09 1.41 E-OB 4.1BE-09 O. 1.3SE-OB O. 4.BOE-OS 

CRS1 O. O. 3.60E-09 2.00E-09 7.B9E-10 S.14E-09 6.0SE-07 

MNS4 O. S.90E-06 1.17E-06 O. 1.76E-06 O. 1.21 E-OS 

MNS6 O. 1.SBE-07 2.B1 E-OB O. 2.00E-07 O. 1.04E-OS 

FESS 3.7BE-06 2.6BE-06 6.2SE-07 O. O. 1.70E-06 1.16E-06 

FES9 S.B7E-06 1.37E-OS S.29E-06 O. O. 4.32E-06 3.24E-OS 

COS7 O. 2.3BE-07 3.99E-07 O. O. O. 4.44E-06 

COSB O. 9.72E-07 2.24E-06 O. O. O. 1.34E-OS 

C060 0 2.B1 E-06 6.33E-06 O. O. O. 3.66E-OS 

NIS9 1.32E-OS 4.66E-06 2.24E-06 O. O. O. 7.31 E-07 

NI63 1.77E-04 1.2SE-OS 6.00E-06 O. O. O. 1.99E-06 

NI6S 7.49E-07 9.S7E-OB 4.36E-OB O. O. O. S.193-06 

CU64 O. 1.1SE-07 S.41E-OB O. 2.91 E-07 O. B.92E-06 

ZN6S S.76E-06 2.00E-OS 9.33E-06 O. 1.2BE-OS O. B.47E-06 

ZN69M 2.40E-07 S.66E-07 S.19E-OB O. 3.44E-07 O. 3.11 E-OS 

ZN69 1.47E-OB 2.BOE-OB 1.96E-09 O. 1.B3E-OB O. S.16E-OB 

SE79 O. 3.73E-06 6.27E-07 O. 6.S0E-06 O. S.70E-07 

BRB2 O. O. 3.04E-06 O. O. O. O. 

BRB3 O. O. S.74E-OB O. O. O. O. 

BRB4 O. O. 7.22E-OB O. O. O. O. 

BRBS O. O. 3.0SE-09 O. O. O. O. 

KRB3M O. O. O. O. O. O. O. 

KRBSM O. O. O. O. O. O. O. 

KRBS O. O. O. O. O. O. O. 

KRB7 O. O. O. O. O. O. O. 

KRBB O. O. O. O. O. O. O. 

KRB9 O. O. O. O. O. O. O. 

RBB6 O. 2.9BE-OS 1.40E-OS O. O. O. 4.41 E-06 

RBB7 O. 1.7SE-OS 6.11 E-06 O. O. O. 6.11 E-07 

RBBB O. B.S2E-OB 4.S4E-OB O. O. O. 7.30E-1S 

RBB9 O. S.SOE-OB 3.B9E-OB O. O. O. B.43E-17 

SRB9 4.40E-04 O. 1.26E-OS O. O. O. S.24E-OS 

SR90 B.30E-03 O. 2.0SE-03 O. O. O. 2.33E-04 

SR91 B.07E-06 O. 3.21 E-07 O. O. O. 3.66E-OS 

SR92 3.0SE-06 O. 1.30E-07 O. O. O. 7.77E-OS 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 10 of 16 

INGESTION DOSE COMMITMENT FACTORS 

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 1.37E-OB O. 3.69E-10 O. O. o. 1.13E-04 

Y91M 1.29E-10 O. 4.93E-12 O. O. o. 6.09E-09 

Y91 2.01 E-07 O. S.39E-09 O. O. O. B.24E-OS 

Y92 1.21 E-09 O. 3.S0E-11 O. O. O. 3.32E-OS 

Y93 3.B3E-09 O. 1.0SE-10 O. O. O. 1.17E-04 

ZR93 S.S3E-OB 2.73E-OB 1.49E-OB O. 9.6SE-OB O. 2.SBE-OS 

ZR9S 4.12E-OB 1.30E-OB B.94E-09 O. 1.91E-OB O. 3.00E-OS 

ZR97 2.37E-09 4.69E-10 2.16E-10 O. 7.11E-10 O. 1.27E-04 

N893M 3.44E-OB 1.13E-OB 2.B3E-09 O. 1.32E-OB O. 4.07E-06 

N89S B.22E-09 4.S6E-09 2.S1 E-09 O. 4.42E-09 O. 1.9SE-OS 

N897 7.37E-11 1.B3E-11 6.6BE-12 O. 2.14E-11 O. 4.37E-07 

M093 O. 1.06E-OS 2.90E-07 O. 3.04E-06 O. 1.29E-06 

M099 O. 6.03E-06 1.1SE-06 O. 1.3BE-OS O. 1.0BE-OS 

TC99M 3.32E-10 9.26E-10 1.20E-OB O. 1.3BE-OB S.14E-10 6.0BE-07 

TC99 1.79E-07 2.63E-07 7.17E-OB O. 3.34E-06 2.72E-OB 6.44E-06 

TC101 3.60E-10 S.12E-10 S.03E-09 O. 9.26E-09 3.12E-10 B.7SE-17 

RU103 2.SSE-07 O. 1.09E-07 O. B.99E-07 O. 2.13E-OS 

RU10S 2.1BE-OB O. B.46E-09 O. 2.7SE-07 O. 1.76E-OS 

RU106 3.92E-06 O. 4.94E-07 O. 7.S6E-06 O. 1.BBE-04 

RH10S 1.73E-07 1.2SE-07 B.20E-OB O. S.31 E-07 O. 1.S9E-OS 

PD107 O. 2.0BE-07 1.34E-OB O. 1.BBE-06 O. 9.66E-07 

PD109 O. 2.S1 E-07 S.70E-OB O. 1.4SE-06 O. 2.S3E-OS 

AG110M 2.0SE-07 1.94E-07 1.1BE-07 O. 3.70E-07 O. S.4SE-OS 

AG111 B.29E-OB 3.44E-OB 1.73E-OB O. 1.12E-07 O. 4.BOE-OS 

CD113M O. 4.S1 E-06 1.4SE-07 O. 4.99E-06 O. 2.71E-OS 

CD11SM O. 2.60E-06 B.39E-OB O. 2.0BE-06 O. B.23E-OS 

SN123 4.44E-OS 7.29E-07 1.0BE-06 S.B4E-07 O. O. 6.71 E-OS 

SN12S 1.19E-OS 2.37E-07 S.37E-07 1.B6E-07 O. O. 1.12E-04 

SN126 1.16E-04 2.16E-06 3.30E-06 S.69E-07 O. O. 2.SBE-OS 

S8124 3.B7E-06 7.13E-OB 1.S1 E-06 B.7BE-09 O. 3.3BE-06 7.BOE-OS 

S812S 2.4BE-06 2.71 E-OB S.BOE-07 2.37E-09 O. 2.1BE-06 1.93E-OS 

S8126 1.S9E-06 3.2SE-OB S.71 E-07 B.99E-09 O. 1.14E-06 9.41 E-OS 

S8127 3.63E-07 7.76E-09 1.37E-07 4.0BE-09 O. 2.47E-07 6.16E-OS 

TE12SM 3.B3E-06 1.3BE-06 S.12E-07 1.07E-06 O. O. 1.13E-OS 

TE127M 9.67E-06 3.43E-06 1.1SE-06 2.30E-06 3.92E-OS O. 2.41 E-OS 

TE127 1.SBE-07 S.60E-OB 3.40E-OB 1.09E-07 6.40E-07 O. 1.22E-OS 

TE129M 1.63E-OS 6.0SE-06 2.SBE-06 S.26E-06 6.B2E-OS O. 6.12E-OS 

TE129 4.4BE-OB 1.67E-OB 1.09E-OB 3.20E-OB 1.BBE-07 O. 2.4SE-07 

TE131M 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-OS O. 9.39E-OS 

TE131 2.79E-OB 1.1SE-OB B.72E-09 2.1SE-OB 1.22E-07 O. 2.29E-09 

TE132 3.49E-06 2.21 E-06 2.0BE-06 2.33E-06 2.12E-OS O. 7.00E-OS 

TE133M 6.44E-OB 3.66E-OB 3.S6E-OB S.11 E-OB 3.62E-07 O. 1.4BE-07 

TE134 4.47E-OB 2.B7E-OB 3.00E-OB 3.67E-OB 2.74E-07 O. 1.66E-09 

1129 4.66E-06 3.92E-06 6.S4E-06 4.77E-03 7.01 E-06 O. 4.S7E-07 

1130 1.03E-06 2.9BE-06 1.19E-06 2.43E-04 4.S9E-06 O. 2.29E-06 

1131 S.BSE-06 B.19E-06 4.40E-06 2.39E-03 1.41 E-OS O. 1.62E-06 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 11 of 16 

INGESTION DOSE COMMITMENT FACTORS 

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 2.79E-07 7.30E-07 2.62E-07 2.46E-OS 1.1SE-06 O. 3.1BE-07 

1133 2.01 E-06 3.41 E-06 1.04E-06 4.76E-04 S.9BE-06 O. 2.5BE-06 

1134 1.46E-07 3.B7E-07 1.39E-07 6.45E-06 6.10E-07 O. S.10E-09 

113S 6.10E-07 1.S7E-06 S.B2E-07 1.01 E-04 2.4BE-06 O. 1.74E-06 

XE131M O. O. O. O. O. O. O. 

XE133M O. O. O. O. O. O. O. 

XE133 O. O. O. O. O. O. O. 

XE13SM O. O. O. O. O. O. O. 

XE13S O. O. O. O. O. O. O. 

XE137 O. O. O. O. O. O. O. 

XE13B O. O. O. O. O. O. O. 

CS134M 2.94E-OB 6.09E-OB 3.13E-OB O. 3.39E-OB S.9SE-09 4.0SE-OB 

CS134 B.37E-OS 1.97E-04 9.14E-OS O. 6.26E-OS 2.39E-OS 2.4SE-06 

CS13S 2.7BE-OS 2.SSE-OS S.96E-06 O. 9.73E-06 3.S2E-06 4.46E-07 

CS136 B.S9E-06 3.3BE-OS 2.27E-OS O. 1.B4E-OS 2.90E-06 2.72E-06 

CS137 1.12E-04 1.49E-04 S.19E-OS O. S.07E-OS 1.97E-OS 2.12E-06 

CS13B 7.76E-OB 1.49E-07 7.4SE-OB O. 1.10E-07 1.2BE-OB 6.76E-11 

CS139 4.B7E-OB 7.17E-OB 2.63E-OB O. 5.79E-OB 6.34E-09 3.33E-23 

BA139 1.39E-07 9.7BE-11 4.0SE-09 O. 9.22E-11 6.74E-11 1.24E-06 

BA140 2.B4E-OS 3.4BE-OB 1.B3E-06 O. 1.1BE-OB 2.34E-OB 4.3BE-OS 

BA141 6.71 E-OB S.01 E-11 2.24E-09 O. 4.6SE-11 3.43E-11 1.43E-13 

BA142 2.99E-OB 2.99E-11 1.B4E-09 O. 2.S3E-11 1.99E-11 9.1BE-20 

LA140 3.4BE-09 1.71 E-09 4.SSE-10 O. O. O. 9.B2E-OS 

LA141 4.SSE-10 1.40E-10 2.31 E-11 O. O. O. 2.4BE-OS 

LA142 1.79E-10 7.9SE-11 1.9BE-11 O. O. O. 2.42E-06 

CE141 1.33E-OB B.BBE-09 1.02E-09 O. 4.1BE-09 O. 2.54E-OS 

CE143 2.3SE-09 1.71 E-06 1.91E-10 O. 7.67E-10 O. S.14E-OS 

CE144 6.96E-07 2.BBE-07 3.74E-OB O. 1.72E-07 O. 1.75E-04 

PR143 1.31 E-OB S.23E-09 6.S2E-10 O. 3.04E-09 O. 4.31 E-OS 

PR144 4.30E-11 1.76E-11 2.1BE-12 O. 1.01E-11 O. 4.74E-14 

ND147 9.3BE-09 1.02E-OB 6.11E-10 O. S.99E-09 O. 3.6BE-OS 

PM147 1.0SE-07 9.96E-09 4.06E-09 O. 1.90E-OB O. 9.47E-06 

PM14BM 4.14E-OB 1.05E-OB B.21 E-09 O. 1.S9E-OB O. 6.61 E-OS 

PM14B 1.02E-OB 1.66E-09 B.36E-10 O. 3.00E-09 O. 9.90E-OS 

PM149 2.17E-09 3.0SE-10 1.2SE-10 O. 5.B1 E-1 0 O. 4.49E-OS 

PM1S1 9.B7E-10 1.63E-10 B.2SE-11 O. 2.93E-10 O. 3.66E-OS 

SM1S1 B.73E-OB 1.6BE-OB 3.94E-09 O. 1.B4E-OB O. S.70E-06 

SM1S3 1.22E-09 1.01 E-09 7.43E-11 O. 3.30E-10 O. 2.BSE-OS 

EU1S2 2.4SE-07 S.90E-OB S.20E-OB O. 2.74E-07 O. 2.17E-OS 

EU1S4 7.91 E-07 1.02E-07 7.19E-OB O. 4.S6E-07 O. 5.39E-OS 

EU1SS 1.74E-07 1.6BE-OB 1.04E-OB O. 6.S7E-OB O. 9.63E-OS 

EU1S6 1.92E-OB 1.44E-OB 2.3SE-09 O. 9.69E-09 O. 7.36E-OS 

TB160 6.47E-OB O. B.07E-09 O. 2.S6E-OB O. 4.19E-OS 

H0166M 3.S7E-07 1.10E-07 7.96E-OB O. 1.61 E-07 O. O. 

W1B1 1.42E-OB 4.SBE-09 4.79E-10 O. O. O. 3.90E-07 

W1BS S.79E-07 1.91 E-07 2.02E-OB O. O. O. 1.6SE-OS 

W1B7 1.46E-07 1.19E-07 4.17E-OB O. O. O. 3.22E-OS 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 12 of 16 

INGESTION DOSE COMMITMENT FACTORS 

TEEN INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 1.81 E-02 S.44E-03 7.01 E-04 O. 1.72E-02 O. S.74E-OS 

BI210 6.S9E-07 4.S1 E-06 S.66E-08 O. S.48E-OS O. S.1SE-OS 

P0210 6.09E-04 1.07E-03 1.23E-04 O. 3.60E-03 O. 6.7SE-OS 

RN222 O. O. O. O. O. O. O. 

RA223 7.11 E-03 1.08E-OS 1.42E-03 O. 3.10E-04 O. 3.43E-04 

RA224 2.31 E-03 S.S2E-06 4.61E-04 O. 1.S8E-04 O. 3.71 E-04 

RA22S 9.37E-03 1.10E-OS 1.87E-03 O. 3.1SE-04 O. 3.27E-04 

RA226 3.22E-01 8.13E-06 2.39E-01 O. 2.32E-04 O. 3.S1 E-04 

RA228 1.37E-01 4.41E-06 1.S1 E-01 O. 1.26E-04 O. S.98E-OS 

AC22S 6.29E-06 8.S9E-06 4.22E-07 O. 9.8SE-07 O. 4.36E-04 

AC227 2.0SE-03 3.03E-04 1.22E-04 O. 8.81 E-OS O. 8.68E-OS 

TH227 1.96E-OS 3.S2E-07 S.6SE-07 O. 2.01 E-06 O. S.7SE-04 

TH228 6.80E-04 1.14E-OS 2.30E-OS o. 6.41 E-OS O. S.97E-04 

TH229 8.39E-03 1.26E-04 4.11 E-04 O. 6.10E-04 O. S.43E-04 

TH230 2.16E-03 1.23E-04 6.00E-OS O. S.99E-04 O. 6.38E-OS 

TH232 2.42E-03 1.0SE-04 1.63E-04 O. S.11 E-04 O. S.43E-OS 

TH234 1.14E-07 6.68E-09 3.31 E-09 O. 3.81 E-08 O. 1.21 E-04 

PA231 4.31 E-03 1.62E-04 1.68E-04 O. 9.10E-04 O. 7.60E-OS 

PA233 7.33E-09 1.41 E-09 1.26E-09 O. S.32E-09 O. 1.61 E-OS 

U232 S.89E-03 O. 4.21E-04 O. 6.38E-04 O. 7.19E-OS 

U233 1.24E-03 O. 7.S43-0S O. 2.90E-04 O. 6.6SE-OS 

U234 1.19E-03 O. 7.39E-OS O. 2.8SE-04 O. 6.S1 E-OS 

U23S 1.14E-03 O. 6.94E-OS O. 2.67E-04 O. 8.28E-OS 

U236 1.14E-03 O. 7.09E-OS O. 2.73E-04 O. 6.11 E-OS 

U237 7.89E-08 O. 2.10E-08 O. 3.24E-07 O. 2.09E-OS 

U238 1.09E-03 O. 6.49E-OS O. 2.S0E-04 O. S.83E-OS 

NP237 1.44E-03 1.2SE-04 S.8SE-OS O. 4.33E-04 O. 8.41E-OS 

NP238 1.9SE-08 S.22E-10 3.04E-10 O. 1.79E-09 O. 3.83E-OS 

NP239 1.76E-09 1.66E-10 9.22E-11 O. S.21 E-10 O. 2.67E-OS 

PU238 7.21 E-04 1.02E-04 1.82E-OS O. 7.80E-OS O. 7.73E-OS 

PU239 8.27E-04 1.12E-04 2.01 E-OS O. 8.S7E-OS O. 7.06E-OS 

PU240 8.26E-04 1.12E-04 2.01 E-OS O. 8.S6E-OS O. 7.19E-OS 

PU241 1.84E-OS 9.42E-07 3.69E-07 O. 1.71 E-06 O. 1.48E-06 

PU242 7.66E-04 1.08E-04 1.94E-OS O. 8.2SE-OS o. 6.92E-OS 

PU244 8.9SE-04 1.23E-04 2.22E-OS O. 9.4SE-OS O. 1.03E-04 

AM241 8.62E-04 3.29E-04 S.7SE-OS o. 4.31E-04 O. 7.87E-OS 

AM242M 8.70E-04 3.19E-04 S.80E-OS O. 4.30E-04 O. 9.90E-OS 

AM243 8.60E-04 3.17E-04 S.62E-OS O. 4.22E-04 O. 9.23E-OS 

CM242 2.94E-OS 2.97E-OS 1.9SE-06 O. 8.89E-06 O. 8.40E-OS 

CM243 6.91 E-04 2.86E-04 4.09E-OS O. 1.91 E-04 O. 8.28E-OS 

CM244 S.32E-04 2.49E-04 3.19E-OS O. 1.49E-04 O. 8.00E-OS 

CM24S 1.07E-03 3.33E-04 6.10E-OS O. 2.8SE-04 O. 7.46E-OS 

CM246 1.06E-03 3.32E-04 6.09E-OS O. 2.84E-04 O. 7.33E-OS 

CM247 1.03E-03 3.27E-04 6.00E-OS O. 2.80E-04 O. 9.63E-OS 

CM248 8.60E-03 2.69E-03 4.9SE-04 O. 2.31 E-03 O. 1.SSE-03 

CR2S2 3.S1 E-04 O. 8.37E-06 O. O. O. 3.0SE-04 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 13 of 16 

INGESTION DOSE COMMITMENT FACTORS 

ADUL T INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCI INGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

H3 O. 1.0SE-07 1.0SE-07 1.0SE-07 1.0SE-07 1.0SE-07 1.0SE-07 

BE10 3.1BE-06 4.91 E-07 7.94E-OB O. 3.71 E-07 O. 2.6BE-OS 

C14 2.B4E-06 S.6BE-07 S.6BE-07 S.6BE-07 S.6BE-07 S.6BE-07 S.6BE-07 

N13 B.36E-09 B.36E-09 B.36E-09 B.36E-09 B.36E-09 B.36E-09 B.36E-09 

F1B 6.24E-07 O. 6.92E-OB O. O. O. 1.BSE-OB 

NA22 1.74E-OS 1.74E-OS 1.74E-OS 1.74E-OS 1.74E-OS 1.74E-OS 1.74E-OS 

NA24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 

P32 1.93E-04 1.20E-OS 7.46E-06 O. O. O. 2.17E-OS 

AR39 O. O. O. O. O. O. O. 

AR41 O. O. O. O. O. O. O. 

CA41 1.B3E-OS O. 2.00E-OS O. O. O. 1.B4E-07 

SC46 S.S1 E-09 1.07E-OB 3.11 E-09 O. 9.99E-09 O. 5.21 E-OS 

CRS1 O. O. 2.66E-09 1.S9E-09 S.B6E-10 3.S3E-09 6.69E-07 

MNS4 O. 4.S7E-06 B.72E-07 O. 1.36E-06 O. 1.40E-OS 

MNS6 O. 1.1SE-07 2.04E-OB O. 1.46E-07 O. 3.67E-06 

FESS 2.7SE-06 1.90E-06 4.43E-07 O. O. 1.06E-06 1.09E-06 

FES9 4.34E-06 1.02E-OS 3.91 E-06 O. O. 2.BSE-06 3.40E-OS 

COS7 O. 1.7SE-07 2.91 E-07 O. O. O. 4.44E-06 

COSB O. 7.4SE-07 1.67E-06 O. O. O. 1.S1 E-OS 

C060 O. 2.14E-06 4.72E-06 O. O. O. 4.02E-OS 

NIS9 9.76E-06 3.3SE-06 1.63E-06 O. O. O. 6.90E-07 

NI63 1.30E-04 9.01 E-06 4.36E-06 O. O. O. 1.BBE-06 

NI6S S.2BE-07 6.B6E-OB 3.13E-OB O. O. O. 1.74E-06 

CU64 O. B.33E-OB 3.91 E-OB O. 2.10E-07 O. 7.10E-06 

ZN6S 4.B4E-06 1.S4E-OS 6.96E-06 O. 1.03E-OS O. 9.70E-06 

ZN69M 1.70E-07 4.0BE-07 3.73E-OB O. 2.47E-07 O. 2.49E-OS 

ZN69 1.03E-OB 1.97E-OB 1.37E-09 O. 1.2BE-OB O. 2.96E-09 

SE79 O. 2.63E-06 4.39E-07 O. 4.S5E-06 O. S.3BE-07 

BRB2 O. O. 2.26E-06 O. O. O. 2.S9E-06 

BRB3 O. O. 4.02E-OB O. O. O. S.79E-OB 

BRB4 O. O. S.21E-OB O. O. O. 4.09E-13 

BRBS O. O. 2.14E-09 O. O. O. O. 

KRB3M O. O. O. O. O. O. O. 

KRBSM O. O. O. O. O. O. O. 

KRBS O. O. O. O. O. O. O. 

KRB7 O. O. O. O. O. O. O. 

KRBB O. O. O. O. O. O. O. 

KRB9 O. O. O. O. O. O. O. 

RBB6 O. 2.11E-OS 9.B3E-06 O. O. O. 4.16E-06 

RBB7 O. 1.23E-OS 4.2BE-06 O. O. O. S.76E-07 

RBBB O. 6.0SE-OB 3.21 E-OB O. O. O. B.36E-19 

RBB9 O. 4.01 E-OB 2.B2E-OB O. O. O. 2.33E-21 

SRB9 3.OBE-04 O. B.B4E-06 O. O. O. 4.94E-OS 

SR90 7.SBE-03 O. 1.B6E-03 O. O. O. 2.19E-04 

SR91 S.67E-06 O. 2.29E-07 O. O. O. 2.70E-OS 

SR92 2.1SE-06 O. 9.30E-OB O. O. O. 4.26E-OS 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 14 of 16 

INGESTION DOSE COMMITMENT FACTORS 

ADUL T INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

Y90 9.62E-09 O. 2.SBE-10 O. O. O. 1.02E-04 

Y91M 9.09E-11 O. 3.S2E-12 O. O. O. 2.67E-10 

Y91 1.41 E-07 O. 3.77E-09 O. O. O. 7.76E-OS 

Y92 B.4SE-10 O. 2.47E-11 O. O. O. 1.4BE-OS 

Y93 2.6BE-09 O. 7.40E-11 O. O. O. B.SOE-OS 

ZR93 4.1BE-OB 2.34E-09 1.09E-09 O. B.B7E-09 O. 2.43E-06 

ZR9S 3.04E-OB 9.7SE-09 6.60E-09 O. 1.S3E-OB O. 3.09E-OS 

ZR97 1.6BE-09 3.39E-10 1.SSE-10 O. S.12E-10 O. 1.0SE-04 

NB93M 2.SSE-OB B.32E-09 2.0SE-09 O. 9.S7E-09 O. 3.B4E-06 

NB9S 6.22E-09 3.46E-09 1.B6E-09 O. 3.42E-09 O. 2.10E-OS 

NB97 S.22E-11 1.32E-11 4.B2E-12 O. 1.S4E-11 O. 4.B7E-OB 

M093 O. 7.S1 E-06 2.03E-07 O. 2.13E-06 O. 1.22E-06 

M099 O. 4.31 E-06 B.20E-07 O. 9.76E-06 O. 9.99E-06 

TC99M 2.47E-10 6.9BE-10 B.B9E-09 O. 1.06E-OB 3.42E-10 4.13E-07 

TC99 1.2SE-07 1.B6E-07 S.02E-OB O. 2.34E-06 1.SBE-OB 6.0BE-06 

TC101 2.S4E-10 3.66E-10 3.S9E-09 O. 6.S9E-09 1.B7E-10 1.10E-21 

RU103 1.BSE-07 O. 7.97E-OB O. 7.06E-07 O. 2.16E-OS 

RU10S 1.S4E-OB O. 6.0BE-09 O. 1.99E-07 O. 9.42E-06 

RU106 2.7SE-06 O. 3.4BE-07 O. S.31 E-06 O. 1.7BE-04 

RH10S 1.21 E-07 B.BSE-OB S.B3E-OB O. 3.76E-07 O. 1.41 E-OS 

PD107 O. 1.47E-07 9.40E-09 O. 1.32E-06 O. 9.11 E-07 

PD109 O. 1.77E-07 3.99E-OB O. 1.01 E-06 O. 1.96E-OS 

AG110M 1.60E-07 1.4BE-07 B.79E-OB O. 2.91 E-07 O. 6.04E-OS 

AG111 S.B1 E-OB 2.43E-OB 1.21 E-OB O. 7.B4E-OB O. 4.46E-OS 

CD113M O. 3.1BE-06 1.02E-07 O. 3.S0E-06 O. 2.S6E-OS 

CD11SM O. 1.B4E-06 S.B7E-OB O. 1.46E-06 O. 7.74E-OS 

SN123 3.11 E-OS S.1SE-07 7.S9E-07 4.3BE-07 O. O. 6.33E-OS 

SN12S B.33E-06 1.6BE-07 3.7BE-07 1.39E-07 O. O. 1.04E-04 

SN126 B.4SE-OS 1.67E-06 2.40E-06 4.92E-07 O. O. 2.43E-OS 

SB124 2.BOE-06 S.29E-OB 1.11 E-06 6.79E-09 O. 2.1BE-06 7.9SE-OS 

SB12S 1.79E-06 2.00E-OB 4.26E-07 1.B2E-09 O. 1.3BE-06 1.97E-OS 

SB126 1.1SE-06 2.34E-OB 4.1SE-07 7.04E-09 O. 7.0SE-07 9.40E-OS 

SB127 2.SBE-07 S.6SE-09 9.90E-OB 3.10E-09 O. 1.S3E-07 S.90E-OS 

TE12SM 2.6BE-06 9.71 E-07 3.S9E-07 B.06E-07 1.09E-OS O. 1.07E-OS 

TE12SM 6.77E-06 2.42E-06 B.2SE-07 1.73E-06 2.7SE-OS O. 2.27E-OS 

TE127 1.10E-07 3.9SE-OB 2.3BE-OB B.1SE-OB 4.4BE-07 O. B.6BE-06 

TE129M 1.1SE-OS 4.29E-06 1.B2E-06 3.9SE-06 4.BOE-OS O. S.79E-OS 

TE129 3.14E-OB 1.1BE-OB 7.6SE-09 2.41 E-OB 1.32E-07 O. 2.37E-OB 

TE131M 1.73E-06 B.46E-07 7.0SE-07 1.34E-06 B.S7E-06 O. B.40E-OS 

TE131 1.97E-OB B.23E-09 6.22E-09 1.62E-OB B.63E-OB O. 2.79E-09 

TE132 2.S2E-06 1.63E-06 1.S3E-06 1.BOE-06 1.S7E-OS O. 7.71 E-OS 

TE133M 4.62E-OB 2.70E-OB 2.60E-OB 3.91 E-OB 2.67E-07 O. 6.64E-OB 

TE134 3.24E-OB 2.12E-OB 1.30E-OB 2.B3E-OB 2.0SE-07 O. 3.S9E-11 

1129 3.27E-06 2.B1 E-06 9.21 E-06 7.23E-03 6.04E-06 O. 4.44E-07 

1130 7.S6E-07 2.23E-06 B.BOE-07 1.B9E-04 3.4BE-06 O. 1.92E-06 

1131 4.16E-06 S.9SE-06 3.41 E-06 1.9SE-03 1.02E-OS O. 1.S7E-06 
Proc No ODCM 

Attachment 8 

Revision 26 

Page 15 of 16 

INGESTION DOSE COMMITMENT FACTORS 

ADUL T INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

1132 2.03E-07 S.43E-07 1.90E-07 1.90E-OS B.6SE-07 O. 1.02E-07 

1133 1.42E-06 2.47E-06 7.S3E-07 3.63E-04 4.31 E-06 O. 2.22E-06 

1134 1.06E-07 2.BBE-07 1.03E-07 4.99E-06 4.SBE-07 O. 2.S1 E-1 0 

113S 4.43E-07 1.16E-06 4.2BE-07 7.6SE-OS 1.B6E-06 O. 1.31E-06 

XE131M O. O. O. O. O. O. O. 

XE133M O. O. O. O. O. O. O. 

XE133 O. O. O. O. O. O. O. 

XE13SM O. O. O. O. O. O. O. 

XE13S O. O. O. O. O. O. O. 

XE137 O. O. O. O. O. O. O. 

XE13B O. O. O. O. O. O. O. 

CS134M 2.13E-OB 4.4BE-OB 2.29E-OB O. 2.43E-OB 3.B3E-09 1.SBE-OB 

CS134 6.22E-OS 1.4BE-04 1.21 E-04 O. 4.79E-OS 1.S9E-OS 2.S9E-06 

CS13S 1.9SE-OS 1.BOE-OS 7.99E-06 O. 6.B1 E-06 2.04E-06 4.21 E-07 

CS136 6.S1E-06 2.S7E-OS 1.BSE-OS O. 1.43E-OS 1.96E-06 2.92E-06 

CS137 7.97E-OS 1.09E-04 7.14E-OS O. 3.70E-OS 1.23E-OS 2.11 E-06 

CS13B 6.S2E-OB 1.09E-07 S.40E-OB O. B.01 E-OB 7.91 E-09 4.6SE-13 

CS139 3.41 E-OB S.OBE-OB 1.BSE-OB O. 4.07E-OB 3.70E-09 1.10E-30 

BA139 9.70E-OB 6.91 E-11 2.B4E-09 O. 6.46E-11 3.92E-11 1.72E-07 

BA140 2.03E-OS 2.SSE-OB 1.33E-06 O. B.67E-09 1.46E-OB 4.1BE-OS 

BA141 4.71 E-OB 3.S6E-11 1.S9E-09 O. 3.31 E-11 2.02E-11 2.22E-17 

BA142 2.13E-OB 2.19E-11 1.34E-09 O. 1.BSE-11 1.24E-11 3.00E-26 

LA140 2.S0E-09 1.26E-09 3.33E-10 O. O. O. 9.2SE-OS 

LA141 3.19E-10 9.90E-11 1.62E-11 O. O. O. 1.1BE-OS 

LA142 1.2BE-10 S.B2E-11 1.4SE-11 O. O. O. 4.2SE-07 

CE141 9.36E-09 6.33E-09 7.1BE-10 O. 2.94E-09 O. 2.42E-OS 

CE143 1.6SE-09 1.22E-06 1.3SE-10 O. S.37E-10 O. 4.S6E-OS 

CE144 4.BBE-07 2.04E-07 2.62E-OB O. 1.21 E-07 O. 1.6SE-04 

PR143 9.20E-09 3.69E-09 4.S6E-10 O. 2.13E-09 O. 4.03E-OS 

PR144 3.01 E-11 1.2SE-11 1.S3E-12 O. 7.0SE-12 O. 4.33E-1B 

ND147 6.29E-09 7.27E-09 4.3SE-10 O. 4.2SE-09 O. 3.49E-OS 

PM147 7.S4E-OB 7.09E-09 2.B7E-09 O. 1.34E-OB O. B.93E-06 

PM14BM 3.07E-OB 7.9SE-09 6.0BE-09 O. 1.20E-OB O. 6.74E-OS 

PM14B 7.17E-09 1.19E-09 S.99E-10 O. 2.2SE-09 O. 9.3SE-OS 

PM149 1.S2E-09 2.1SE-10 B.7BE-11 O. 4.06E-10 O. 4.03E-OS 

PM1S1 6.97E-10 1.17E-10 S.91 E-11 O. 2.09E-10 O. 3.22E-OS 

SM1S1 6.90E-OB 1.19E-OB 2.BSE-09 O. 1.33E-OB O. S.2SE-06 

SM1S3 B.S7E-10 7.1SE-10 S.22E-11 O. 2.31 E-10 O. 2.SSE-OS 

EU1S2 1.9SE-07 4.44E-OB 3.90E-OB O. 2.7SE-07 O. 2.S6E-OS 

EU1S4 6.1SE-07 7.S6E-OB S.3BE-OB O. 3.62E-07 O. S.4BE-OS 

EU1SS B.60E-OB 1.22E-OB 7.B7E-09 O. S.63E-OB O. 9.60E-06 

EU1S6 1.37E-OB 1.06E-OB 1.71 E-09 O. 7.0BE-09 O. 7.26E-OS 

TB160 4.70E-OB O. S.B6E-09 O. 1.94E-OB O. 4.33E-OS 

H0166M 2.70E-07 B.43E-OB 6.40E-OB O. 1.26E-07 O. O. 

W1B1 9.91 E-09 3.23E-09 3.46E-10 O. O. O. 3.6BE-07 

W1BS 4.0SE-07 1.3SE-07 1.42E-OB O. O. O. 1.S6E-OS 

W1B7 1.03E-07 B.61 E-OB 3.01 E-OB O. O. O. .2.B2E-OS 
Proc No ODeM 

Attachment 8 

Revision 26 

Page 16 of 16 

INGESTION DOSE COMMITMENT FACTORS 

ADUL T INGESTION DOSE COMMITMENT FACTORS (MREM/50Y PER PCIINGESTED IN FIRST YR) 

ISOTOPE BONE LIVER TOTAL BODY THYROID KIDNEY LUNG GI-LLI 

PB210 1.S3E-02 4.37E-03 S.44E-04 O. 1.23E-02 O. S.42E-OS 

BI210 4.61E-07 3.1BE-06 3.96E-OB O. 3.B3E-OS O. 4.7SE-OS 

P0210 3.S6E-04 7.S6E-04 B.S9E-OS O. 2.S2E-03 O. 6.36E-OS 

RN222 O. O. O. O. O. O. O. 

RA223 4.97E-03 7.6SE-06 9.94E-04 O. 2.17E-04 O. 3.21 E-04 

RA224 1.61 E-03 3.90E-06 3.23E-04 O. 1.10E-04 O. 3.40E-04 

RA22S 6.S6E-03 7.7BE-06 1.31 E-03 O. 2.21 E-04 O. 3.06E-04 

RA226 3.02E-01 S.74E-06 2.20E-01 O. 1.63E-04 O. 3.32E-04 

RA22B 1.12E-01 3.12E-06 1.21 E-01 O. B.B3E-OS O. S.64E-OS 

AC22S 4.40E-06 6.06E-06 2.96E-07 O. 6.90E-07 O. 4.07E-04 

AC227 1.B7E-03 2.4BE-04 1.11 E-04 O. B.OOE-OS O. B.19E-OS 

TH227 1.37E-OS 2.4BE-07 3.9SE-07 O. 1.41 E-06 O. S.40E-04 

TH22B 4.96E-04 B.40E-06 1.6BE-OS O. 4.67E-OS O. S.63E-04 

TH229 7.9BE-03 1.19E-04 3.91 E-04 O. S.7SE-04 O. S.12E-04 

TH230 2.06E-03 1.17E-04 S.70E-OS O. S.6SE-04 O. 6.02E-OS 

TH232 2.30E-03 1.00E-04 1.S0E-04 O. 4.B2E-04 O. S.12E-OS 

TH234 B.01 E-OB 4.71 E-09 2.31 E-09 O. 2.67E-OB O. 1.13E-04 

PA231 4.10E-03 1.S4E-04 1.S9E-04 O. B.64E-04 O. 7.17E-OS 

PA233 S.26E-09 1.06E-09 9.12E-10 O. 3.99E-09 O. 1.64E-OS 

U232 4.13E-03 O. 2.9SE-04 O. 4.47E-04 O. 6.7BE-OS 

U233 B.71E-04 O. S.2BE-OS O. 2.03E-04 O. 6.27E-OS 

U234 B.36E-04 O. S.17E-OS O. 1.99E-04 O. 6.14E-OS 

U23S B.01 E-04 O. 4.B6E-OS O. 1.B7E-04 O. 7.B1 E-OS 

U236 B.01 E-04 O. 4.96E-OS O. 1.91 E-04 O. S.76E-OS 

U237 S.S2E-B O. 1.47E-OB O. 2.27E-07 O. 1.94E-OS 

U23B 7.67E-04 O. 4.S4E-OS O. 1.7SE-04 O. S.SOE-OS 

NP237 1.37E-03 1.19E-04 S.S4E-OS O. 4.12E-04 O. 7.94E-OS 

NP23B 1.37E-OB 3.69E-10 2.13E-10 O. 1.2SE-09 O. 3.43E-OS 

NP239 1.19E-09 1.17E-10 6.4SE-11 O. 3.6SE-10 O. 2.40E-OS 

PU23B 6.BOE-04 9.SBE-OS 1.71 E-OS O. 7.32E-OS O. 7.30E-OS 

PU239 7.B7E-04 1.06E-04 1.91 E-OS O. B.11 E-OS O. 6.66E-OS 

PU240 7.BSE-04 1.06E-04 1.91 E-OS O. B.10E-OS O. 6.7BE-OS 

PU241 1.6SE-OS B.44E-07 3.32E-07 O. 1.S3E-06 O. 1.40E-06 

PU242 7.29E-04 1.02E-04 1.B4E-OS O. 7.B1 E-OS O. 6.S3E-OS 

PU244 B.S2E-04 1.17E-04 2.11 E-OS O. B.9SE-OS O. 9.73E-OS 

AM241 B.19E-04 2.BBE-04 S.41 E-OS O. 4.07E-04 O. 7.42E-OS 

AM242M B.24E-04 2.7BE-04 S.43E-OS O. 4.0SE-04 O. 9.34E-OS 

AM243 B.1BE-04 2.7BE-04 S.30E-OS O. 3.99E-04 O. B.70E-OS 

CM242 2.06E-OS 2.10E-OS 1.37E-06 O. 6.22E-06 O. 7.92E-OS 

CM243 6.39E-04 2.41 E-04 3.7SE-OS O. 1.7SE-04 O. 7.B1 E-OS 

CM244 4.B3E-04 2.07E-04 2.B7E-OS O. 1.34E-04 O. 7.SSE-OS 

CM24S 1.02E-03 2.B7E-04 S.76E-OS O. 2.69E-04 O. 7.04E-OS 

CM246 1.01 E-03 2.B7E-04 S.7SE-OS O. 2.6BE-04 O. 6.91 E-OS 

CM247 9.B4E-04 2.B3E-04 S.67E-OS O. 2.64E-04 O. 9.09E-OS 

CM24B B.1BE-03 2.33E-03 4.67E-04 O. 2.1BE-03 O. 1.47E-03 

CF2S2 2.64E-04 O. 6.29E-06 O. O. O. 2.BBE-04 
PALISADES 10 YEAR X1Q - D/Q DATA 

USNRC COHPUTER - XOQDOQ, VERSION 2. RUN DATE: 28FEBl 

FALISADES XOQDOQ82 USING 01/01/2004 -

GROUND LEVEL RELEASE - OE' CoNTAINblENT BUILDING 

RELEASE 

ID 

A A 

A 

A 

A A 

A 

A 

A 

A 

A 

A 

A 

A 

A 

A 

A A 

A 

A A 

A 

A 

TYPE OF 

LOCA'l'ION 

SITE BOUNDARY SITE BOUNDAR! 

SITE BOUNDARY SITE BOlJNDARY SITE BOUNDARY 

SITE BOUNDARY SITE BOUNDARY SITE BOUNDARY SITE BOUNDARY 

RESIDENCE 

RESIDENCE 

RESIDENCE 

RESIDENCE 

RESIDENCE RESIDENCE 

RESIDENCE RESIDENCE RESIDENCE 

GARDEN GARDEN GARDEN 

GARDEN 

GARDEN 

GARDEN 

GARDEN 

GARDEN GOAT 

GOAT 

BEEr' CATTLE 

DIRECTION FRON SI'rE 

NNE 

NE 

ENE 

E 

ESE 

BE 

SSE 

S 

SSW 

NNE 

NE 

ENE ESE 

SSE 

s 

SSW 

NNE 

NE 

ENE 

ESE 

SE 

SSi'1 

ENE 

E 

SE 

DISTANCE 

.bIILES 1 ( HE'l'ERS ) 

0.50 

0.65 

0.87 0.82 

O. 

o. 

0 .. 

o. a. 8 

1. 68 

1.1'1 

1.19 

l. 

0.99 0.90 

O. 

0,77 

O. 

1. 75 

1. 

2. 2.68 

1. 3 

1. 9 

O. 

.82 

2.62 

.25 

,27 

805. 

1046. 

1320 .. 

1014. 

676. 

:e704. 

18 

1915. 

88. 

1593. 

1448. 

1239. 

89. 

1688. 

16. 

4313 •. 

L945. 

:e398. 

1 10. i757. 

4216 

6840. 

6872 .. 

/2013 blET DATA 

X/Q 

SEC/CCB.NETER 

UNDEPlETED 

1.23E-06 

5.B8B-O? 

1.39B-06 

2.28E-06 

1. 

1.16E-07 

1.31E-06 

4. 

X/Q 

SEC/CUB. HETER) 

2.260 DAY DECAY 

UUDEPLETED 

.57E-06 

.23E-06 

5.8GE-07 

6.9GE-07 8.31E-O 

.3SE-06 

2.28E-06 

.95E-06 .2SE-06 

.S7E-07 

5.30E-07 

.o7E-07 .41E-07 

.58E-O 

.98E-07 .04E-06 

.84E-O 

21E-06 

2 43E-07 

3.0IE-07 

.20E-07 

.22E-O'] 

3.7SE-0 

.31E-06 

,IBE-08 

1 14E-07 

OSE-08 

.8SE-08 

SEC ICUB. Z-1ETER l 

.000 DA¥ DECAY 

DEPLETED 

.44E-06 

.1 

5.19E-G7 

.1 

.42E-07 

1. 

.2. 09E-06 

1.SOE-06 

3.19E-07 

., 

.. , 

.06E-08 

PER 

7

8

4

6

I. 

2

1

3

2

L 

4

6

S

4

1

6

6

1

2

1

1

6

3

4
ATTACHMENT 2 

BIG ROCK POINT INDEPENDENT SPENT FUEL STORAGE INSTALLATION 

2014 RADIOACTIVE EFFLUENT RELEASE REPORT 

This report provides information relating to radioactive effluent releases and solid 

radioactive waste disposal at Big Rock Point (BRP) for the year 2014. The report 

format is detailed in the BRP Offsite Dose Calculation Manual (ODCM). Effluent 

releases from BRP are controlled by the Defueled Technical Specifications and the 

ODCM requirements. The ODCM was not revised in 2014. 

2014 Operating History 

On January 8,2007, the Nuclear Regulatory Commission (NRC) approved release of 

the former BRP Nuclear Plant property for unrestricted use in accordance with the BRP 

License Termination Plan 1. On April 11 ,2007, the license for BRP, DPR-06, was 

transferred to Entergy Nuclear Operations, Inc. 

During 2014, normal Independent Spent Fuel Storage Installation (lSFSI) operations 

continued. There were no operational activities that generated any solid radioactive 

waste. 

Liquid and gaseous effluent monitoring is no longer conducted as the former BRP 

nuclear plant property has been released from the license. Short-lived radionuclides, 

including iodines and noble gas, are neither expected nor reported. 

1. Supplemental Information 

A. Batch Releases 

There were no batch releases of gaseous or liquid effluents during 

2014. All batch releases of radioactive liquids as described in the 

ODCM ceased in 2004. 

B. Abnormal Releases 

There were no abnormal releases from BRP during 2014. 

C. Radioactive Effluent Monitoring Instrumentation 

BRP ODCM currently specifies required actions when less than the 

minimum number of radioactive effluent monitoring instrument 

channels are operable. The ODCM also specifies these actions be 

taken when installed effluent monitoring systems are removed from 

service for decommissioning. 

All plant-installed liquid and gaseous radioactive effluent monitoring 

instrument channels have been permanently removed and dismantled. 

1 Letter from the USNRC dated January 8,2007, "Release of Land from Part 50 License for Unrestricted Use" 

Page 1 of 8 
2. Gaseous Effluents 

Although there were no gaseous effluents released during 2014, Table 2 

provides a summary of all gaseous radioactive effluent monitoring conducted 

during the reporting period as required by the aDCM. 

3. Liquid Effluents 

There were no liquid effluent batch releases during 2014. Table 3 lists and 

summarizes liquid effluent releases in accordance with the aDCM. 

4. Solid Waste 

There was no solid radioactive waste generated or shipped during 2014. 

5. Summary of Radiological Impact on Man 

The aDCM specifies that the annual effluent release report provide potential dose 

calculations based on measured effluent to liquid and gaseous pathways, if 

estimates of dose exceed one millirem to an organ or total body of any individual or 

more than one person-rem to the population within 50 miles. During 2014, there 

were no releases. Therefore, no calculations were required. 

6. affsite Dose Calculation Manual 

The aDCM describes the radiological release requirements for the BRP site. 

There were no revisions to the aDCM in 2014. 

7. Process Control Program (PCP) 

The Process Control Program (PCP) describes solid waste processing and 

disposal methods utilized at the BRP site. The PCP was not revised during 2014. 

Page 2 of 8 
A. GASEOUS 

B. LIQUID 

Number of Releases 

Total Release Time 

Maximum Release Time 

Average Release Time 

Minimum Release Time 

TABLE 1 

Big Rock Point 

Batch Releases 

January 1,2014 to December 31,2014 

Units 1ST QTR 2NDQTR 3RD QTR 

N/A N/A N/A 

Minutes N/A N/A N/A 

Minutes N/A N/A N/A 

Minutes N/A N/A N/A 

Minutes N/A N/A N/A 

Page 3 of 8 

4TH QTR 

N/A 

N/A 

N/A 

N/A 

N/A 
TABLE 2 

Big Rock Point 

Gaseous Effluent Releases 

January 1, 2014 to December 31, 2014 

1ST 2ND 

A. FISSION AND ACTIVATION GASES Units OTR OTR 

1. Total release Ci N/A N/A 

2. Average release rate for period !-lCi/sec N/A N/A 

3. Percent of annual avg EC % N/A N/A 

B IODINES 

1. Total iodine Ci N/A N/A 

2. Average release rate for period !-lCi/sec N/A N/A 

3. Percent of annual avg EC % N/A N/A 

C PARTICULATES 

1. Particulates with half-life >8 day Ci N/A N/A 

2. Average release rate for period I-lCi/sec N/A N/A 

3. Percent of annual avg EC % N/A N/A 

4. Gross alpha radioactivity Ci N/A N/A 

D TRITIUM 

1. Total Release Ci N/A N/A 

2. Average release rate for period !-lCi/sec N/A N/A 

3. Percent of annual avg EC % N/A N/A 

E WHOLE BODY DOSE 

1. Beta Air dose at Site Boundary due to Noble Gases 

(ODCM Section 1, 1.3.2 a (1) (2)) mrads N/A N/A 

2. Percent limit % N/A N/A 

3. Gamma Air dose at Site Boundary due to Noble 

Gas (ODCM Section 1, 1.3.2 a (1) (2)) mrads N/A N/A 

4. Percent limit % N/A N/A 

F. ORGAN DOSE (ODCM Section 1, 1.3.2b (1) (2)) 

1. Maximum organ dose to pubic based on Critical 

Receptors (child bone) mrem N/A N/A 

2. Percent of limit (7.5 mrem/quarter) % N/A N/A 

Page 4 of 8 

3RD 4TH Est Total 

OTR OTR Error % 

N/A N/A 

N/A N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 
1. FISSION GASES 

Krypton-85m 

Krypton-8? 

Krypton-88 

Xenon-133 

Xenon-133m 

Xenon-135 

Xenon-135m 

Xenon-138 

Total for Period 

2. IODINES 

lodine-131 

lodine-132 

lodine-133 

lodine-134 

lodine-135 

Total for Period 

TABLE 2 

Big Rock Point 

Gaseous Effluent Releases 

January 1,2014 to December 31,2014 

Units 1ST aTR 2ND aTR 3RD aTR 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Page 5 of 8 

4TH aTR 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 
3. PARTICULATES* 

Chromium-51 

Manganese-54 

Cobalt-58 

Iron-59 

Cobalt-60 

Zinc-65 

Silver-110m 

Cesium-134 

Cesium-137 

Barium-140 

Europium-152 

Strontium-89 

Strontium-90 

Net unidentified beta 

Total 

TABLE 2 

Big Rock Point 

Gaseous Effluent Releases 

January 1, 2014 to December 31, 2014 

Units 1ST aTR 2ND aTR 3RD aTR 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

Ci N/A N/A N/A 

* PartIculates wIth half-lIfe >8 days 

Page 6 of 8 

4TH aTR 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 

N/A 
TABLE 3 

Big Rock Point 

Liquid Effluent Releases 

January 1,2014 to December 31,2014 

A. FISSION AND ACTIVATION PRODUCTS Units 1ST OTR 2ND OTR 

1. Total release (not including tritium, gases, alpha) Ci N/A N/A 

2. Average diluted concentration during period ~Ci/ml N/A N/A 

3. Percent of EC % N/A N/A 

B. TRITIUM 

1. Total release Ci N/A N/A 

2. Average diluted concentration during period j..JCi/ml N/A N/A 

3. Percent of EC % N/A N/A 

C DISSOLVED AND ENTRAINED GASES 

1. Total release Ci N/A N/A 

2. Average diluted concentration during period ~Ci/ml N/A N/A 

3. Percent of EC % N/A N/A 

D. GROSS ALPHA RADIOACTIVITY 

E. VOLUME OF WASTE RELEASED 

(Prior to dilution) Liters N/A N/A 

F. VOLUME OF DILUTION WATER USED DURING 

PERIOD Liters N/A N/A 

G. MAXIMUM DOSE COMMITMENT WHOLEBODY mrem N/A N/A 

Percent of ODCM Section 1,2.3.2 a (1.5 mrem) % N/A N/A 

H. MAXIMUM DOSE COMMITMENT - ORGAN Mrem N/A N/A 

Percent of ODCM Section 1, 2.3.2 b (3.0 mrem) % N/A N/A 

Page 7 of 8 

Est Total 

3RD OTR 4TH OTR Error % 

N/A N/A 

N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 

N/A N/A 
1. NUCLIDES 

RELEASED Units 

Chromium-51 Ci 

Manganese 54 Ci 

Cobalt-58 Ci 

Iron-59 Ci 

Cobalt-60 Ci 

Zinc-65 Ci 

Strontium-89 Ci 

Strontium-90 Ci 

Molybdenum-99 Ci 

Silver-110m Ci 

lodine-131 Ci 

Cesium-134 Ci 

Cesium-137 Ci 

Antimony-125 Ci 

Tin-113 Ci 

Net Unidentified Beta Ci 

Fission & Activation 

Product Total Ci 

Xenon-133 Ci 

Tritium Ci 

Grand Total Ci 

TABLE 3 

Big Rock Point 

Liquid Effluent Releases 

January 1,2014 to December 31,2014 

1ST aTR 2ND aTR 3RD aTR 

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

-- -- --

Page 8 of 8 

4TH aTR 

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--